var title_f31_25_32144="Healing toddlers fracture";
var content_f31_25_32144=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F51722&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F51722&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 540px\">",
"   <div class=\"ttl\">",
"    Healing toddler's fracture in an 18-month-old child",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 520px; height: 417px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 18-month-old child had a limp but no fever or signs of infection. The radiograph shows a left distal tibial toddler's fracture with mild associated sclerosis and periosteal reaction (black arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jennifer Chapman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32144=[""].join("\n");
var outline_f31_25_32144=null;
var title_f31_25_32145="Perilunate dislocation";
var content_f31_25_32145=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F77044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F77044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Perilunate dislocation AP and lateral views",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 387px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The lateral view in particular provides a clear view of this dislocation. The normal juxtaposition of the proximal surface of the capitate and the concave distal surface of the lunate (black arrow) is lost. The lunate lies anteriorly and distally displaced&nbsp;relative to the&nbsp;dorsally and proximally displaced capitate bone (white arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Patrice Eiff, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32145=[""].join("\n");
var outline_f31_25_32145=null;
var title_f31_25_32146="Zinc chloride: Drug information";
var content_f31_25_32146=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Zinc chloride: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/0/33795?source=see_link\">",
"    see \"Zinc chloride: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?28/50/29475?source=see_link\">",
"    see \"Zinc chloride: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F235727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Trace Element",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F235722\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nutritional supplement:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Stable with fluid loss from small bowel:",
"     </i>",
"     12.2 mg zinc/L TPN or 17.1 mg zinc/kg (added to 1000 mL I.V. fluids) of stool or ileostomy output",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Metabolically stable:",
"     </i>",
"     2.5-4 mg/day, add 2 mg/day for acute catabolic states",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Clinical response may not occur for up to 6-8 weeks.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F235724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?28/50/29475?source=see_link\">",
"      see \"Zinc chloride: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Nutritional supplement:",
"     </b>",
"     I.V.: Added to I.V. solutions:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Premature Infants &lt;1500 g, up to 3 kg: 300 mcg/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants (full term) and Children &le;5 years: 100 mcg/kg/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F235723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F235718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 1 mg/mL (10 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F235709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F235719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cofactor for replacement therapy to different enzymes; helps maintain normal growth rates, normal skin hydration, and senses of taste and smell",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F235726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     &lt;1% (Limited to important or life-threatening): Hypotension, indigestion, jaundice, leukopenia, nausea, neutropenia, pulmonary edema, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F13880761\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:6em;\">",
"     &bull; Copper: I.V. administration of zinc without copper may cause a decrease in copper serum concentrations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Aluminum: Solutions may contain aluminum; toxic concentrations may occur following prolonged administration in premature neonates or patients with renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6223728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: Zinc Salts may decrease the serum concentration of Eltrombopag.  Management: Separate administration of eltrombopag and any polyvalent cation (e.g., zinc-containing products) by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Zinc Salts may decrease the serum concentration of Trientine. Trientine may decrease the serum concentration of Zinc Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F235715\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13880759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Zinc crosses the placenta and can be measured in the cord blood and placenta. Fetal concentrations are regulated by the placenta (de Moraes, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13880760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Zinc is found in breast milk; concentrations decrease over the first 6 months of lactation. Concentrations are generally not affected by dietary supplementation (IOM, 2000)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5549683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Tracefusin (MX)",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      de Moraes ML, de Faria Barbosa R, Santo RE, et al, \"Maternal-Fetal Distribution of Calcium, Iron, Copper, and Zinc in Pregnant Teenagers and Adults,\"",
"      <i>",
"       Biol Trace Elem Res",
"      </i>",
"      , 2011, 139(2):126-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/25/32146/abstract-text/20195918/pubmed\" id=\"20195918\" target=\"_blank\">",
"        20195918",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine),",
"      <i>",
"       Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc",
"      </i>",
"      , Washington, DC: National Academy Press, 2000.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10325 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-FA0D210239-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32146=[""].join("\n");
var outline_f31_25_32146=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235727\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235722\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235724\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235723\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235718\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235709\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235719\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235726\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13880761\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300236\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6223728\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235715\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13880759\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13880760\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5549683\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10325\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10325|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/0/33795?source=related_link\">",
"      Zinc chloride: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?28/50/29475?source=related_link\">",
"      Zinc chloride: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_25_32147="Construction of an ostomy cruciate incision fascia";
var content_f31_25_32147=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F68865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F68865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Construction of an ostomy - cruciate incision anterior rectus fascia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 447px; height: 585px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts the full thickness excision of skin in preparation for the ostomy (colostomy or ileostomy). A cruciate incision is made through the anterior rectus fascia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32147=[""].join("\n");
var outline_f31_25_32147=null;
var title_f31_25_32148="Lupus pernio - nose";
var content_f31_25_32148=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F63312&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F63312&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lupus pernio in sarcoidosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous to violaceous plaque is present on the nose of this patient with cutaneous sarcoidosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32148=[""].join("\n");
var outline_f31_25_32148=null;
var title_f31_25_32149="Male and female pattern hair loss PI";
var content_f31_25_32149=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F74652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F74652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 478px\">",
"   <div class=\"ttl\">",
"    Hair loss in men and women",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 458px; height: 691px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Men and women have different patterns of hair loss.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32149=[""].join("\n");
var outline_f31_25_32149=null;
var title_f31_25_32150="Lidocaine and prilocaine: Drug information";
var content_f31_25_32150=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lidocaine and prilocaine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/17/4373?source=see_link\">",
"    see \"Lidocaine and prilocaine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/43/34486?source=see_link\">",
"    see \"Lidocaine and prilocaine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F188755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      EMLA&reg;;",
"     </li>",
"     <li>",
"      Oraqix&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F188756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      EMLA&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F188773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Local Anesthetic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F188758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Anesthetic:",
"     </b>",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cream: Apply a thick layer to intact skin and cover with an occlusive dressing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Transdermal patch (CAN; not available in U.S.): Apply patch or patches to intact skin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Dermal analgesia can be expected to increase for up to 3 hours under occlusive dressing and persist for 1-2 hours after removal of the cream",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Minor dermal procedures (eg, I.V. cannulation or venipuncture):",
"     </b>",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cream: Apply 2.5 g of cream (",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     of the 5 g tube) over 20-25 cm",
"     <sup>",
"      2",
"     </sup>",
"     of skin surface area, or 1 anesthetic disc (1 g over 10 cm",
"     <sup>",
"      2",
"     </sup>",
"     ) for at least 1 hour.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Transdermal patch: (Canadian labeling; not available in U.S.): Apply 1 or more patches to skin surface area &lt;10 cm",
"     <sup>",
"      2",
"     </sup>",
"     for at least 1 hour (maximum application time: 5 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Major dermal procedures (eg, more painful dermatological procedures involving a larger skin area such as split thickness skin graft harvesting):",
"     </b>",
"     Topical: Apply 2 g of cream per 10 cm",
"     <sup>",
"      2",
"     </sup>",
"     of skin and allow to remain in contact with the skin for at least 2 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Adult male genital skin (eg, pretreatment prior to local anesthetic infiltration):",
"     </i>",
"     Apply a thick layer of cream (1 g/10 cm",
"     <sup>",
"      2",
"     </sup>",
"     ) to the skin surface for 15 minutes. Local anesthetic infiltration should be performed immediately after removal of cream.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Adult female genital mucous membranes:",
"     </i>",
"     Minor procedures (eg, removal of condylomata acuminata, pretreatment for local anesthetic infiltration): Apply 5-10 g (thick layer) of cream for 5-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Periodontal gel (Oraqix&reg;):",
"     </b>",
"     Apply on gingival margin around selected teeth using the blunt-tipped applicator included in package. Wait 30 seconds, then fill the periodontal pockets using the blunt-tipped applicator until gel becomes visible at the gingival margin. Wait another 30 seconds before starting treatment. May reapply; maximum recommended dose: One treatment session: 5 cartridges (8.5 g)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F188767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/43/34486?source=see_link\">",
"      see \"Lidocaine and prilocaine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Although the incidence of systemic adverse effects is very low, caution should be exercised, particularly when applying over large areas and leaving on for &gt;2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Local anesthetic (procedures):",
"     </b>",
"     Topical (to intact skin):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream: Should",
"     <b>",
"      not",
"     </b>",
"     be used in neonates with a gestation age &lt;37 weeks nor in infants &lt;12 months of age who are receiving treatment with methemoglobin-inducing agents",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Dosing is based on child's age and weight:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Age 0-3 months or &lt;5 kg:",
"     </i>",
"     Apply a maximum of 1 g over no more than 10 cm",
"     <sup>",
"      2",
"     </sup>",
"     of skin; leave on for no longer than 1 hour.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Age 3 months to 12 months and &gt;5 kg:",
"     </i>",
"     Apply no more than a maximum 2 g total over no more than 20 cm",
"     <sup>",
"      2",
"     </sup>",
"     of skin; leave on for no longer than 4 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Age 1-6 years and &gt;10 kg:",
"     </i>",
"     Apply no more than a maximum of 10 g total over no more than 100 cm",
"     <sup>",
"      2",
"     </sup>",
"     of skin; leave on for no longer than 4 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Age 7-12 years and &gt;20 kg:",
"     </i>",
"     Apply no more than a maximum 20 g total over no more than 200 cm",
"     <sup>",
"      2",
"     </sup>",
"     of skin; leave on for no longer than 4 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     If a patient &gt;3 months of age does not meet the minimum weight requirement, the maximum total dose should be restricted to the corresponding maximum based on patient weight.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Transdermal patch: Canadian labeling (not available in U.S.):",
"     <b>",
"      Note:",
"     </b>",
"     Should not be used in neonates with a gestation age &lt;37 weeks nor in infants &lt;12 months of age who are receiving treatment with methemoglobin-inducing agents.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Dosing is based on child's age and weight: Apply patch(es) to skin area(s) &lt;10 cm",
"      <sup>",
"       2",
"      </sup>",
"     </i>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Age 0-3 months or &lt;5 kg:",
"     </i>",
"     Apply 1 patch and leave on for ~1 hour (do not exceed 1-hour application time); do not apply more than 1 patch at same time; safety of repeated dosing not established",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Age 3 months to 12 months and &gt;5 kg:",
"     </i>",
"     Apply 1-2 patches for ~1 hour (maximum application time: 4 hours); do not apply more than 2 patches at the same time",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Age 1-6 years and &gt;10 kg:",
"     </i>",
"     Apply 1 or more patches for minimum of 1 hour (maximum application time: 5 hours); maximum dose: 10 patches",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Age 7-12 years and &gt;20 kg:",
"     </i>",
"     Apply 1 or more patches for a minimum of 1 hour (maximum application time: 5 hours); maximum dose: 20 patches",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     If a patient &gt;3 months of age does not meet the minimum weight requirement, the maximum total dose of EMLA&reg; Patch should be restricted to that which corresponds to the patient&rsquo;s weight.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F188759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F188760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Smaller areas of treatment are recommended for patients with renal dysfunction.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F188761\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Smaller areas of treatment are recommended for patients with hepatic dysfunction.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F188738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical: Lidocaine 2.5% and prilocaine 2.5% (5 g, 30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     EMLA&reg;: Lidocaine 2.5% and prilocaine 2.5% (5 g, 30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, periodontal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oraqix&reg;: Lidocaine 2.5% and prilocaine 2.5% (1.7 g)",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F10193334\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Patch, transdermal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     EMLA&reg; Patch: Lidocaine 2.5% and prilocaine 2.5% per patch (2s, 20s) [active contact surface area of each 1 g patch:10 cm",
"     <sup>",
"      2",
"     </sup>",
"     ; surface area of entire patch: 40 cm",
"     <sup>",
"      2",
"     </sup>",
"     ]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F188725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Cream",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F188740\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream: For external use only. Avoid application to open wounds or near the eyes. In small infants and children, observe patient to prevent accidental ingestion of cream or dressing.  Apply a thick layer (2.5 g/site ~",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     of a 5 g tube) of cream to designated site of intact skin. Cover site with occlusive dressing. Mark the time on the dressing.",
"     <b>",
"      Allow at least 1 hour for optimum therapeutic effect.",
"     </b>",
"     Remove the dressing and wipe off excess cream (gloves should be worn).",
"     <b>",
"      Smaller areas of treatment are recommended for debilitated patients.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Transdermal patch (CAN; not available in U.S.): Apply patch or patches to intact skin.",
"     <b>",
"      Allow at least 1 hour for optimum therapeutic effect.",
"     </b>",
"     After removing patch or patches, clean treated areas thoroughly prior to procedure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oraqix&reg; is a viscous liquid. Make sure it is in the liquid form before administration; if gel forms refrigerate until becomes liquid again. Do not use dental cartridge warmers; heat will cause product to gel. Apply slowly and evenly on gingival margin around selected teeth. Not to be used with standard dental syringes; use Oraqix&reg; Dispenser to apply.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F188739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topical anesthetic for use on normal intact skin to provide local analgesia for minor procedures such as I.V. cannulation or venipuncture; has also been used for painful procedures such as lumbar puncture and skin graft harvesting; for superficial minor surgery of genital mucous membranes and as an adjunct for local infiltration anesthesia in genital mucous membranes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Periodontal gel: Topical anesthetic for use in periodontal pockets during scaling or root planning procedures",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F188771\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Cream/patch:",
"     </b>",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Angioedema, hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Shock",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Burning, erythema, hyperpigmentation, itching, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Blistering of foreskin (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Burning, edema, stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Bronchospasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Alteration in temperature sensation, hypersensitivity reactions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Periodontal gel:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;10%: Local: Application site reaction (1%, includes abscess, edema, irritation, numbness, pain, ulceration, vesicles)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Central nervous system: Fatigue (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Gastrointestinal: Bitter taste (2%), nausea (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Respiratory: Infection (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome (1%), allergic reactions",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F188743\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to amide-type anesthetic agents; hypersensitivity to any component of the formulation selected; application on mucous membranes or broken or inflamed skin; infants &lt;1 month of age if gestational age is &lt;37 weeks; infants &lt;12 months of age receiving therapy with methemoglobin-inducing agents; children with congenital or idiopathic methemoglobinemia, or in children who are receiving medications associated with drug-induced methemoglobinemia (eg, acetaminophen [overdosage], benzocaine, chloroquine, dapsone, nitrofurantoin, nitroglycerin, nitroprusside, phenazopyridine, phenelzine, phenobarbital, phenytoin, quinine, sulfonamides)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F188729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with severe hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Class I and III antiarrhythmics: Use with caution in patients receiving class I and III antiarrhythmic drugs, since systemic absorption occurs and synergistic toxicity is possible.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Acutely ill patients: Use with caution in acutely ill; reduce dose consistent with age and physical status.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated patients; reduce dose consistent with age and physical status.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; reduce dose consistent with age and physical status.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Although the incidence of systemic adverse reactions with EMLA&reg; is very low, caution should be exercised, particularly when applying over large areas and leaving on for longer than 2 hours. Avoid use on open wounds or near the eyes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Topical application: When topical anesthetics are used prior to cosmetic or medical procedures, the lowest amount of anesthetic necessary for pain relief should be applied. High systemic levels and toxic effects (eg, methemoglobinemia, irregular heart beats, respiratory depression, seizures, death) have been reported in patients who (without supervision of a trained professional) have applied topical anesthetics in large amounts (or to large areas of the skin), left these products on for prolonged periods of time, or have used wraps/dressings to  cover the skin following application.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F188768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F188733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antiarrhythmic Agents (Class III): Lidocaine (Topical) may enhance the arrhythmogenic effect of Antiarrhythmic Agents (Class III). Antiarrhythmic Agents (Class III) may increase the serum concentration of Lidocaine (Topical). This mechanism specifically applies to amiodarone and dronedarone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May increase the serum concentration of Lidocaine (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Darunavir: May increase the serum concentration of Lidocaine (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: May enhance the arrhythmogenic effect of Lidocaine (Topical). Disopyramide may increase the serum concentration of Lidocaine (Topical). Specifically, the unbound/free fraction of lidocaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: May enhance the adverse/toxic effect of Local Anesthetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methemoglobinemia Associated Agents: May enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia. Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F188735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F188746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to Lidocaine (Topical) monograph.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F188764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Lidocaine enters breast milk/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F188747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F188745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (EMLA External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5-2.5% (30 g): $53.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Lidocaine-Prilocaine External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5-2.5% (5 g): $8.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Kit",
"     </b>",
"     (Lidocaine-Prilocaine External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5-2.5% (1): $38.40",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F188748\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Anestecin crema (CO);",
"     </li>",
"     <li>",
"      Anestil (EC);",
"     </li>",
"     <li>",
"      Ansederm (FR);",
"     </li>",
"     <li>",
"      Dolones (ID);",
"     </li>",
"     <li>",
"      Duocaine (MY);",
"     </li>",
"     <li>",
"      Emla (AE, AR, AT, AU, BB, BE, BF, BG, BH, BJ, BM, BS, BZ, CH, CI, CL, CY, CZ, DE, DK, EG, ET, FI, FR, GB, GH, GM, GN, GR, GY, HK, ID, IE, IL, IQ, IR, IT, JM, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, MX, MY, NE, NG, NL, NO, NZ, OM, PE, PH, PL, PY, QA, RU, SA, SC, SD, SE, SL, SN, SR, SY, TH, TN, TR, TT, TW, TZ, UG, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Emla Cream (NZ);",
"     </li>",
"     <li>",
"      Emla Patch (NZ);",
"     </li>",
"     <li>",
"      Emlocaine (PH);",
"     </li>",
"     <li>",
"      Lidiprine (HK);",
"     </li>",
"     <li>",
"      Liprido (TW);",
"     </li>",
"     <li>",
"      Liprikaine (TH);",
"     </li>",
"     <li>",
"      Lipril Cream (KP);",
"     </li>",
"     <li>",
"      Lipro (MY);",
"     </li>",
"     <li>",
"      Oraqix (SE);",
"     </li>",
"     <li>",
"      Prilox (IN);",
"     </li>",
"     <li>",
"      Racser (MY)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F188728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Local anesthetic action occurs by stabilization of neuronal membranes and inhibiting the ionic fluxes required for the initiation and conduction of impulses",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F188742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     EMLA&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of action: 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Peak effect: 2-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duration: 1-2 hours after removal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Absorption: Related to duration of application and area where applied",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     3-hour application: 3.6% lidocaine and 6.1% prilocaine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     24-hour application: 16.2% lidocaine and 33.5% prilocaine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oraqix&reg;: Duration: ~20 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Broadman LM, Soliman IE, Hannallah RS, et al, &ldquo;Analgesic Efficacy of Eutectic Mixture of Local Anesthetics (EMLA&reg;) Vs Intradermal Infiltration Prior to Venous Cannulation in Children,&rdquo;",
"      <i>",
"       Am J Anaesthesiol",
"      </i>",
"      , 1987, 34:S56.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Halperin DL, Koren G, Attias D, et al, &ldquo;Topical Skin Anesthesia for Venous Subcutaneous Drug Reservoir and Lumbar Puncture in Children,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1989, 84(2):281-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/25/32150/abstract-text/2748256/pubmed\" id=\"2748256\" target=\"_blank\">",
"        2748256",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Robieux I, Kumar R, Radhakrishnan S, et al, &ldquo;Assessing Pain and Analgesia With a Lidocaine-Prilocaine Emulsion in Infants and Toddlers During Venipuncture,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1991, 118(6):971-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/25/32150/abstract-text/2040936/pubmed\" id=\"2040936\" target=\"_blank\">",
"        2040936",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Taddio A, Shennan AT, Stevens B, et al, &ldquo;Safety of Lidocaine-Prilocaine Cream in the Treatment of Preterm Neonates,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1995, 127(6):1002-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/25/32150/abstract-text/8523173/pubmed\" id=\"8523173\" target=\"_blank\">",
"        8523173",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vickers ER, Mazbani N, Gerzina TM, et al, &ldquo;Pharmacokinetics of EMLA Cream 5% Application to Oral Mucosa,&rdquo;",
"      <i>",
"       Anesth Prog",
"      </i>",
"      , 1997, 44:32-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/25/32150/abstract-text/9481979/pubmed\" id=\"9481979\" target=\"_blank\">",
"        9481979",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9561 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.247-661AF214C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32150=[""].join("\n");
var outline_f31_25_32150=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188755\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188756\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188773\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188758\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188767\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188759\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188760\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188761\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188738\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193334\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188725\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188740\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188739\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188771\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188743\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188729\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188768\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188733\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188735\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188746\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188764\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188747\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188745\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188748\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188728\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188742\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9561\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9561|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/17/4373?source=related_link\">",
"      Lidocaine and prilocaine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/43/34486?source=related_link\">",
"      Lidocaine and prilocaine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_25_32151="Basic principles of medical lasers";
var content_f31_25_32151=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Basic principles of medical lasers",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/25/32151/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/25/32151/contributors\">",
"     Henri G Colt, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/25/32151/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/25/32151/contributors\">",
"     Hilary Sanfey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/25/32151/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/25/32151/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/25/32151/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 13, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lasers are devices that emit a single, coherent wavelength of electromagnetic radiation that is used to cut, coagulate or ablate tissue for a variety of clinical applications. Laser systems produce a variety of wavelengths of varying pulse duration and energy levels. Computer-based imaging and guidance systems allow procedures to be performed precisely, quickly and with greater control. Although lasers are commonly used superficially for cutaneous and ocular applications, smaller, efficient laser delivery systems are available for minimally-invasive applications including endoscopy, bronchoscopy, laparoscopy and endovenous ablation.",
"   </p>",
"   <p>",
"    The safe and appropriate use of lasers requires a trained clinician with a working knowledge of laser delivery systems and laser-tissue interactions to achieve the desired clinical effect while minimizing complications.",
"   </p>",
"   <p>",
"    The basic principles of medical lasers will be reviewed here. The use and effectiveness of lasers for specific clinical indications are discussed in separate topic reviews. (See",
"    <a class=\"local\" href=\"#H54652888\">",
"     'Clinical utility of lasers'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18438081\">",
"    <span class=\"h1\">",
"     ELECTROMAGNETIC SPECTRUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Light is electromagnetic radiation within the range of wavelength that is visible to the human eye. Medical lasers produce photons of electromagnetic energy that can be within, above or below this range (",
"    <a class=\"graphic graphic_figure graphicRef59189 \" href=\"mobipreview.htm?33/9/33937\">",
"     figure 1",
"    </a>",
"    ). The ranges of frequency for each region of the electromagnetic spectrum are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Gamma rays: &lt;0.1 nm",
"     </li>",
"     <li>",
"      X-Rays: 0.1 to 10 nm",
"     </li>",
"     <li>",
"      Ultraviolet: 10 to 400 nm",
"     </li>",
"     <li>",
"      <strong>",
"       Visible: 440 to 760 nm",
"      </strong>",
"     </li>",
"     <li>",
"      Near-infrared: 700 to 1400 nm",
"     </li>",
"     <li>",
"      Mid-infrared: 1400 to 20,000 nm",
"     </li>",
"     <li>",
"      Far-infrared: 20,000 to 100,000 nm",
"     </li>",
"     <li>",
"      Microwaves: &gt;100,000 nm",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     LASER PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lasers are devices that rely upon the stimulated emission of radiation to produce a beam of light. The word laser is an acronym for",
"    <strong>",
"     l",
"    </strong>",
"    ight",
"    <strong>",
"     a",
"    </strong>",
"    mplification by",
"    <strong>",
"     s",
"    </strong>",
"    timulated",
"    <strong>",
"     e",
"    </strong>",
"    mission of",
"    <strong>",
"     r",
"    </strong>",
"    adiation. Lasers are comprised of an energy source, a resonant chamber, and an active medium (",
"    <a class=\"graphic graphic_figure graphicRef67991 \" href=\"mobipreview.htm?17/59/18366\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In the unexcited state, electrons orbit the nucleus at their lowest energy level or ground state occupying orbits that are closer to the nucleus. However, absorption of energy causes the electrons to become excited moving to a higher orbit (",
"    <a class=\"graphic graphic_figure graphicRef61725 \" href=\"mobipreview.htm?35/35/36413\">",
"     figure 3",
"    </a>",
"    ). As the electrons return from the excited state back to ground state, they spontaneously emit photons of energy (electromagnetic radiation). In other words, they stimulate emission of radiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The radiation that is produced has unique properties including monochromaticity, coherence and collimation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Monochromatic means that all the photons in a laser beam are of the same wavelength. Thus, the laser beam achieves sufficient intensity to destroy tissue the degree to which is based upon its wavelength and the scattering, reflection, and absorption coefficients of the target tissue. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Tissue ablation'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Coherence&nbsp;refers to the synchronization of the laser beam in time and space. The photons of the beam are in-phase or coherent. By comparison, the photons in conventional light travel randomly.",
"     </li>",
"     <li>",
"      Collimation&nbsp;indicates that the elements of the laser beam are nearly parallel. Because there is little divergence, laser beams can be focused to a small area. This property differs from conventional light which diverges substantially. Because of collimation, the energy emitted from a laser source can be captured and delivered through flexible optical fibers.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Energy source",
"    </span>",
"    &nbsp;&mdash;&nbsp;The source of external energy, known as the pump source, used to excite the electrons can be electrical, optical or chemical. In medical applications, the energy source is most commonly electrical (eg, electric current flowing through a laser medium) or optical (eg, from another laser). Chemical energy is often used in industrial applications. The pump power can be maintained continuously or switched on only for short intervals, which may help to limit the damaging thermal effects of the laser. (See",
"    <a class=\"local\" href=\"#H20089841\">",
"     'Modes of operation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Resonant chamber",
"    </span>",
"    &nbsp;&mdash;&nbsp;The resonant chamber or cavity contains the active laser medium and reflective mirrors. Photons reflect back and forth between mirrors. Since one of the mirrors is highly reflective and the other is only partially reflective, some of the laser light that is produced is permitted to exit the device and is directed to the tissues. (See",
"    <a class=\"local\" href=\"#H18438242\">",
"     'Laser beam production'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Active medium",
"    </span>",
"    &nbsp;&mdash;&nbsp;The active medium contains the atoms that produce the electromagnetic radiation. The type of active medium usually gives the laser its name and, for medical applications, includes gas, solid crystalline materials, semiconductor materials, and liquid dye solutions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48655044\">",
"    <span class=\"h3\">",
"     Gas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gas lasers apply an electric current through the gas. Gas lasers use noble gases (eg, argon, helium) and other types of gases (eg, carbon dioxide). The first gas laser used helium-neon (HeNe) to produce a coherent infrared beam.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Carbon dioxide &ndash; The carbon dioxide (CO",
"      <sub>",
"       2",
"      </sub>",
"      ) laser uses carbon dioxide, nitrogen, and helium and was developed in 1964 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/2\">",
"       2",
"      </a>",
"      ]. It produces a mid-infrared wavelength (10,600 nm) (",
"      <a class=\"graphic graphic_figure graphicRef59189 \" href=\"mobipreview.htm?33/9/33937\">",
"       figure 1",
"      </a>",
"      ). The CO",
"      <sub>",
"       2",
"      </sub>",
"      laser is excellent as a cutting instrument because scattering is minimal, absorption in water is excellent, soft tissue vaporization is rapid and the surrounding tissue damage is negligible. The CO",
"      <sub>",
"       2",
"      </sub>",
"      laser permits the coagulation of blood vessels smaller than 0.5 mm in diameter. This laser type is primarily used in otorhinolaryngology.",
"     </li>",
"     <li>",
"      Argon ion &mdash; Argon ion gas produces blue-green light at a wavelength of 488 to 514 nm (",
"      <a class=\"graphic graphic_figure graphicRef59189 \" href=\"mobipreview.htm?33/9/33937\">",
"       figure 1",
"      </a>",
"      ). The argon ion laser is used primarily for coagulation of blood vessels in dermatology, ophthalmology and liver surgery. Soft tissue effects are unpredictable. Argon lasers are also used to pump dye lasers for phototherapy.",
"     </li>",
"     <li>",
"      Excimer &mdash; The excimer laser uses an active medium composed of excited dimers, which are a combination of a noble gas (eg, argon, krypton, or xenon) and a reactive gas (eg, fluorine or chlorine). The excimer laser emits ultraviolet radiation with enough energy to break chemical bonds between molecules but with no to little thermal damage. The excimer laser is used to remove surface material with almost no heating and these lasers are often referred to as &ldquo;cool&rdquo; lasers. A good example is laser-assisted in situ keratomileusis, otherwise known as LASIK.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18438655\">",
"    <span class=\"h3\">",
"     Solid state",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solid-state lasers use an active medium that is a solid. Semiconductor-based lasers are also in the solid state, but are generally considered as a separate class from solid-state lasers. (See",
"    <a class=\"local\" href=\"#H28033310\">",
"     'Semiconductor'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Generally, the active medium of a solid-state laser consists of a glass or crystalline material (eg, sapphire, ruby) that is doped with neodymium, chromium, erbium, or other ions. Neodymium doped: yttrium aluminum garnet (Nd:YAG) lasers are perhaps the most commonly used solid state laser. The medium is a rod composed of neodymium ions and crystals of yttrium-aluminum-garnet. Nd:YAG lasers emit light at mid-infrared wavelengths (1320 nm, 1064 nm) with pulse durations in the millisecond range (",
"    <a class=\"graphic graphic_figure graphicRef59189 \" href=\"mobipreview.htm?33/9/33937\">",
"     figure 1",
"    </a>",
"    ). The longer wavelength of the Nd:YAG laser penetrates deeper into the tissue and can cause collateral thermal damage.",
"   </p>",
"   <p>",
"    Other solid-state lasers emitting radiation with millisecond pulse durations include the potassium titanyl phosphate (KTP), and alexandrite lasers. KTP lasers emit green light at 532 nm corresponding to the second oxyhemoglobin peak and overlapping the absorption peak of melanin. Alexandrite lasers emit red light at a wavelength of 755 nm which is absorbed by deoxygenated hemoglobin and melanin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28033310\">",
"    <span class=\"h3\">",
"     Semiconductor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Semiconductor lasers (ie, laser diode) use an active medium that is formed by doping a thin layer on the surface of a crystal wafer to form a p-n junction, which comprises a diode. Semiconductor lasers are injection laser diodes as compared with the optically-pumped laser diodes (solid-state lasers) described above. Diode lasers emit light at wavelengths between 800 and 900 nm (",
"    <a class=\"graphic graphic_figure graphicRef59189 \" href=\"mobipreview.htm?33/9/33937\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20089793\">",
"    <span class=\"h3\">",
"     Dye",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dye lasers have liquid active medium. A fluorescent organic dye in liquid solution is injected into a tube. Pulse dye lasers (PDLs) emit yellow light at 585 and 595 nm which corresponds to the second oxyhemoglobin peak (",
"    <a class=\"graphic graphic_figure graphicRef63932 \" href=\"mobipreview.htm?28/5/28766\">",
"     figure 4",
"    </a>",
"    ). These lasers produce pulse durations in the millisecond range and are used in cutaneous vascular applications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18438242\">",
"    <span class=\"h2\">",
"     Laser beam production",
"    </span>",
"    &nbsp;&mdash;&nbsp;The composition and design of the laser device produces a coherent beam of electromagnetic radiation as a result of the following sequence of events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    Atoms within the resonant chamber absorb energy from the energy source. As atoms in high energy states spontaneously return to ground state, they release energy, some of which is absorbed by other atoms causing them to achieve a high energy state. This phenomenon is known as &lsquo;pumping&rsquo;. As more and more atoms become excited and then return to ground state, more and more energy is produced (amplification of stimulated emission). Eventually, stimulated emission of radiation becomes the primary source of energy within the chamber, and eventually produces population inversion meaning that there are more atoms in a high energy state than in a low energy state within the resonant chamber. The energy reflects between the mirrors in the chamber and becomes coherent and collimated. But, since one mirror in the chamber is only partially reflective, some energy is allowed to escape as a bright, monochromatic, coherent beam of laser radiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20089841\">",
"    <span class=\"h3\">",
"     Modes of operation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Continuous-wave lasers emit a continuous laser beam, provided the pump source is switched on by the operator. Examples of continuous-wave lasers include the argon, krypton, and some CO",
"      <sub>",
"       2",
"      </sub>",
"      lasers. Long periods of continuous exposure to the laser beam or insufficient cooling time can lead to excessive tissue heating. Automated scanning devices have been developed to move the laser beam in predetermined patterns to minimize excessive exposure, but these are not always effective. As a result, continuous-wave lasers have been largely replaced by pulsed lasers.",
"     </li>",
"     <li>",
"      Pulsed lasers emit energy in the form of brief pulses rather than continuously. The power output of short-pulse lasers is in the megawatt to gigawatt range, heating the target so quickly that the tissue is disrupted mechanically by shockwaves. Long-pulse lasers produce peak powers in the kilowatt range, damaging collateral tissue minimally.",
"      <br/>",
"      <br/>",
"      Different methods of pulse generation produce pulses of varying duration, energy and repetition rate and include Q-switching, gain switching and mode-locking.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Q-switching uses an electro-optical switch to release energy stored in the laser chamber in a brief pulse with high peak power. Nanosecond pulse, high energy laser beams are produced with Q-switched solid state lasers including ruby, alexandrite, and Nd:YAG lasers. Excimer lasers produce nanosecond ultraviolet laser energy.",
"     </li>",
"     <li>",
"      Mode-locked lasers produce short pulses with high repetition but with lower peak power than Q-switched lasers. Picosecond pulses can be produced with mode-locked solid-state, fiber or semiconductor lasers.",
"     </li>",
"     <li>",
"      Gain-switched lasers produce shorter pulses, usually in picoseconds, and are used to pump certain solid state and dye lasers. Lower energy nanosecond pulses can be produced with gain-switched semiconductor, fiber lasers. Longer pulse lasers (1 to 50 milliseconds) include the 595 nm pulsed dye laser (PDL) or the alexandrite 755 nm laser.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Quasi-continuous-wave operation refers to a mode for which the pump source is automatically switched on and off. The laser is optically in a state of&nbsp;continuous-wave operation. The interval of time over which the pump source is turned on, which may only be a few percent of the total time, is short enough to decrease tissue heating and negative thermal effects, but long enough to maintain the laser at a steady state. Quasi-continuous-wave lasers include the potassium titanyl phosphate (KTP) lasers.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18437675\">",
"    <span class=\"h1\">",
"     LASER DELIVERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once produced, the laser beam is delivered to the tissue directly or via flexible optical fibers primarily for dissection or ablation of tissue. Technology that uses lasers to perform high resolution imaging of tissues is an area of active clinical research. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Tissue ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Absorption of light is necessary for the laser to have any effect upon the tissue. Molecules that absorb light are called chromophores (the part of a molecule responsible for its color) and include melanin, oxyhemoglobin, bilirubin and water (",
"    <a class=\"graphic graphic_figure graphicRef77528 \" href=\"mobipreview.htm?40/57/41873\">",
"     figure 5",
"    </a>",
"    ). The effects on the tissue are due to the dissipation of the absorbed energy by conversion to other forms of energy including thermal, mechanical or chemical energy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Photothermal &mdash; Laser therapy of many tissues is based upon the concept of selective photothermolysis, whereby thermal injury is induced with limited damage to the surrounding structures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/5-7\">",
"       5-7",
"      </a>",
"      ]. The wavelength of light is chosen based upon the chromophore of the target structure and its depth. Thermal effects include denaturation of proteins, coagulative necrosis, and vaporization.",
"     </li>",
"     <li>",
"      Photoablative &mdash; Photoablation refers to the mechanical disruption of tissue due to delivery of energy that is sufficient to produce thermal explosions or shock waves within the tissue leading to its disintegration.",
"     </li>",
"     <li>",
"      Photochemical &mdash; Photochemical reactions occur following laser treatment of tissue after injection of a photosensitizer of a specific wavelength. Although the photosensitizer is absorbed by other cells in the body, it is preferentially absorbed by malignant cells which maintain levels of the photosensitizer after the agent has left normal cells. Exposure of the tissue to the photosensitizer wavelength selectively destroys the malignant cells through chemical reactions (usually production of oxygen radicals) or activation of the immune system. Photosensitizers can also be applied to the surface of tissues to achieve a photochemical effect such as in dental bleaching [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20090065\">",
"    <span class=\"h3\">",
"     Laser parameters",
"    </span>",
"    &nbsp;&mdash;&nbsp;When laser energy strikes the tissue surface, energy can be absorbed, reflected, transmitted, or scattered. The effect of the interaction between the laser and tissue depends upon the active medium, wavelength, power density, properties of the target tissue, and duration of tissue exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/9\">",
"     9",
"    </a>",
"    ]. Wavelength and pulse duration are the most important laser parameters that govern the effects of laser light on the tissue. Fluence, power, and spot size are additional laser settings that influence clinical effectiveness. With optimal laser settings, laser energy can be directed precisely to a target chromophore, avoiding damage to healthy tissue.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Wavelength &ndash; The wavelength of the laser beam determines the degree of tissue penetration, absorbed energy and scattered energy. Longer wavelengths penetrate more deeply (near",
"      <strong>",
"      </strong>",
"      infrared&gt;red&gt;yellow&gt;green&gt;blue&gt;ultraviolet) (",
"      <a class=\"graphic graphic_figure graphicRef70045 \" href=\"mobipreview.htm?15/8/15502\">",
"       figure 6",
"      </a>",
"      ). Scattering is the laser energy that is directed away from the original laser target. Light scattering decreases with increasing wavelength. A laser with a low scattering coefficient makes an excellent scalpel because the laser energy is absorbed in a confined area. By comparison, a laser with a high scattering coefficient may result in good photocoagulation.",
"     </li>",
"     <li>",
"      The laser wavelength should be chosen to be near the maximum absorption of the target chromophore, long enough to penetrate to the depth of the target and away from the target range of competing chromophores.",
"     </li>",
"     <li>",
"      Pulse duration &ndash; The optimal pulse duration is determined from the thermal relaxation time of the target chromophore. The thermal relaxation time is the time needed for the tissue temperature to return to its baseline temperature after heating [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/5\">",
"       5",
"      </a>",
"      ]. If a tissue is heated for a period less than or equal to its thermal relaxation time, the accumulated heat and subsequent damage is confined to the target object, whereas if a target is heated for longer than its thermal relaxation time, heat conduction leads to heating of surrounding structures.",
"     </li>",
"     <li>",
"      Spot size &ndash; Spot size is the diameter of the beam emitted from the laser as it strikes the tissue surface. Energy entering the target tissue is attenuated more rapidly with a small spot size compared with a larger spot size, because scattering is greater with small spot size.",
"     </li>",
"     <li>",
"      Energy delivery &ndash; Energy is measured in Joules (J) and fluence, a measure of radiant exposure, is energy over area",
"      <span class=\"nowrap\">",
"       (J/cm",
"       <sup>",
"        2",
"       </sup>",
"       ).",
"      </span>",
"      The destruction of very large structures usually requires high fluence (20 to 50",
"      <span class=\"nowrap\">",
"       J/cm",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"      due to the amount of tissue that needs to be heated to achieve thermal coagulation. Although fluence is commonly used in discussing pulsed lasers, power density (ie, irradiance) is preferred for continuous wave devices.",
"      <br/>",
"      <br/>",
"      Power describes the rate of energy delivery measured in Joules per second",
"      <span class=\"nowrap\">",
"       (J/sec)",
"      </span>",
"      or watts. Power density, the power transmitted per unit area of cross-section of a laser beam",
"      <span class=\"nowrap\">",
"       (watts/cm",
"       <sup>",
"        2",
"       </sup>",
"       ),",
"      </span>",
"      is inversely proportional to the square of the diameter of the spot size [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/10\">",
"       10",
"      </a>",
"      ]. Low power density produces slow heating that coagulates tissue, while high power density heats tissue quickly and can vaporize tissue [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/4\">",
"       4",
"      </a>",
"      ]. At extremely high power density, heating is so rapid that the target tissue disintegrates from photomechanical disruption rather than vaporization.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20090378\">",
"    <span class=\"h2\">",
"     Tissue imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Confocal microscopy uses a low-energy laser to provide a pinpoint light source that increases spatial resolution for tissue imaging. This technology requires tissue fluorescence and intravenous or topical contrast agents depending upon the type of tissue being studied. The pinpoint laser is focused to a particular tissue depth and fluorescent light reflected from that plane passes through the confocal aperture, whereas scattered light from above or below that plane is not detected.",
"   </p>",
"   <p>",
"    A confocal laser endo-microscope can be integrated into the distal tip of a conventional endoscope, bronchoscope, laparoscope, or cystoscope [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. A dedicated single optical fiber serves as the illumination point source and the detection aperture. The use of laser endo-microscopy for imaging gastrointestinal tissue is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/2/3113?source=see_link\">",
"     \"Confocal laser endomicroscopy and endocytoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H54652888\">",
"    <span class=\"h1\">",
"     CLINICAL UTILITY OF LASERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lasers are used in a variety of clinical applications commonly related to external structures that are easily reached, such as the skin and cornea. Minimally invasive technology allows access to deeper structures including the gastrointestinal mucosa, biliary tree, bronchial structures and urinary tract via endoscopy, and hollow or solid organ surfaces via laparoscopy and thoracoscopy. Most commonly, tissue ablation occurs as a consequence of thermal effects. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dermatology &ndash; Progress in laser and light therapy technology has led to the development of safer and more efficient methods of achieving the desired effects on skin. Skin cooling limits inadvertent damage to tissues adjacent the targeted sites. The principles that govern the interactions between skin and laser light or intense pulsed light (IPL), and the types of these devices used in the treatment of skin, are discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/53/22360?source=see_link\">",
"       \"Principles of laser and intense pulsed light for cutaneous lesions\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37014?source=see_link\">",
"       \"Removal of unwanted hair\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Gastroenterology &ndash; Pulse dye lasers and Q-switched solid state lasers are used to fragment gallstones identified during choledochoscopy and ablate mucosal tumors. Confocal laser endomicroscopy has aided in the differentiation between dysplastic and malignant tissue. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/29/16856?source=see_link&amp;anchor=H3#H3\">",
"       \"Laser lithotripsy for the treatment of gallstones\", section on 'Laser lithotripsy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/2/3113?source=see_link\">",
"       \"Confocal laser endomicroscopy and endocytoscopy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/60/20426?source=see_link\">",
"       \"Management of superficial esophageal cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/60/20426?source=see_link&amp;anchor=H21#H21\">",
"       \"Management of superficial esophageal cancer\", section on 'Laser ablation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pulmonary medicine and surgery &ndash; In bronchoscopy, lasers are used to either photocoagulate or vaporize tissues obstructing the airway (",
"      <a class=\"graphic graphic_picture graphicRef81276 \" href=\"mobipreview.htm?10/58/11171\">",
"       picture 1",
"      </a>",
"      ). They can also be used to make concise radial incisions to enhance airway dilation in central airway strictures. Lasers have also been used to remove blebs and bullae during thoracoscopy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/47/38645?source=see_link\">",
"       \"Bronchoscopic laser resection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cardiology and cardiac surgery &ndash; Laser energy is used to create transmural channels in ischemic myocardium to restore myocardial perfusion in a procedure called transmyocardial laser revascularization. The procedure can be performed using a carbon dioxide or holmium: YAG laser. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/32/28167?source=see_link\">",
"       \"Transmyocardial laser revascularization for management of refractory angina\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ophthalmology &ndash; The excimer laser is used to remove a precise amount of corneal stroma during laser-assisted in-situ keratomileusis (LASIK), which is one of the most common applications of laser. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42457?source=see_link\">",
"       \"Laser refractive surgery\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      General surgery &ndash; In general surgery, laser energy can be used to provide hemostasis or to ablate tumors identified in solid organs such as the liver. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/40/14984?source=see_link\">",
"       \"Devices for dissection and hemostasis in laparoscopic surgery\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Gynecology &ndash; The Nd:YAG or carbon dioxide laser is used for tissue ablation in a variety of gynecologic applications. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/18/9513?source=see_link&amp;anchor=H5#H5\">",
"       \"Reproductive surgery for female infertility\", section on 'Excision and ablation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/34/27178?source=see_link&amp;anchor=H22#H22\">",
"       \"Treatment of vulvar and vaginal warts\", section on 'Laser ablation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/17/33048?source=see_link&amp;anchor=H4#H4\">",
"       \"Cervical intraepithelial neoplasia: Procedures for cervical conization\", section on 'Laser conization'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urology &ndash; Lasers can be used to fragment ureteral stones, but are becoming more popular for the treatment of benign prostatic hyperplasia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40056?source=see_link&amp;anchor=H10#H10\">",
"       \"Surgical and other invasive therapies of benign prostatic hyperplasia\", section on 'Laser prostatectomy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27079?source=see_link&amp;anchor=H5#H5\">",
"       \"Management of ureteral calculi\", section on 'Holmium laser lithotripsy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vascular Surgery &ndash; Lasers are commonly used to manage the visible signs of chronic venous disease. Several types of lasers might be used depending upon the size and depth of the vein to be treated (",
"      <a class=\"graphic graphic_table graphicRef80164 \" href=\"mobipreview.htm?19/47/20220\">",
"       table 1",
"      </a>",
"      ). Laser is one form of energy used to effect closure of veins that demonstrate reflux (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/40/17031?source=see_link\">",
"       \"Laser and light therapy of lower extremity telangiectasias, reticular veins and small varicose veins\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/34/30250?source=see_link\">",
"       \"Endovenous laser ablation for the treatment of lower extremity chronic venous disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dentistry &ndash; Although incoherent light may be used in conjunction with photoactive dental bleaching systems, coherent light produced from a diode laser has also been found to be effective [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18440723\">",
"    <span class=\"h1\">",
"     LASER SAFETY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to most industrial applications of laser in which the laser beam is enclosed, medical and research use of lasers can expose the user and other people in the vicinity to potentially hazardous laser radiation. Adverse health effects of exposure to laser radiation are theoretically possible across the entire optical spectrum, but the risk of retinal injury due to radiation in the visible and near infrared regions is of particular concern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/15\">",
"     15",
"    </a>",
"    ]. The biological effects induced by optical radiation are essentially the same for both coherent and incoherent sources for any given wavelength, exposure site and area, and duration. However, laser radiation is a special case because the radiant exposures and irradiances that can be achieved are potentially much higher compared with conventional optical sources [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/16\">",
"     16",
"    </a>",
"    ]. Thus, most states have training regulations for personnel who use lasers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/17\">",
"     17",
"    </a>",
"    ] .",
"   </p>",
"   <p>",
"    The eye and skin are the most susceptible to damage by laser radiation. As with other tissues, the biological effects of laser on the eye vary depending upon the wavelength and exposure duration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/18\">",
"     18",
"    </a>",
"    ]. Thermal injury to the retina is the predominant effect for exposure durations &lt;10 seconds due to pigmented epithelial injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/19\">",
"     19",
"    </a>",
"    ]. Photochemical injury predominates in the ultraviolet spectral region and is also the principal type of injury from lengthy exposure (&gt;10 seconds) to short-wavelength visible radiation (principally \"blue light\") [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/15\">",
"     15",
"    </a>",
"    ]. Pulsed lasers of &lt;0.1 msec duration can lead to hemorrhagic injury from thermoacoustic mechanisms, and optical breakdown and plasma formation become important with sub-nanosecond exposures.",
"   </p>",
"   <p>",
"    Because of these mechanisms, eye protection is essential when operating lasers. In the workplace, eye protection is required by the United States Occupational Safety and Health Administration (OSHA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32151/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18437310\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Laser energy can be used to cut, coagulate, ablate or image tissue. Although lasers are commonly used superficially for cutaneous and ocular applications, minimally invasive surgical techniques have increased the use of laser systems for use in endoscopy, bronchoscopy, laparoscopy and endovenous procedures. Complications are reduced with guidance systems that allow lasers to be applied more precisely and with greater control. &nbsp;(See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lasers are devices that rely upon the stimulated emission of radiation to produce a single, coherent wavelength within the ultraviolet, visible or infrared portion of the electromagnetic spectrum. Lasers are comprised of an energy source, a resonant chamber, and an active medium. The active medium determines the wavelength produced. Laser beam production can be continuous, pulsed or quasi-continuous depending upon the characteristics of the active medium and switching mechanism of the device. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Laser principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lasers are used predominantly as a source of energy to effect tissue destruction but also provide a coherent energy source for phototherapy or confocal microscopy which allows for real-time imaging of tissues. (See",
"      <a class=\"local\" href=\"#H18437675\">",
"       'Laser delivery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lasers destroy tissue through one of three mechanisms including production of heat (photothermal), disruption of chemical bonds (photoablative) or reactions with a photosensitizer (photochemical). Selective photothermolysis describes the use of specific wavelengths of laser energy to target specific chromophores and thus minimize damage to adjacent tissues. The interaction between the laser and tissue depends upon the wavelength, power, duration of exposure and properties of the target tissue. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Tissue ablation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lasers are used in a variety of clinical applications commonly related to external structures that are easily reached, such as the skin and cornea. However, minimally invasive technology allows access to deeper structures including the gastrointestinal mucosa, biliary tree, bronchial structures and urinary tract via endoscopy, and hollow or solid organ surfaces via laparoscopy and thoracoscopy. (See",
"      <a class=\"local\" href=\"#H54652888\">",
"       'Clinical utility of lasers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The eye and skin are the organs that are most susceptible to damage by laser radiation. The biological effects induced by non-ionizing radiation are similar for coherent and incoherent sources; however, laser radiation produces greater radiant exposures. In the workplace, eye protection is required by the United States Occupational Safety and Health Administration (OSHA). (See",
"      <a class=\"local\" href=\"#H18440723\">",
"       'Laser safety'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/1\">",
"      Einstein, A. On the quantum theory of radiation. Physikal Zeitschr 1917; 18:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/2\">",
"      Patel, CKN, McFarlane, RA, Faust, WL. Selective excitation through vibrational energy and optical maser action in N2-CO2. Phys Rev 1964; 13:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/3\">",
"      Boulnois, JL. Photophysical processes in recent medical laser developments: A review. Lasers Med Science 1986; 1:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/4\">",
"      Nelson JS, Berns MW. Basic laser physics and tissue interactions. Contemporary Dermatology 1988; 2:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/5\">",
"      Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/6\">",
"      Kunishige JH, Goldberg LH, Friedman PM. Laser therapy for leg veins. Clin Dermatol 2007; 25:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/7\">",
"      Wollina U, Schmidt WD, Hercogova J, Fassler D. Laser therapy of spider leg veins. J Cosmet Dermatol 2003; 2:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/8\">",
"      Dom&iacute;nguez A, Garc&iacute;a JA, Costela A, G&oacute;mez C. Influence of the light source and bleaching gel on the efficacy of the tooth whitening process. Photomed Laser Surg 2011; 29:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/9\">",
"      Polanyi TG. Physics of surgery with lasers. Clin Chest Med 1985; 6:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/10\">",
"      Fisher JC. The power density of a surgical laser beam: its meaning and measurement. Lasers Surg Med 1983; 2:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/11\">",
"      Goetz M, Kiesslich R, Dienes HP, et al. In vivo confocal laser endomicroscopy of the human liver: a novel method for assessing liver microarchitecture in real time. Endoscopy 2008; 40:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/12\">",
"      Kiesslich R, Burg J, Vieth M, et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology 2004; 127:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/13\">",
"      Wiesner C, J&auml;ger W, Salzer A, et al. Confocal laser endomicroscopy for the diagnosis of urothelial bladder neoplasia: a technology of the future? BJU Int 2011; 107:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/14\">",
"      Wu K, Liu JJ, Adams W, et al. Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy. Urology 2011; 78:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32151/abstract/15\">",
"      International Commission on Non-Ionizing Radiation Protection. ICNIRP statement--Protection of workers against ultraviolet radiation. Health Phys 2010; 99:66.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.icnirp.org (Accessed on January 19, 2011).",
"    </li>",
"    <li>",
"     file://fsmb.org/pdf/GRPOL_Laser_Regulation.pdf (Accessed on September 12, 2011).",
"    </li>",
"    <li>",
"     Occupational Safety and Health Administration. www.osha.gov (Accessed on March 31, 2009).",
"    </li>",
"    <li>",
"     file://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=1705&amp;p_table=DIRECTIVES (Accessed on February 09, 2011).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2883 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-3011E4F32C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32151=[""].join("\n");
var outline_f31_25_32151=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18437310\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18438081\">",
"      ELECTROMAGNETIC SPECTRUM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      LASER PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Energy source",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Resonant chamber",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Active medium",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H48655044\">",
"      - Gas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18438655\">",
"      - Solid state",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28033310\">",
"      - Semiconductor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20089793\">",
"      - Dye",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18438242\">",
"      Laser beam production",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20089841\">",
"      - Modes of operation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18437675\">",
"      LASER DELIVERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Tissue ablation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20090065\">",
"      - Laser parameters",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20090378\">",
"      Tissue imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H54652888\">",
"      CLINICAL UTILITY OF LASERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18440723\">",
"      LASER SAFETY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18437310\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/2883\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/2883|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?33/9/33937\" title=\"figure 1\">",
"      Electromagnetic spectrum and medical laser wavelengths",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?17/59/18366\" title=\"figure 2\">",
"      Diagram of laser components",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/35/36413\" title=\"figure 3\">",
"      Atom with electrons orbiting the nucleus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/5/28766\" title=\"figure 4\">",
"      Hemoglobin absorption spectra",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/57/41873\" title=\"figure 5\">",
"      Absorption of laser and light by various tissues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?15/8/15502\" title=\"figure 6\">",
"      Electromagnetic spectrum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/2883|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?10/58/11171\" title=\"picture 1\">",
"      Bronchoscopic laser coagulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/2883|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/47/20220\" title=\"table 1\">",
"      Laser and light sources for treating leg veins",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/47/38645?source=related_link\">",
"      Bronchoscopic laser resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/17/33048?source=related_link\">",
"      Cervical intraepithelial neoplasia: Procedures for cervical conization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/2/3113?source=related_link\">",
"      Confocal laser endomicroscopy and endocytoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/40/14984?source=related_link\">",
"      Devices for dissection and hemostasis in laparoscopic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/34/30250?source=related_link\">",
"      Endovenous laser ablation for the treatment of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/40/17031?source=related_link\">",
"      Laser and light therapy of lower extremity telangiectasias, reticular veins and small varicose veins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/29/16856?source=related_link\">",
"      Laser lithotripsy for the treatment of gallstones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/29/42457?source=related_link\">",
"      Laser refractive surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/60/20426?source=related_link\">",
"      Management of superficial esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27079?source=related_link\">",
"      Management of ureteral calculi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/53/22360?source=related_link\">",
"      Principles of laser and intense pulsed light for cutaneous lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37014?source=related_link\">",
"      Removal of unwanted hair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/18/9513?source=related_link\">",
"      Reproductive surgery for female infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40056?source=related_link\">",
"      Surgical and other invasive therapies of benign prostatic hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/32/28167?source=related_link\">",
"      Transmyocardial laser revascularization for management of refractory angina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/34/27178?source=related_link\">",
"      Treatment of vulvar and vaginal warts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_25_32152="Sexual maturity rating of pubic hair in boys";
var content_f31_25_32152=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80005%7EPEDS%2F79782&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80005%7EPEDS%2F79782&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sexual maturity rating (Tanner staging) of pubic hair development in boys",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 347px; height: 542px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAIeAVsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD59+HngnUfHmtT6ZpE9nBPDbtcs10zqpUMq4G1WOcuO3rXfv8As6+LE66loP8A3+m/+NVN+yR/yUjUc9P7Jk/9HQ19I6D4c07XtT8YXeszazJ9j1FYYktdTvIVSMWVtJtWKGQAnc7ngZJPeuaU6jqckXbQ2jGChzSPmF/2fvFKEA6jof8A3+m/+NUz/hQfifOP7R0T/v7N/wDGq+p/CfhTwf4q0p9QsIfE0UKXE1sUu9Z1CKQPE5RsoZsryp4YA+oB4rlvBDz3XgnQJ7iVpZ5dOt5HlkbczsY1JJJ5JJ71jXqVqKTb/A2o06VR2szwdP2e/FTdNR0IfWab/wCNUv8Awzz4qwP+JnoP/f6b/wCNV9LROcLgnNWkO5sbs1gsZUaNJYWCPmL/AIZ18V5A/tTQOf8AptN/8aqRf2b/ABa3TVPD/wD3/m/+NV9QocHBPPtVtGwuAapYup3I+rxPlUfs2+Licf2p4f8A+/8AP/8AGqef2afF4/5ivh7/AL/z/wDxmvqtJD/e4qcnJ5NX9amL2ET5M/4Zq8X/APQV8Pf9/wCf/wCNUD9mrxec/wDE18Pcf9N5/wD41X1qGGM9aME5o+s1GHsIHyT/AMM2eLsf8hTw9/3/AJ//AI1SH9m3xdz/AMTTw/x/03m/+NV9ZnvkcdKTpUvFVB+wgfJh/Zv8XD/mJ+H/APv/ADf/ABqmH9nLxYP+YnoH/f6b/wCNV9ZEnIqCR/mJHXNJ4qp3H9XgfKb/ALOnixfvanoA/wC283/xqq8n7P8A4oj66noR+k03/wAar6qnfdkD0z1rPuFBJORz29KzljKq6lRwsHufLzfAjxKHC/2jomT/ANNZf/jdWIv2ffFUg+XUdDH1mm/+NV9KQW3mupbj0rZjjXoOPeksbVfUcsNTWh8qn9nnxWOupaF/3+m/+NVwHj3wdf8AgnV4dO1We0nnlgFwrWzMyhSzLg7lU5yh7elfb90NuRnIHOa+WP2mznx3p5BznTE/9HTV1YfETnPlkY1aMYQ5kaB/Zs8YDrqOgf8Af+b/AONU0/s3+LwOdR0D/v8Azf8AxqvpjxPbLqOt+E9Onmu4rW81N45xa3UtuzqtncuFLxsrY3IhxnsKoa14bj0zXLaFtB1qXSLi9hskuV8XX5nbzAMyCAORsXndlwQFY4wK1pyqzV0zOahF2sfOg/Zy8Xc/8THQf+/83/xqmj9nTxcemoaF/wB/5v8A41X0pHpkGh+P9X02ynv3sv7MsrgR3d9PdbZGlu1YgyuxGRGnAOPlFbS/ITnNY1K9SEuVs0hShKPMfKP/AAzr4t76joQ/7bzf/Gqaf2ePFmcf2joX/f8Al/8AjVfVjMFbjOTUDKWYgDj61m8XU6FqhBnyz/wzz4s/6CGh+v8Arpf/AI1R/wAM8eK8gf2joXP/AE3m/wDjVfUoOeOuOKVyEIzgelH1uoP6vA+WT+zx4sH/ADENCP8A22m/+NUh/Z68V4z9v0Mj/rtN/wDGq+pi3PBAxSx4VuGPrzR9aqC+rwPlf/hnvxWf+Yjof/f6b/41Sj9nrxWWx/aGh5/67S//ABqvqaQB2wxA9xTMAEck46UfW6g/q8D5eP7O/i0An7fof/f+X/41Ubfs+eK1HN/of/f6X/43X1MZiVOQSPpUcrnbjqMd6X1yoNYaB8rv8BfE6nBv9F/7/S//ABuom+BniZf+X7Rz9JZf/jdfUEknynA7VSmlCDI44xmp+u1DRYWn2Pmh/gh4kRSWvdIx/wBdZP8A43VCf4Ta7ArNJd6WAv8A00k5/wDHK+ib+cgNtIz2Ga5fUWL7DnMm4jaO3vVRxdRlfU6fY8VtvhjrNwxWK608kf7b8/8AjlaMfwa8RPgi70sZGeZZP/iK9t8N6cXbeV4B7V1TW6oqjCipljan2SngqS3Pk/xH8O9W8P6XcX97PYvDCVDCJ3LHLBRjKj1rjK+mfjVCqeAdWZR3i/8ARqV8zV3YWq6sOaRwYmnGnJKPY9v/AGR/+Skal/2CZP8A0dDX0j4Y8W6D4f1fxvbatrmi2F+2qJLFb39/HblwbC0APzHIUkEZAPQ9cV83fsj/APJSNSz/ANAmX/0dDX1tk7TxxWdSp7Oq5W6BCHPTSOU+G3jHQ9FstUt9e8VeCIvtGoXN/E1l4gSf/XzPKyNuRMbdwAIzu5OF6HD8AKF8AeGWI4OmWvb/AKZLXdXCCRSDnA5rLmY7gpANc1ev7VJWsb0aXI73I43ADBQCCMU1W2sQT+lJ82TnjJ7DtT1JLHJA5rk2OqxaRwEyM+9WEcAZ4qipOcHnPSrcQH3cHdT5ibFiJgw+pq1glQeRmqcOA2KsqSGHcVakRJEgGCB19ae3A96jyN59TTs4HJ61d7EDGHAJFNdx0wac5OPWomYKSM/nUtjSGSttXHBzVd5Mjk4p8zhtuOKqXcu3A44FZSkXGJDJIOenoapOpklY9QKlDhw2Omaktk8zgDrWV7myVkWbVQuw49qvkDJPQYotYQT8x6VNcgBTWkdDOXcybxWCEj73TBPSvlT9pck+OtPzyf7NT/0bLX1PfSbCc9a+Vv2kyT45sSRjOnJ/6Olrswn8VGGI/hH1V4q1Cx0fX/Bl9qt5bWNlFq0nmXFzKsUaZsLsDLMQBkkD6mq8vijS/wDhLLjVoPij4Ja0fakNrdFJGt4hjcqOt0q5Y5JYoT0HIAFdU5G33FVnZQozWtPEezjaxlOjzu9znP7b0rXfiTrN1omp2OpWqaTp8bS2c6TIria8JUspIzgg49xW50XI5oaMMjEnGOlQByPlI5rnq1OeTkawjyx5SaQBxnAxUMp4Jz1qZc5x+lJMM5Ws3qUtCiGbDLjGPUUxgWZSxP0BqzIMDkgcVU2hTwepqNtzVO4rFt2QOPrT/OyOg6YqNpNoxjimow3HPX0pXLtoTtJxxgge1RtPliP0prMc/KQKhVm81lHzHtTuLkLQlIz6YqOVec84x60OjKjMep6ZpkpIQhs5x2qW7Ds7lO5yVwCdtUJQDEx6Y/Wrkm7ackAVnXchAPyn0+tZt8zNbW3MPVplQZLYz3rO0yzkvrxG5K52/hVi9ie5vgg5XgEZ7V2fhvSxCqkgbeCeOlavRWRafKrsuaXpwt4QuwAgcYpL2NQpzxz1FbTcngZGPWsu9UsGOMAUrW0MFJyd2eT/ABti/wCLd6wwzgGE8/8AXZK+XK+sPjip/wCFX6y3OCIf/R8dfJ9epl/8J+v6I8/HaVPke3fskEj4kaj6f2TJn/v9DX1s5A43fSvkr9kX/kpOpZ/6BMn/AKOhr61cfN161GJ+MVH4Su/Xaao3EXzAjr61pFR3yfeq03fpn0rjkzpiZkhwBvPzA4qISguVB+an3C7nZT3qlIvlyZz909ayudKimaSAFeSMipIQd2KpxMAo3H8c1ZVskFCaQmjRhVd44qYDkngDpUEHY5P41IDkkDkVpEwkWMjPr7VHJgkUE4XvTT1zn8K0b0JSHHGOeBVaT5j2FTs25cVXkJTqCazkVErzMEB61mXDFnzzn3q5cvkjHC1mM4DNx9Kykzogh0KbG9NxrVtoQuGxWfbfLy3Y1rQngZ6HpRBJ6k1G9icHoVGaSYnbljx0xUqYC9qguSXwABgetb2VjCL6GPdDzpjkYweK+Xv2mhjx5YDGP+Jan/o2WvqSQDzjznivl79p5Nnj2wz30xD/AORpa6MJ/EIxL/d2PsOYdj+dVXxgjOBV2U7jg8mqroBn0rFjTIDzxzg1VZtsgzVqTjgHNUbg4IPT3qGXEtI21w3XNSkljk8DtWXHON6puxjn61dWTOBuxQNxsOdf+BVEY8kErj1qxsBHXJoKKgCnJB9+lHKJMpSxjacggA8e9QiMFiVxk9DWkRjqBUPlKOAMHPrUNGkZFAQ4J2nBPapYoAOQMk85z3q1Igzx1qRE56ikVzEQhJGT35NVJl3MQBz3q/ICoyDxVeTY2SB8w60hJmTMhDc/d7cViarIBGQp5znp3rdvHKId4z9O1czfyPNciFRndgnac9aSVjaKcmWNCsfOnEgjwWPJx1rvLe3EMX3OcVn+H9PNvAGYYfj8K19pJ6nINOOuplWkr2RWkjDA7gQpFVLwcEMBjFajr8uc81mz7SDnhgepqnGxEXdnmHx4G34W62AMAeR/6Pjr5Ir67+PKY+FWtt6+R/6Pjr5Er1MD8D9f0Rx43416f5nt37JBx8SNR99Kk/8AR0NfWoB3Hqe1fJP7JGf+Fj6jjr/ZMn/o6GvrVXw4OCD6Vhi3aoOgvcGs5VcDk1WmIPJA4qzJx8yjmqspJGcCuSTOmKKNzgkbetULjALAdcYJq/J985AAxWfcsFwGBwe9ZM3iCSALyc46Vbt2ymcDmsZS/mkdR/StG1cnC9fepUtTWUdDYgPPXtVpCAcis+Bsj734VciOBkjnNbRZyTRM5B9ahJye9ErjNMJBAI+lNy6CUdLiktjGahlYqvOTT2yqg5IqrdODgBuKmT0KiipPIAp55IwB6VSij3tnkqaWaXL4Y1NaqSaxbudFrItxxAfMOMDkVbh2gAk9+lJGu1e+elI3GBk5zxitkkjnbuy0zMRheveoZfUAGpRlVJJJJoZFEWCPvVomZtGesYMjOOxr5c/akx/wn+nY/wCgXH/6Omr6ouE2kFeO3FfLX7VIx8QNN/7BUf8A6Omrpwv8Uxr/AAH187c46VAw56jbU0wAznvUDAYHpWDZqiGRduRms+4DNz27VoyAED3qhP1x3xUMqG5lByk65GDWjDIMcn3rLuiPM6fNTreYAB8ZxUXOhxurm/CwZhk4zUsh9MntWfbEPhgTjqKm8wj5vXvVX0MGtSfOBnb+NNySeePpQCWAOetI33sIRnrUNlJCkIBuJ/Sml/lLAjOcgY605wDtB6ioZ2XBB4wKV7DsK8oUYbGTzgVSeXBOQoPPemlysoPYdDVS/kVGJbO6ocjSMCpqdwNjqFU/Lkc98VT8IWbX1008+DEpGD6kGsW9ke/1FbK2ZgzHMh9B9a9G0ixjs7WK3jGEXjOaE3sbN+zhfqzSU5BGABnsKlKhRx1NKi4OF496JOF5HNbxWhwN6kMjcde3pWbODISe1XLo4HvVQnnC8DvUvVmsEeafHo/8Wp1wf9cP/R8dfIVfX3x+GPhXrmR/zw/9Hx18g16mB/hv1/RHFjfjXp+rPb/2Rv8AkpGpf9gmT/0dDX1lIu19w618mfsjkj4kakR/0CZP/R0NfXMpBXArnxn8QrD/AAEIBKcflVacKgHHXrVtcgY/nVS5JPTpXHex0LVmddtg4HTPU1k3kn7s55PrWrcAqxDH5T39KxrlgEfOMDispM6aaKbSDfvDEHpn1q9bT/JxWDJKquckYHWp4bzdwMEeuMVmzrcLnT2s+0diRWiJwYwcYz6VxM2s2+mW73F7MIol/vdSfQeprmp/E+oazOwti1rZjov8ZHqT2+lbU1Jq5hKjzS5Ueqy3UaKWLCkW6j2rhwfUZry0ytHGd87lcfN82eah0vUJ/Nbc7HsDSSk9Snh4rS56vNcgJgE4qhLIMMTnHSuetNRlUo+S0T8EEfdNaM05xzk5NZub6h7Ll2JIUEjZzmtK0TaQSMYqnZREgsue1aUKYOehHQ04Gc2W8EjBOOc1JEgB5yT70yPLY4OKsRIO+a3Sucj0BRnOegNNbEf48ipDkZxUZ5A3YzV3sSlcimUsm6vlL9qg5+IGm/8AYLj/APR01fWUozH1xXyb+1Rj/hYGnY/6Bcf/AKOmrpwb/eGWI+A+vpSPTJFV2OTx+NT3CHGRVUnk5HHrWFzWxGT8x3VTuVVnzkZx0q6y5Ocn61WmAOMD8TUNjWjMW6Tkt3Has9JQjsi46cZrcuAPMO7nI/Oud1KPy3DJzjg1m0dUHfQ2bG42R7Cee31q8JRgBj0rmYLpVaN2wFb5SPetmO4VlJGMVPN0Y5QL32koxPWnRyln3ZGSMDtWVc6jDCm5yAAOTnAFYb6tPqRCWiNBC/3ZXGCfp/8AXov1KhRc9jq7vUordlEjruP8I5P4CqQvXucEIVQnrjrVXTbYRhXf55D1Pf8AOtaNUXBXoeMVm5Nl8kYEEmAnDFcHvXFa9eyw3ro5OzacH+9XY3ZUdScD261wviPb9p+bndnZ3xVU7N6jitTa8CWRDvc3HzPIcggYr0aFQMZxiuV8C/PpqgYyvFdcF+Vc8Y/nVwV22c2Kl73L2HEkZAHSoy2Qc8U7IJPPJqOQ8Yxx061tc5kiCYkg5I9uKpDLEkjv6VbmPy5zUDfdzmsmzeOx5v8AH9cfCjXDnnMH/o+Ovj2vsL4/4/4VPreP+mH/AKPjr49r1cvd6b9f0RwY3416fqz2/wDZFGfiRqQ/6hMv/o6GvriTK4wK+SP2Rf8AkpOpf9gmX/0dDX1wx45rHF/xCsP8BApwDnP41VuH4/wqdwW6daqSZ2kZHpXDI6Y7lK6+dD/jWLeDMZHAPfBrZkGCAMVkX21GfcePyrCTOumjjrl/LnYNgL296gm1aO0gaRzxjODWV4v1iG2vEgibMnckZ4zXGX2oveSrFuOSQcHoAOtd1HCuqk3sa1MQoaLc0b7U5NVnNxMcQRnCJux+P19+1aWjXiW+hXN8/CxKThT6nAxXI38w+zlUdSoBPBx9TUXiDVDF4bWGAlVYoCuegVR/UZ967nhlNRilpc5HifZ80n2Om0/XjeSbZQyhjwo/rXR+bsjRwwReB8teT6Bfi4iimj/hHIPrXpWlObu0jLEE47c4rPFUFTfu7FYWq6sdTpYLtvJ5yS2VJxxn1ro9Mj88IzglQOvrXL6Vh4/LbDY4OfSux0GVHtdhXmI7Mdz6GvKqJI6XorI3LGLCdcE9qt+XgfKeO9Q25IGT17VY3HaMD60Rs0ck73BMAgLVgPhOBnIqvhex5pUbqMVonYyauTAjA70FPl6cUiLuPvUjnEfvTWpJCfuV8nftUgD4haft6f2XH/6Omr6y5OCepr5Q/avG34iacP8AqFR/+jpq68G71DLEfAfXj9z2qs6qzDH41NLu2nB4qqXHTgketczZtYbIWU/LyKq3GTjirbsGXgVSmYFu/IqWVFFO4II6DIrI1FAY3IGQe3vWkwIO1uap3KHBBJ6d6m5tGyOTmnMG5dw2hwQOwrTudYhstLa5uJFAAyea57xQ32PTr64bpBGz9PQE1yvhHVR4pninkH+iQHCof42x1I9BWio80XN7I6rxdodWdzpyz60/2q/DJbf8soAf/Hj71uSsilQyqij7p/wqhHIEysAyOgq1HG72zELukbIy3oa5pXbuzotYfYSs8jEAiNTjLnr9K3bSQSADAIHTFc9rLnS9Ojdj8pXG73P+TU9lqcMIVGkPz4IHf6Ci3UynFzV0bF0FJH865fxRphexkfGWX5hmujhuBJk4/On38ImhcELyKSfLK5ldx0ZzXw31TLPbs+Rz17GvSw2VO0j614vZbtK8RFV4QkE4GOtew2jh4Qw5B6VutJGGJjtPuTBcg5qN8cDp9KmdgBj+VVmZiTjnmm2c0dyNxlTgk1Wkbys4qZ24OeB6iqk5+YAdPes7m8FY89+PrbvhRrZAwP3Gf+/8dfIFfX/x8BX4Ua2O37g/+R46+QK9bLv4T9f0R5+OVpr0/Vnt/wCyMdvxI1L/ALBMn/o6GvrZ2ySK+SP2SBn4j6kP+oTJ/wCjoa+tXGfrWWM/iBQ+Ajl4+6Ko3I2HpjJq+4yp5qjdjKZPXrXFPY6oblGb7w9a4nxvqi2NuylvmPP612dwflDDBPXrXiHxXvWGptDvIC5P+FTh6XtaqidTmqcHJnE67fb7xJiS2/JOTnofWqumXSyXMj9SemOwrG1i8LzQZ54IPP0qfQ2J1DYOdijI+pr6dU1CnY8RV5Tr36G/coDHtBOc9D3zWRqL+dbQhlIOWz9Oa25C2D7dz061iX+NsS5OAT93jrntU0Xsb4paMy/CcwhnmtTn5ZMrkc16r4fvVSHa3ykcfWvGA5svECNnhmAPHY16t4Yi81137sgj2rnxkU4mmXzadjudLlRZZFJzk5Brp9Fn8u+RRj96pB9yORWXoenW011t2gYTIzmtZrIWk4lhJ+Rg5z2wa8Gor7Hr8y2OvSQbAD35zUsZLdB8oqkCFA5HPtVm3fABY1nF6HLKPYs8kH/CnqoApEy3rUoBzyK0RiwXAXhsU5x8ow2aFTmnKM8HtVogai8+1fJ/7WYx8RtN/wCwVH/6Omr6z+63HQ18m/tanPxH07P/AECo/wD0dNXXg1aoYYj4D65lG5QDxVOTAJAxVxwCOOtVJhtbGPmPQ1zSOiJVkYIATjjk1UkbJIC/L61amXPB79aqSAYI4xms2zeKK9yg2buh7VnTsfuk9RwTV6VlCMGPX26VlXTgbhk/nSZpGNzmfF9r9r0nU4FOGmtnUY7ttNeTfB6/zZPaICHQ8mvar8oGUt91v09q8X+HFolj4t12yVcLFcOq5/uhjj9MV2UHejOLCV1WpyXmj2ewiDAYHLY//XXR2Vrv2bw2M/lXN6e2y4CIeq4OTXZ2cyJFu3BsDHAri5bnVXbitDiPjFO1h4e86MjCOcjGc8VmeHB/aKwSlsjaCMHpmp/jg4bwfcOob5SSPyrk/hZqWzSLeLzMtGNpLenUV0zpXoc0d0zLD1Gqjh3V/wAT1/T4USMkEfL6nrVm4w0TAEDiq+mSiWE8Ak85rQkSMx9OTXn77invqeb+IIjDrUEpGAy/hwa9M0O4E+nxNkV57402J5W5sHdx+tb/AIKuN9j5ZJ+TJB/Guhu0YsJx56fodk7e5PvVdnI4GDUPmEnk4WkB5JBFK5zKFiSU/ICfy9ahIXknJOOlObJI70xyQBg9+9K+pcYnnfx8dT8J9bABBJg/9Hx18gV9efHs5+FetncSP3H/AKPjr5Dr18u/hP1/RHm47416fqz3D9kXA+JOo5/6BMv/AKOhr62Iw2MV8kfsjf8AJSNS/wCwTL/6Ohr64bJORWWL/iBQ+AikXKkj0qhKNy7cA1fkYYxVKTqQK4pHTAzZxjeGxx618+/GNTb+JS/ADpkc19AXBDb88nGDmvDvjpbhLmzndflZCM/St8t0xCHitaEjw+/n8y6GzB8tDnAxnPtWh4QkaXUbljydoJ9uTXOySFnkY8b8960fC1wIdWUMSFdSp5+le7KXM7Hl0lyNM9CMpkHp1wWH6Vk6grBB7nk//Xq8JmVjhshvQ8iqt1yGJGcnj2qafus66/vR1OP1pgmoQSDkjBz9DXpWhXzLMoUkg8+5NcgdMN9PFOoxHB8zknt1rUsrhrO6RQPm6rxmnVgp3Rjh5uk03se++EWaSAyDkeoHU1t3OcLFkEsw/nWB4IuM6Wm5k3FcsPrW9Fia+Rc5EZ3N6V8vP4mj3murN1EUAHOc+vapwm5xtOBmqw4XDHn2q9axEsCT+tRExk7E0GQO3Bq3z1FV8YPapd5x71slY5pagpIc8g1MpGOlV13BuveptvB55q4olgoBPHWvkv8Aa1/5KNp3/YKj/wDR01fW0YyK+S/2t/8Ako+m/wDYJj/9HTV2YRfvDCv8B9blju9qqTH95kde9Wn+bocGq0n+z0rjbOlaFacbly3JFUWOSSeKvPynK1Tk77vwFZtm0DNu2yTk81mXYBBY8VrXce4H1AzmsW63hR1561KdzohtoZN8/wAg5GfavLLNDYfE/U1+YpdxpOB9Rz/I16fqGSjE5VSOOOnvXmPi24jsPHWj3M2Akts0ROO4Ynr+NduG3lFdUOr7qjPs1+On6nptlJG0p8xWDD7uBxit6LUz5YQIxAA6nArjba/j8pSrKeBjn1qprPiaHTrWR5WAbBCqDzWUacpOyR0VXBLmkyr8YtaWXSI9NjBkluG5APasbwoY7SZLdGxL5I3dOoP+BrFjFxqupHULsPIxOIY8c+1egeG/At99gutRuFaO5C74I+pYjsfqK7ajjSpeyb1/U4KV3V9r0/Q7rw5Jm3VR98de2K2bgFYwSQB6Vw+hX4ilWSMttI+YHrx7V1S3i3ChmJwBnnvXkzi0dVSPvXOJ8az7rmIZXnsa6bwEpNgrZz9fr0rj/F0sc2pI8IxGByR3Oa7fwOo/spWzx7fWtJ6QSB6QZ1BX5TtAAz3pqnnA5pHbKkA5PvUaNsCgn5jWVzlS01JJDtTcAQfY1Afu/N8rHpUjAkc80KueDgHFCd2WtDzz49qF+Euuc5J8g/8AkeOvj6vsL4/IB8KNcIP/ADw/9Hx18e17GW/wn6/ojysd8a9P8z279kjn4j6l/wBgmT/0dDX1sWxgHr9a+Sf2SM/8LH1LH/QJk/8AR0NfWbHg5rPF/wAQdD4BjkFc4qm0ntj3q07dRVZ1+TriuJnTEoXP8XfNeQ/HOAy6LZv2WUgkehFeuXIx1OTniuP8f6R/a2imFV3Mjq4H0PP6VWHmqdVTfQ2lD2kHHufHd1bNCfmxzzj05pltKYZ4pFHKNmu58RaN5Gr3tngYilZBu9M8CuXutGnRmMQ3Adu9fRuF1zxPE1i+WW501rfxvGrAgn0XirESS3UirHlVHGSTgCua0/S9RJZY1bb1x/hXSaToerTwqrbwnU4O3NOU4xV27GkI1Zu1rm0JIbLTDFayJhm5Z2A3H259qyWjdolePblDwV6Fc9cdjVp9GmtHzIpzjb16j0x0rY8OaYbmQebH+7+6VIwK53UhTi5p3OlUqlSXK1Y63wpfSW+k2pa3JWYMPM3YxivRdEDR2Kswwz8nPX2rk/DPh60sY0MytdbOY/MJAQ564zg121sCfl7E18/XlFyfKeyuZRtI07VCw3mtaIqAMDP1qhagiMAAZ6VoRqEXJ5/pURRyVGPbkZyM1IqjI61GGJHC5INSo3TIx7VojBigkseOKl2nFN4HtTw3Aq0RcAAEwBx718kftbf8lG03/sEx/wDo6avrcZx7V8kftbcfEfTf+wTH/wCjpq68J/EMa/wH1ozbQcCoZH+TlcUO5x82c1Xfnb1IFcLZ2qIyXK57g+9UZSA2QvfoT0q/KV28CqM6kjIYj61k2awKN2FwSTk+ntWTdf6lueD39K1blhj04xnrmsa5XMGDwvNJHRBGLfPuVg3QcH3ryj4xxiW00ecAq8czx59iM/0r0y7+UN1yRivN/i983hqJ0xlLle3qrCvQwmlRMjFx/cSt2/VFe1uIYdHR5brDsuAgPzE+gHc103g/wBd61N9u1hpYbc/NHH1c/XPSud+DunwPcie6RZZwQAz87fpnpX0ZZAEDA5/LiqxmJdKTpw0ZhRp88FOexn6B4T0rSQDDb75QMCSU7j+vSukTCJgYqpG7ZCkfKTgGrXzcA49OK83mctXuaz7M4TxdoM1pdPq2kxM0bfNcwxqM5/vqO+e4/H1rOs9ZM0HlR/Kf4jnjp6/4V6au1evODmuS1HwjbTX9xdWkzQrNk+SgChSepX0z3rXmjJe+XTqW0lscJqTebKEiOVyc9M57fTvXofg6JodNVHyM5NZen+D5DfB7hhtXkAGu0hgjijVFGFBxSqTUrJGlSSjHlvdsYhGDgmlGPbpTnXk9AKixwSCMdqzMFqSE5Xj0pjBt4wfwpYfuhj0pwbJH9KEg2PPfj62fhPrgPX9x/wCj46+Pa+wvj9/ySfXOOf3H/pRHXx7Xs5d/Cfr+iPKx3xr0/Vnt37I4z8SNSH/UJk/9HQ19ZvgE88V8m/sjHHxJ1I/9QmT/ANHQ19ZzgEjis8X/ABAw/wAJWfI/OoS5OR6VO7ckN1HQ1WlyMlO1ccjqWpWuQHIPvWVfoDGV9RWpM52qcc1SuV3AEDrxWcjeGjPnLx1CE8Z6qvA3SAn8VB/Osu2thtUgDBPU96674k2Yj8XTvg4lhR+R9R/7LWRZ25dl4O0jOTXtxrfu0/JGCo8036l3S7dAgEagbefm7+tbsKYAHp7dKoWUBhGMqC3GM9K1bLkoWA5wCPWvNqyctT06UEkRy2C3QIaMZArS03ThAQAPlHQ+tWrC3O35gCx71sWtsVwrDgc4z1rmlUbVjS0Y7FzT4lAGPTvWrbKvme2c5qpCAApUYA7CtK0UkDPQ9c1j1MJsvWzKOM5q2hDMKqx7VUAnGBU1uBncCSelaROWSvqW0OM8ipI+W6cVApwFHOfep14IJq0YMl3ZbG3pTiOeO1NUAnPSlOd3FaogXrxnp6V8lftbjHxH03/sEx/+jpq+uFX1r5H/AGuP+Sj6b/2CY/8A0dNXXhf4hhX+A+rmJ3c9Owqu53HI6VYmGT83TtVdjtOMGvPZ3Ihd8AjjFVJcKcZzntVmXlm4qlcht42jgDFZSRtHUo3HII7dKyroGONzuA4rTkOW5BH41Q1I4Q7cBgcnIzxSWh0w7HJX+RJKWOefuiuD+Iyed4UvNwyI2jccdtw/xrudSJWR+APc8VxPjZhJ4cv1HzHYpIP+8O1d+H+KPqLE60pLyf5EXwbIVmGACSB+tfQNoQipg+/NfPHwlBQncemOD9a+hLEK8S9eO9Z5iv37MsPrh4l1DtK54GasTOSQ3HSqpKo244OO1Kz7iBxiuO+g2rkpUurFuPQ5pxPyAbcN0yOlRZGeRxSu7jAH3cVPMJpliORYwoByST3omZc5xnPGM1UEm84x0p5BYfMv41SYnCzB3B57DtShQVGAeaYi5GdpAz+dT8kfKO1FxvTYYqjKop496djaOlPA7nANRS5BK98VcUSndnnXx9Yf8Kq1wevkf+j46+QK+vvj3x8KtcHf9x/6Pjr5Br18u/hP1/RHl47416f5ntv7JPPxH1Lj/mEyf+joa+tpa+S/2R/+Skal/wBgmT/0dDX1i5yxz+lZYv8AiDw69wgkPzcD8agk6gZ4qW4I5C9qq53sRnGOa42dSRG5UscgcVTuXXovY5qeRj5nI9qqXu0AFeM9TWbehvFao8n+KMX/ABPbR1wN1uecejH/ABrDtvkVF/jPG0j+Vdd8SYVlvNPkLEsqOMfiK5yGPewyMlRgnNdaqfu0dFOC5rk8KkRghcD074rQsl4G8qMH7wqKFQxweg74rQtoVAIU59K55O51JWNe0A+UIAVrSYgjDcMPSsyz+RQu3n1q8N4Ysxz6DFYsho0bJsg5wSa1YWAAxWPasQuTwe1almSCocdqV7HPUXUug7toq5bgjGOtVEwrY/WrSOFX0NWjllsTbhzgYIqWIZGTUCqCd386tJwq1cTKRIqlR1609AQpJFNU+/NPLYX1zWyM3qI5JVea+R/2tjn4jabn/oEx/wDo6avrVySOCfpXyR+1nn/hYunZ/wCgVH/6Omrpwr/eGNf4D6xcnkDHHeoJGO3GRmpJSWVv0xUY4wOh9689s7ktCs4cgksB2xVZwWByc471bYE54yDzVZxtYhQ3OTg1MjSLMyUAEjuOayNQ5IZsEda1p/lYlgQSKx71gVZ2IB6ZNQdcFrc5PUzkyNnB/nXF+LsyeH9SVTz5Yz/30K7PVMshVBkrXEeLAY/D+os+0BogARzzuFehh/ij6hifgfp+hX+Faj7SRyORnPbmvoOw+WMccEV4B8KVzdZYFsY6Z4596+h7JVFspPHFZZjrXZhhnbDxFiyzegNOG7cfUetPjwuAO1PHMmePyrisW2NRGycZzjvUpBMZUnt1py88KOvWmnG5iuTnqKLE3uxsUQB7GpMMcjOAKFBwuflp+OgPrmnFEt6kYO4EHPFOTC8E9qVgNuQMDvxTJPu/K3JpvQN9BWmGMDtUEjMxyCfQ5oCHBO7jPNI2TJjBAFJMdlE89+PjZ+FmudP+WH/o+OvkOvrv498fCvWgBx+4/wDR8dfIle1l/wDCfr+iPJx/8Ren6s3fCPirWfCGpSX/AIdvPsd3JCYGk8pJMoSrEYcEdVX8q6s/G74hE5PiDn/ryt//AI3XV/sgf8lL1P8A7BEv/o6GvqD/AISS7l1PUrPS/DOs6munzLbzT28loieYYo5do82dGOFlTnGM1tUknPl5bswimo35rHxifjV8QCTnX+vX/Q7f/wCN00fGXx6Dka9z/wBedv8A/G6+1f7a1z/oRvEP/gRp/wD8lVoaFqkOuaHp2q2iSJb31tHdRrKAHCuoYBgCRnB5wTWcpRjvTX9fIuPM9FNnww3xk8eMedd/8k4P/iKjf4u+OJPv63n/ALdIP/iK+9JF61EcCsnWpr/l2v6+RqoVH9t/18z4C1D4j+K9QKG81XzCmdv+jxDGfovtVZPHXiNPu6jjnP8AqI//AImv0FzTt35U1Xp/yL+vkPlqr7b/AB/zPz8HxA8TBiRqfJ7+RF/8TTx8RfFK9NU/8l4v/ia/QESGjdk0e3p/yL+vkH77/n4/vf8AmfAi/E3xcv3dW/8AJaH/AOIqQfFTxkDkaz2x/wAesP8A8RX3uzU1n96XtaX/AD7X9fILVf53+P8AmfBg+K/jQf8AMa/8lYf/AIipk+MHjpBhdcx/26Qf/EV91bs0x3IpOtS/59r+vkHLVf23/XzPhr/hcnjz/oO9P+nOD/4inj40ePwMDXuP+vO3/wDjdfa9xMBmsi/kBICnOewqHiqS/wCXa/r5FRw85fbf9fM+Qf8AhdnxBP8AzMH/AJJW/wD8bpf+F2fEH/oYP/JK3/8AjdfZFhbKsW5h+lYnjKPfplymAQ0TKB9RihYqm/8Al2v6+Q/qsm7c/wDX3nyn/wALu+IX/Qwf+SVv/wDG6X/hd/xDH/Mw/wDklb//ABuvP2G0sPTimdMc16Ps4fyo4ry7noZ+N/xDPXxB/wCSVv8A/G65LxZ4p1nxdqMV/wCIbz7ZdxxCBX8pI8IGZgMIAOrNz71iv9402qjCK1SIcpPRs9H/AOF2fEHOf7f5/wCvK3/+N0h+NfxAJydf5/68rf8A+N19s+INaOkNp0cWn3mo3V/cG1gt7QxBmYRSSkkyOigBYn7+lV/7Z1z/AKEbxD/4Eaf/APJVYKMJaqCNm5LebPiw/Gjx+Tzr/wD5J2//AMbprfGTx4xydd5/687f/wCN19s6Pr0uoape6beaPqOlXtrDDcNHeNA2+OVpFUqYpHHWF8gkHpWwPepaprRwQ057qTPgmX4u+OJWBfW8kf8ATpAP/ZKgf4peMXXDaxkf9esP/wARX342cdeKhYj6Um6S+wi1Kr0m/vZ+f8nxC8USff1PP/bvF/8AE1RuvFmt3UMkU97vjkG1x5SDIznsK/QsuRShye/I7UKrBbRQ5e1ejmz88tJ8Wa3pLltPvTCx7+UjfzBroF+LvjhU2rreF/69IP8A4ivu7dxyaQvgbW4z3NEqlObvKCbElUSspux8Kf8AC4PHW3H9u8f9ekH/AMRTv+Fx+PMj/ie9P+nOD/4ivuh2KjnkGnNLxjoM0r0v5F/XyD95/Oz4WPxk8eE5Ou8/9edv/wDEUf8AC5PHnbXf/JOD/wCIr7uD4yAaC5LYx0p/uv5ETep/Mz4R/wCFy+PCQf7d5H/TpB/8RS/8Lm8e/wDQe/8AJO3/APiK+7N+eacHA4PWj91/Ig/efzM+Ef8Ahc3j3/oPf+Sdv/8AEUn/AAuTx5/0Hf8AyTg/+Ir7tMigHNIjhlBHANK9L+Rf18h/vP5mfCJ+MXjs9ddP/gJB/wDEUf8AC4vHef8AkOn/AMBIP/iK+9Yzxipx0pr2T+whOVRfbZ+eWvfEjxXr+kz6bq2q/aLKfb5kf2eJN2GDDlVB6gHrXIV93ftMf8kQ8R/9u3/pTFXwjXTSUVH3VYwm5N+87nuf7H//ACUvU/8AsES/+joa+pPCPlbviH9ou2soP7T+e5WQIYV/s60y4Y8Lgc5PAxXy3+x//wAlL1L/ALBEv/o6GvpgaRr1pf66+lapoosdWuBcS29/pUlyQfIihK7luEBUiIHBXuetYuahWbl2NFFyp6dw+Hy3Wm+PNf0i4vbuW2Wytri2ik1OXUVKF5V81pJfmjd8DMYG0YyC3Y+GBx8NfCX/AGCLT/0SlRaHoviDQIpIdCm8F6ZFK26RLPw3JCHPTJC3Qya1/DWlnQvDWkaR532j7BZw2nm7dvmeWgXdjJxnGcZNZYmrGaXKy6NNxeppuwIx3qBhjNOLYIpjjK9cVxN3R1RVhA3y8Y4p27gVWOVbGacrc4zUcxbRPu4PpSBuMVGDnIoY46YqibDsnPXimM3BprE1Gzc0XBEpk461Xlm+U80jtVeQhlbJIH0qJSLUSOeX5eSBVK2Rri5y44WkuGLSbRya0rOPYgIyTWXxOxs1yRLRwqVz3iT95buvcgit+U7h6VzuttkP0OKt6EU1eWp8K3amO6mHcSMDn6moa0fEkXk+ItUh/wCed1KuPo5rO7GvfTurnlPRkUn3jTac33qbVmT3P0X1/wD5GvwN/wBheX/033lcd4on19/it4Xv9X0PVRDDrUtrp0cU9sYGg+zXAMgHnbjI/Dneq7VTaPmzu7fxNpV9fzaRd6Ve21ne6beG6ja5tWuI3zBLCVKrIh6TE53dQOtM3+OMD/ieeG//AARz/wDyZXPTqRjGzZrODbuhJf8AkqeuH/qDad/6Pvq2Nx54rG0fStVi1/UdX1zUbG8ubq1t7RVs7J7ZESJ5mBIaWQkkznuOgrZx+VY1ZXldGkFaNmNc8cVE5yM1M3ao2PpWbNEQMeMZ/Gowx7t+NPc5bI/WoHIBJOAR61k2apDzJglWUYHeoGuW2MMYIyBnuahml82NgRuwM8Gsw30UhMcZywJKqTzkDmoc+xUadzdSZZYl55A5HoRUbzDaQc4DA1j298o2shaQlCrcfe4H+NQajeW6XUc28ldvlkKeowcGqUnYPZ6nTRSB03AkDOBUqSkhic1zmlXrP4etGk2eaYw7lem7Pzc+lNXV4xZpIobbM7BSe2Djn04/rVc5DgzpElLMR27+1DXCrl2PABOfYVjPqMcOnmZyf3ibkX29PyOazJ7x7yzhjiy6vFh23gYBU4A9Tx/nNCndXB0zpbeUsIzI3zM2cVNaSCRmIIwDxg54rjn12NY0WFt0yg7VQA+gPOeo5711Ph8l7VJFZHRxlWGMEetLmdxyhZG5HyoqTtTI+cVIK6UcrPMP2l/+SIeI/wDt2/8ASmKvhKvu79pj/kiXiT/t2/8ASmKvhGuqnsYT3Pc/2PwD8S9Tz/0CJf8A0dDX18OlfIP7H3/JS9T/AOwRL/6Ohr7BxXFif4jOmi/cGEkMMCkfpT2FMPzZz0rmZsmVnPzUHpSSfe9qGbBAFZXs9TboRSDJpoHzZHWpP4gTTZFIHTmp8ykwVz6fpSdSCRxQMbQTxS9qExNAxGM01iMU49MBsZ9qgkY5XrT5g5RkzgHtmqM8o+7zntU9xIFy3JAGTVS2iaeZWb7orKUrmsVbVk9jbDdvYEk1pIm1afCu1QMnH0p7EHgYI9q1hC25lKTkUrg4G4A1zmrNvVwAcdT710tygMeAOP51iX8QEUmOuKzm+hpSdpI+LPiRF5Hj3XUx1unbGPU5/rXN8YznnNdp8ZIxH8SNZC4wzI3Hugri+/TivepO8F6Hl1V78vUif7xptOf75ptbHOz9NuTwelJ0pxpp+7+NecdYrHA5pjZ2njinPTT060myhp7VG/I4FPz70xyB60mxoquCc9azr15B91QT6n071qSMMsV64rF1DdKfLDMoPJx3x2rmqPQ6aSu9SibgF43VtsIXKsOCB7iqU8cJjjuI1TMgbdtbjHX9SOtZ19dH7ZcR58qdF4I4BBOePxrA1LxNDaLdhSN6futv3cHHbPbNZw95nW4NGkNau7OUJKgEBJ3F+zfX06H6c1zN94qtobhDcLhcFjG2TglcheOo68+xrmLnxLPcI8Fy0UrmNZkAG3zNyEc54+tclc64t9NcXEwmeN4vJSRUOY035b6j5sdK9Cjhr6s462IjHZntWn+IFXwvaSGdYJbizZ+emCwG/HcZ7mok8Ti+s7hrSZNwDBcsFABwpOOvXd+Oa8g1DUxfK8NqtwPlSIRxndtTbjgHnBAxj1q5BdmKxtnguJ3kBVcLGFCfOGUe4IXcenNW8LZLXUxjilfY9i0XWZL2VV1OWK0gsoULvJhQQ2B948ZHFMstchlsb2ygdlkhlNxHg4JTbkHJ7ZP4EGvPrLWY7myuY3ZDP5YxJIcK5GCwcEcEZA578jvVI6jBFJOIpTDeAbUd4myTt+5lThlcjkYOMj0rKNBu66msqiWx3aXcq63HZWkzqhdZHBcHAJG5geRnvjvgmvWfC0Yi0e3WFf3Wc4HQZJxj+f4185+H9Rvr3Vm81UuZHWJ/9HuBGyspwFGeucjjocn3x9AeFdShnsEtrjzIJowW8mYFGAzwff8AOoqQ5ZIObnhdHZRt071MKpWtx5iAKj7gMEkVaVhnGRkVtFnJKJ5n+0v/AMkT8S/9u3/pTFXwlX3f+0x/yRDxJ/27f+lMVfCFddLYwnue6fsff8lL1L/sES/+joa+we1fHv7H/wDyUvU/+wRL/wCjoa+wc8YrixP8Q6KPwiHGaacZPrSnrSGuZvU2RXnHy/4VWLdqtS/yqlKwXOawnubw2JN/y5oaUMp9aoCcfMCeBVaefdETGSGHIrF1LGyp3NFnBIGcn0p3mgAcfXmuSur25Zyu7EiEDg4wfUVr2Ucs0eXZtg98VEat3oazocqu2XZLxEAJbjOOTTXlDRqwb6VUkhiDsWkcgf3uQKzNVmeCDzUOUB3Dn0qnJ9RRpJ7F+4k38Z5Y9PYVqWKKkag1yWkSyztncuGOSST35wK6eGVsIBjPfrUwld3HVhZcpphhzijgL71FFkdelPPOa6k7nG1Yik+7WPqAAVyASCK1pDlKy9Q6EA1lNm1PRnx38bUC/EjUwOhWL/0AVwnUnqK7/wCOq4+JF+fWOI/+O15+c5yTXu0HelF+R5lf+JL1I3+8abTn+8abXQcrP05+lMxinEdxSHpXnWOoYRnpTWHFSDoaY4z0pFkRBAz2qGRgBkH61OfunmqF020Ejis5uyuaQV2QzXG0cYz0rDvNRWMuZPlcDrn/AD6VbvLhthHQ9j71xWuvO8lvIrusnmElB0YAdOeo59q4pyuehQpKW5i+JdYtxLm5VZ1LYBx0Pp/WuNv4oL+G4EbLM8I+583yjPzc+px+npXQeJklkgeWCYQOnUpHjDE4wc//AKua8o1HVLjTPNkzJlsq5Zh8xJ55HXHFduEp86unqicZVVLRrQbqd8kN7KYQhFyifNuzwGzz+tY2p3qRi4ht0CqF2Als5Qk8EE9c/jWHPczSMhkYMwBwwOfrUjMs9vI8uFaPBA5ySc8n3r11orHgSbbuzT0vVJLO5Ibf9w4yc/N1AJGMc1btdQyweeaRQjAhuME7cEn0IxjvkdjXPzKmxmjYZbG5UXAI7Y/r/OtzastshMgcPGvKoQ+4HBU/z/rVJ33Ibelhy6lF5nlyAo0e5/MUY8/HHT3GBntitAamb+yjN5OQY0VE3ZbMfI2Z5xjp/wDrxWRqlvac/ZJUw4BGCQCCT69Ocf8A1qTToLe5uYEnkEPmA7ZWHynbg9ew7ZHTFTa2pV7aHuvwg06xu5nvrlrVXQ+WISS0hV/mDk4yDk+vvxXqdhL9kufsttctchnJEEh+dRxnk89T+teD+GLe4eKJ7GO4mAVWhgMvlQnaQAx4yeexPv3zX0BoFki6fDPcrHMxG7dGhCox9ATlefc15OI0k2erTfuI6HT78SgRFJBIOSD2HofXFayZGCVFYVnG1tNASrFpSwO85ZT7Hoe1biAlASSD6EUQZlUR5t+0yc/BDxHj/p2/9KYq+EK+7v2lx/xY/wAR/wDbt/6UxV8I16FH4Tjnue5/sf8A/JS9S/7BEv8A6Ohr7AxzXx/+x/8A8lL1LP8A0CJf/R0NfYHauLE/GdFH4RGxTTxS4w1Nk61zM3RDIAQeeTVG7yq5HTFXW9qqXPzIR2xWNTU2gc1JcMl9OkmMbQw/KsjUry7wRbldvTJGTyKXxFqMNprNsjH5njYfUjH9DWdJqImYBV+bBIPYV57uj2qNO9pWGad9t+1s87Rqq9DjBIHTjNdNBqscEAiQliByWrk5biNGVn4wOucmodIke9ndt4OwZGT2/wAmiLe5rUoqXxHZPfeYWJOFI4PcfSsbVLghEy7bNwJ+lRWl206gOQsmQd3rzWy8SPCI2wQemKfM+pg4ezZVspo8J5RYk9ACOldZZqCiMOvf6VxKyrZXKwtuG44HHSun0m+QhUXnPSqptJmGIi7XRvqAF5oducD0pA2RmmgYyc811p2POI3wB1xWZfH06mtKU54BrOuyOcDketZyZrDc+SP2gE8v4iTf7VtGf5ivNTnp2616r+0ZGE8c27AY32an/wAecV5WAPf2r3sN/Bj6Hm4j+LL1IX+8abTn+8abXScrP03yRTWY96GGTTWrzmdaFB60g647008UBgtIZG/U1Ru1yhzV9iOc1SvhiPisp7GsNzmr+V0kIH3K5nWp5GQtszGcg+3vW5rMxt0Ysc56CuG1zUWdCoAHPQGuCV+Y9ihC6ucN4lv57GPcSZfMypAHQc/0xXluo3ouJZEYFVI2nI49smu48av5SwMGcsWZWJA64OPz/wAK4Ge4umuN0UksZIwCPrhvr36V72DilTTR4WYTk6vJ2KQVpZVQoViUFgoHYZIH6/rV3ctsJ/MEbZQBDzwc9cd/pVy304vsnmtl2t8hHGSTj8MdOap6oqfbY1k+RURcgcnPYn1GK6rWOBu+hCsDROFkQeWxONx4cZH6cHn3rv8ASNLW5tIvNjMVuWCloW4DYJIxnI+v1OK4WAxNJMUM8e4YI4+bvyO4r1LwpaQZtymftKjb5kZA28Zznuaxrz5InThaftJ2Zm654XW8SRYLgyuGEYOfmcFuG/D0/XFYun+Hbqx17+zNRhVJ0Bwdu5XXg9B1Bxj25717HbaEkdphy0cisXhl+95bHv71Jr+gf2pFFeLIsd7aDKzbcFkP31OD39fWuSGKe3Q7KmCXxdTOsPBPk2FutnLC14y7orm3dl3DAOHHUDb39unauw8HXGr2s5TUMyyopjP2eNjuYkEN124654FL4WQRzm1Sd5rlPkdv4lJIG4gcHg5rrZILq3AaMmRXK792BuYN+n1965JVHJ2Z0cqirHR6Q5uY1a4j2SL1+vTNa8YygJOazLZXWWN1iVFZRnJ5B960kbgZ61tTOKrq7nmn7TH/ACRDxJ/27f8ApTFXwhX3f+0x/wAkR8SH/r2/9KYq+EK76Wxxz3Pcv2Qv+Slal/2CJf8A0dDX2CuOma+Pf2Qv+Slal/2CZf8A0dDX2Cn6etcWJf7w6qPwCsCTxUT9alz15qNgetc7NUQt0JzVGYZByauP0NVZMEZrnmzeOx4l8Yb06R4j0WcklJnMeB6kYqxauAI/N+6RknoKzv2mYNulaHqC4xb3wD/Qg/4VLaXC3FnAQcqVBGO9RWgvZxkvNHr4Krdyg+li9qMkcSKAx2seB1DfSmWkgttFknV0UAks3cDPGfxpfIZ1ACsBn5mPpiq/iyP7L8OrxwQNsbNuXrwSf5CueCUpRh3Z21pcsHLsaegypJblpWG9QQcnvXTWsxaBfmXaD+JryfwLqTNbosrD5hnOefX+tejaXJG9wVU5GPXgVniacoScTC6qwU0at7arOiyKmXXkHvT9PQwuWZ2Zc5XHGB6VYi4iX1Hr3qCNtk7xk/L94ZqKSezOeWqsdRZyiRfapc1jWs+0jbxWwjKyZzXbB3Vjz5xsyNyN3FU7wfKxxzVuTLHOeKqXedhHcc/hRII7o+V/2lFx4v049jYj/wBGPXkeOcH869h/aWUr4l0onPNqw/8AHyf6149xjrXu4PWhH0PNxX8WRC/3jTac/wB802uo5XufpuelRmnnpxTCDXnHWJTHFP6GmHnP60mUhhBx1qvOu4YPSrPGDmq8uT9KzZpE4nxg3lW7kL8qgnP4V4vq2oqZokZhvkcde2K9p+IR8nQ7iUcHoDXzdqt68mtCPkeVH1Pctz/IVFGl7STO51/Z0426st+JJUvIhFldo5VgP51w0tmwmjVUYEPjjJB56/WunEpmmJckgDbjP8NXLGCKbVY92wg7VHHHAJ/mK9CnL2MLHDWp/WJ3Oa1SQxw7AjJbhGYg8sCT1J/Acjisi7j3Xf2iKMw27lFy/wB0cc4P19K6TxNCsFzqAVAMBFAB6gkA1g3XlXKw4IkuPKy+Tlg4xjj0xXRGXNFM8+pDlm0RSrbzwQvAWEquxbB5PHAHbqTXeeH5pFe0KStgEHaRkDjqa4CxYC6hZIwNhwcHIkI4yfwOa9A0vb58YQbQhw5J4Xnrx6g1niH7mpvgv4h7PoN80kMZG0KVBYnnd7iunj2Fw52EMuDxXnuj30VukY6bByM5z7fyNdXY3pmRVC4Ujua8NSse7Onc15NPRNTgvEAQSERztGACUIIyT7ZH4fSu0sbeIxKuM7OjE5PWuUtZpdgyue4rqdJkDxLgbW24KelbQabucFZNI0IY9uSeW7VKg5pAg7nJ9aeBiuuKRxSbPMf2mf8AkiHiT/t2/wDSmKvhCvu/9pn/AJIj4k/7dv8A0pir4QrspbHPLc9y/ZB/5KVqX/YIl/8AR0NfXqk7vavkL9kHj4lal/2CJf8A0dDX18rDtXBiv4h10fgHmmSU+msaxexaK7jjmqUuMHpV2Rux6VUlwSQOtc0zppnjf7ScYf4cXDY5juYmH5kf1rhfA+om70DTiT8wwhOfQV6H+0Opb4bal6CSI/8Aj1eP/B53ls5UZflhlO1vqBxWqinhW+zOjDzccTFLqj1rzWEWS2AemDWheaemqeCZbF8KtzHJFv7gkMB+tZnlMUDEHA5rotHw2kLFIhyGLKfbJ4ry1o00e7WScPI+dNP1h9Pm0wSxlrmOT7LOOhyCRmvbdMuQ0UEkB+dgM4715j8Y9DOka5Fq1pHiN3WR0HA3k/eHpzXY+Fb8T2dpMp+SdN6nPRv4h/X8a9LGqNSnGrDr/X+Z5eBcoTnRn5W/I9M0+UuoVicmpbm3KYkQ/MvP4VR0WYvEP72euK2rsbrSQf7PWvPglYuo3GVhkQPlDHB65rTsJd6BWHWsa0kDwA8n5cVb0ONreORZJWlZ5C+T2B7VpF9TmqR0dzZIH4VTuujnOOMVeBG04FUbwjDVrLY547nzD+00B/b+jHOSYJAf++hXjB4JNe0/tMnOt6Icf8sZR/48teLE9unvXt4P+BH+up5+L/iv+uiIZPvGm05/vGm11nIz9NcEUNTjTGzjivPsdQjDnNRDvUjZxzTDUyLQ1scYqJ8YIqRqiJyDWUi0cJ8VCI/C9xIegYV8wzyZ1S5bdlRgAjvgAV9P/F1C3gi/I/h2t+tfKqSCPzGIwGdjz07munBw+IMTOyivUseaDdhYz8xU7cEfnityxJXUbXKhv3gXJGMgjAOB71ymn7pdZJUlhDBkkN64A/ka7BoJYUgnkOALiPgcYy2Ov5VpiHbT1Hg7yXM+/wCpi+J8R6ndW8+1PtERwO2RgjafqpGK4xrpbbUGlBZT2KrztPf6ivRPGmmFro3igFbcoCHGflPHI9ORXATWr751eLcIXwxUZ47Z9u1Xh5qdNMwxlN06rTG2Eq7hG7gqw78Y6mu+0+4ZreNE7EuV3Y3H1+uOB6VxK2wilyijawCSEDnHBz7c4rc0S7wTGXBKtggVpVi5RM8NJKZ6HpkztIgRMnOWy2QOOK9Q8O2TyeW+DI4A3Z+70715roCqskZT+LrXtPhx0S0jXnb9OtfPzfNOx9HJuFK5v2dkixKGzuA5q1CBHMhBJycHPpTLeQsMhcZ9akUZlB9xXVGKS0PLcm3qbK4HSn5pmMGnV1ROGTPMf2mcf8KQ8Sf9u3/pTFXwhX3d+0z/AMkR8Sf9u3/pTFXwjXXS2MZ7nuP7If8AyUnU/wDsES/+joa+vF618hfsif8AJSdS/wCwTL/6Ohr69Q857VwYr+IdlD4B+/mnHpzUbHpnpQTgYzWFzSxFMOOKpTZ+9jmrkp4qjckhfxrnqI3pnmPx7w3w11QEZAKE44/iry74RWP2bQrZ2B3XBMp/E8foBXqnxvXf8ONbxyRGpx/wIVw/gEoNIscdoYwMewFU5WwrXmdmEpr6wn2j+p2UNo7EDcACM810WloqQqByASCc9a5/z5QwQEYPHStKC5W3R97YVeeK89aanrVU2rM4r9oFYx4cDZCuAQM/mKyfhraSP4OMwX540E2T9TnH4Zqp42muPGmux6fASLdMCU4yFH+Qa9J0S0tdE0lLOHlQmzPrxXbUmoUI03u9TgpRkqzqdlb1fX7iDQ9RAdUUkZweT1rpnuyllKXIxg5561xulwxxXVx8oyGbyhnoK6GysprzdcTDFsjYCH+Jv8BXGl2OquofEy/Y/JaRoT82Aa19NQBgwBH1rKtl3y+Ww5610dpD5a8nJrSmrnm1pWLGCFOKzb3ncB1zWkTgNmsi/PU4xitp7HPT1Z82/tNjGs6H6+TL/wChLXi3Pr0r2b9pRt2s6Kc8GKX+a14zkdq9rB/wI/11ODF/xpf10RDJ9802nSffNNrrON7n6bZ4pG9KMYorgZ1DcHpUecZqQ9DjrUTHBrNloaR7009Keehpjcis2aI5nx/am58HatFjJMDEfgDXxbNc+e0iJjaMBTjrjqT+P8q+6NahFzpV3Cf44mGPXivhdrbyL6aBB+88xgTj7oBIFdeDdm7mGKTlFGp4NtWklupSCWZwox3wM1315ar/AGW+1PugNweQRk1leGdN+zaeoUY2njH866mOENA6luxX16jH9a4sTWvUuj2sFhnGlZ9Sve6fHfvNCx2iaMqD2HUZ/UV5pq1o/nTMx5YmN8/wuOevpz/KvTYlkS2s5drs0Q2OqgZOBj8+9ZWp2sF1cXZ2h4pNrOpPRtuA2O3oT/hTwtZ03Zjx2G9qrrc88SFJbaOSHcDgqQwxz2zn8Km0nSZrrUY1twRJOQUJ4GferBt3tLhwEeRA2FZgT+or1X4b+FmvrZWQgSxusqvtznIHT8sV3YjE+yhda3PKwuD56nv6WMXRpS9pA+DnAyM8575r1bwjfqY4t7fORnOeMDiuN8f+GZfDerrcKd2n37F0KptEMn8SE9Bk5YfU+lXPCl+ryBAcsO56AV5FVNWkezTcakOVM9ntWXIYHI+tWxjcAMg5Fc/o87SRDbjb2JHX3rorEGSUHjA64rem+ZHmVY8jdzV4PNKKQUorsSPPZ5j+0z/yRHxJ/wBu3/pTFXwhX3h+00P+LJeJP+3b/wBKYq+D66qWxlPc9v8A2RRn4k6l/wBgmT/0dDX10CcnnpXyL+yL/wAlJ1L/ALBMv/o6GvrYt7V5+Lf7w7cOvcJQ3OO4px561ArfN7VISM8VzJ3NrDZB8uao3XINXJG4qlOeSD6VFQ0gcB8WozP8PtdQAcWrH8ua8i+GeqrdeH4AuA8P7twe2AK9u8aQ/afDGrw4zvs5lx/wBq+Y/hfY38epARuVhmA3r2OelXSgqmHmn0d/wOmjVdLERaV7qx7Ta3RUq5fPPGe1S6zO0lhiI4lYHkUieFdXMQKPC0Z6fMQfypknhfW7qRYpFRIFwSFkyW+vt7VwKOtz2alem1vqY/hGxSwR55GDzSuWdge/QfgK7Oxjlv5gkY444IqxpHg7ysfa5MgDAUDtXXWNlBZR4gUD3xzTlF1JczOOpioU48sNzBl8HQy3CTpdyRMQBIoQMG+nPFdKLSMWqxR4CAYAH86erBunQUpYA8AVtGKR506s525nsU7PT1hcuxzk8VpBs8HpURPAPYUE4pxilsRKTlqx7kYOe9Y+pPy+K05HyBjNY+qYDPz16Up7FUviPm39o4qdY0fB+Xypf/Qlrx2vXv2iWB1fR/URS5/76WvIa9rB/wACP9dTz8b/ABpf10RE/wB402nP9402us42fpucZppPHFBz0pD9K4DqQ1hTDzzT26UznBzUMpDT0phqTjBzUb8g1mzRETAOGB6EEfnXxlqtj9m8XavG4HyX0o6ckBz/AEr7PQZNfKHj2Nbb4ma5D3W4DnHoyKf61pQbXNYuybV+5raXEFtskAe3pzWnboN5GDj7uKztKkWSNRknA6nvWr8qkHrn0715U27tH09KK5VYmisTuMecAjAOM++Kq6rpjxOkrhSjkqGI4JAztI9xmt20cTkIDgnHHfPqK6ebSLe/8PXdvcbTlC6uR9xwOGopSfMZYiSgrM8ei0kxzRTSNvs9w3YOTCx4AA9Pb2r3D4ZQwR6ZF5cfIUliV2nqa8d0i9aC+AnDSI2T8oyQfU+oH9favZvCU6JC32YqefmjY5z/AJzW7k3JX6HDXSVN8vU3PFOn2uraZLY3kIkgn4YBsH6huxHUH2rwHU9KvPCHiRLOUrPbyIZLecDAcZxz2DDuPxr38q0j5kUtjpWL488PrrPheYoi/a7VvtMT7QWGB8yj6rkfXHpWvPzvltocUH7KzuHhBvNs0LjDkZGep/DtXc2MapHnjd7V5v8ADSSW5sfOH+rCnluuTya9Hsi3lAnGDzxVYZaXJxuk2izTgaT+VKOldiPNZ5j+03/yRHxJ/wBu3/pTFXwfX3h+0z/yRDxJ/wBu3/pTFXwfXTT2Mpbnt37JH/JSNR/7BMn/AKOhr6yYkHFfJP7Jxx8RNR/7BUn/AKOhr6vJ+Uetedi3+8O7D/ATqwp5bPAqruPbNLvOcniuW5vYmkeqNwwC5zz71PLIccVQuHOCOOaibKgc/wCJpB/ZWoNgkC2kHX/YNeO+C7VYb23xgZ2jA9q9X8XyhND1JzwPs7jn3BH9a838MNt1CFgR94dqzUmqckj1MPBX5me1WRAt4gOcAZq6rDg4xWTZuTCD0zzVoyZwueRSjscc1qWfMyCM1E03y4yPaojKEyvU+pqDAyCT0qrkqKNCOX5cZwcelOVyQv1qiX3kc1Or7QADQiZFwt8tNJGOtQhmB+ZqA4JqjMc8gAP61k30gJJY4HbFXZHOG4rG1B8RtkdKzkzektT52/aGbdrel/8AXKQ/+PCvJjXqPx6Yvr2n8j/UMc/8CP8AhXlpI4Fe7hP4MTzMZ/HkRyffNNpz/eNNrqON7n6bHmmkGnfWkPtXnnWMbpTTj3qQ00jmkxoibpTcVKRzzUbcZrNmiI1HNeC/FbwzbXHja7ufmWaSON968HO3H9K97Ugtz1rzP4jQ7/EiMByYVzWVWbhFyizswUYzqqMloeVWWi3dqE8i5ZlOOJFzkVqQ2d+HAZFb6N09OtdRaQjIyoIzitu1gULjjBrzZV5Sep7SSpfCYehWl8km6S28tzwpYgj6/wD167iO1lubQQTSeUp+8Yzyw9Cfeq9vAjDYpcFelbEQdQoBQqAO3NXCTOHEVHIxdP8AAuj2lx50SStIQAfMcMD+ldRbWUMK/uo40BPRVxxT4vujPcVYQce1dMVc4ZzkxY05z6VZiAAweh61CowOO9WEOMcVvBJHPN3Mrw/4dtdESaK0Z/JkcyKp/hz2rdHA4pgOeaeK2iktjGpOUneTJAeKUdKavSnCtUYs8y/aa/5Ij4j/AO3b/wBKYq+D6+8P2mf+SH+JP+3b/wBKYq+D66qexlLc9n/ZUYL8Q9QJ/wCgXJ/6Nhr6sMnSvk79lx9nj/UD66XIP/IsVfUbTEkrmvNxn8Vnfhl+7Lpm98UhfK9cmqJlJUdDinLMuck4riudPKSvIduaq3MuB74pk8wONpzmqE8/GSe+KmTNIQOY+IMzf8Izer3bYp+hYVxvhfDX8K4AwRWv8TbzZpKRAnMs6jr2GT/hWP4TdTexBQTgjr2pW/c3PRotJtHsFoxEQGMADFSCUk/KeKoW837tRnn0p4lwvOKmL0OSa1LrSHaQTz64ppYge4FVxIrKcZFKHPIJ696ZKRaikAHIp5lwwX171URgD6nvUoYZyPwyKpK5DRa3MR2x6VHJLzn+VM8wc5wfaoixBAbAp3FGLB5OvuM9aydUkxGw4HNX5CQpOOcViauxcNjOKzlubwWp86/GuYyeJbZT0W2H4ZZq89xwOK7D4rTibxjcAEkJHGvv0z/WuOHWvoMOrU4ryPFxMuatJ+ZG/wB402nP9402uhHK9z9NM4NA5pDSivPOsMU1uKdnrTWB60MBpOTTGI7incDr1qNjzWb1NENONxI71598RU/4nFuT3iFehZHavPviF82r245JWPOBXNiP4b/rqjuwH8ePz/IwrFcHAHytxgVs2a/Nlsj6GsyzX5QNprWtF+cE9emDXlRZ7FY0raMBlJJBPXJrStwM4HSqMCoFG3n3q/DgbRxXTA86oX4u1WUGVFVYgd3HSrsfQV0wOKY9RkipwPQVEp5qVfrW8TGQ8dCKeKYOtSCtosxkOXpTxTB0pwFaxM2eZftM/wDJEPEn/bt/6UxV8H194ftM/wDJEfEn/bt/6UxV8H11U9jGW56L8DvEel+GPFt3e63d/ZbZ7J4Vfy3fLmSMgYUE9FP5V7r/AMLh8D4/5DnP/XpP/wDEV8i0VlVwsKsuZtm1PEypx5UkfXC/GDwQM51sn/t0n/8AiKQfF/wQWJbWzjt/ok//AMRXyRRWf1Gn3Zf12p2R9ZN8XfBX8Otc/wDXrP8A/EVVufix4OZCE1nP/brN/wDEV8r0Unl9Puylj6i6I9r8d+OtB1a5svsV+ZY4wxc+TIACcY4Kijwt418PWEyNdaiEwck+RIf5LXilFU8FTcFC7sio5jVjJyVtT6oj+LHg1UH/ABNxn/r1m/8AiKkb4teC9oxrHP8A16zf/EV8p0VH9nUu7E8wqPWy/H/M+rI/ix4LXP8AxOuv/TrP/wDEU7/hbfgsqSdZ5/69Zv8A4ivlGvqU/s9+FR/zENcI9RPF/wDG6zqYOhTtdv8Ar5GkMZWnskWU+LfgsNk6z/5Kz/8AxFSD4veCx01rH/brP/8AEVln4AeFs4/tDWh9Zov/AI3UE3wG8LoMDUNZJ/66xf8Axus/Y4ddWX7au+iNyL4ueCAp3a0c9v8ARZ//AIinH4u+CM5Otk/W0n/+IrjZ/gr4fi5N7qpXviWPP/oumx/Bnw43P27VSD6TR8f+Q6n2eGXV/wBfItSxD6L+vmdfL8W/BbAga39P9Fn/APiKx774oeE3RvL1fdk9BbTdPxSqMPwS8MuBm+1gE+ksf/xurI+BXhluFv8AWCfQzRf/ABuj2OGfV/18hqtiYPZHhvjPVINX8S317bvuhkcCM4IyoAA61ibl9f0r6O/4UV4XCjdfa1nviWI/+06RvgV4XwCuoawR3/fRcf8AkOu6OIpRVkcUqFWTbfU+bn+8cc02vpUfAfwx8ub/AFnnqBNF/wDG6a/wM8LLg/btaIPpNFx/5DqvrVNEfVah6ofjt8OP+hi/8kbn/wCN0D47/Dj/AKGP/wAkbn/43Xln/CivC/mqq32tEH/ptFkf+Q6efgP4XVCzX2tYH/TaL/43WPtKPdmvsa3keoH47fDjP/Ix/wDkjc//ABumn47fDjP/ACMX/kjc/wDxuvMR8CfCg8oNf61ucZI86Lj/AMh05fgP4VkwE1DWQevM8XI9h5dHtKPdi9lVPSm+Onw5P/Mxf+SNz/8AG6afjn8Oif8AkYv/ACRuf/jdedp8AvCrOQb/AFsDOBmeL/43T2+AHhPadmo63uHrPD/8bpc1F9WPkqrojvz8cfh3njxFx/15XP8A8brjfF3xZ8GahqwltNa8yERhQ32Wcc9+qVlRfAXwvLLsS/1o4OCfOi/+N1qwfs6eE3Hz6jrv1E8X/wAaqJRoVFyts1p1K9CXOkipb/FPwchBbWOnrbTf/EVpQfFzwQGBbWsD0+yTn/2Smn9nHwiCf+Jjrx+k8P8A8ark/ih8FPDnhTwDrGuafe6vJd2axGNJ5Yyh3TRocgRg9HPcc4rJYLD3sm/w/wAjaePxDTbS/H/M7qP4xeAx11z/AMk5/wD4ircfxo8AArnXRx3+x3H/AMbr40orpWXUl1f4f5HG8fUfRfj/AJn2qnxt+Hwz/wAVBj/tyuP/AI3ViP44/DsKAfEX/klc/wDxuviKirWCgur/AK+Rm8VN9EfcQ+Onw5HTxF/5I3P/AMbqQfHb4c458Rc/9eNz/wDG6+GaKtYWC6sl15M+6E+O/wAOAefEf/kjc/8Axun/APC+Phvn/kY//JG5/wDjdfClFUsPFEuq2fdo+PPw2x/yMn/kjc//ABunD49fDYf8zJ/5I3P/AMbr4QoqvYxJ52fWvxz+LngfxR8LNb0fQtb+1ajc+R5UP2SdN22eNj8zIAOFJ5PavkqiitErbEt3CiiimIKKKKACiiigAooooAKKKKACvu/V9MsNV8T+DrHVLO2vrOXVJfMt7mJZI3xY3RGVYEHBAP1Ar4Qr7z1m8j0zxF4V1G4iu5LS01GSSdra1kuGRWs7lASkas2NzqM471y1napD5nRSV4SKGr6L4fsfHc+m3fhjwhpOkC4toLWa68HvMl0ZFUlRdKyxI24lQCOuOD0p2t6JpehfEfVLbQtLstOt20mxlMNlAkKlzNeAsVUAE4AGfYVo6trfhbVNVNxf6z4zlsGuYrs6W2i3ZtjJEVKH/j18wKGRW2h9pYZx1rH1/XIdZ8f3+p6bb3xsf7MtLcy3NlPanzFlumYASopOBImSBjkUYqS9k7P+rjw0X7VXRV1KUKCJFZR/e6VlpfI0x2FJVHA2rjrT9cv2I/4+EVXJ4dev0NcLrWtvAhmtZtzOv7vkEA/X68Yrx4wc3ZHr8ygtT0S3uwwJQkD+6RjBrThnAwz8DodteW2HiaVIw8spY5PmqOFVfXp9KvReNbe33K5WVJFygX5WBz6Hgir9lOL2E5Qetz0tnTJG9cjuxxn2qn9ugjm27uSMEA5FeeP48gE0oZoLm2U8ZlCNnOOh/Kop/F0Nwo+z7U3ugkhl5CoR1XsfqKfJU7E88O56Sl4GcPFtztO4E+/FQzarCkEihHEjHGzHPHWuNs9TW7vC9tcB1UDbIRjdx93HfnHNVl12a21OWLU0ETuu8XDLujYADGznI6kfhStK9i7I9Ag1WFovPVS0OSC2cDP481M17FNbNsLbW5LbSQPx6CuJ03UXnsPs7NGoQspDZyFJyCTwOnNQHWbppGttN4h3bJAx3IqnA4A5BPPB9KE3cbirHcNfFEVtgcyvwFYlv9noPY1BDqHmTyxLIyiN9g+YMDxyN314+tcjLrUlrPPArozKo+QAKyrkKOQeB1468fhWZJrv2NVtorlYRFGWOF+TOflbnn1GD0xk1XLKWxDcVq2elLMBcMIgJSq7QTkDOezelF/qO0NuiZiCF4bIJPGMiuCg8YW8VvELx/IlG7cu4t8oBwQcY5ORn0FaPgvVRq19ie5RY4gJcFSPmOeCe56fnUuMkrtBGUW9GemaPb7IF3j94TknrW1Cm3vVHT2yF83g+33f/r1qKn5duK2prQ5qjuxSvI5Arzf9oMf8Wc8T85+S3/8ASqGvSXIz2GB1xXnH7Qg/4s14m/3Lb/0qhraHxoyn8DPiWiiivTPPCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAr9DwgY4PJFfnhX6JsQuCBx0rgx32fmduE+18inOnzYJAU9PasLXyEgLD7w+9n0966KdFkQnB6ZrB1dEltZFbcDtKnPP515smejDdHkPiS/CRtCitAQxMiGTdj3DdRkA8VxGoXqW0rrvk3O3yoG+X6g9AR/LNb/AI1jmSeYtkjARpGQZkA46+n4V55q7SRAvbhAoONqjgH8/rz0r08HBctzjxk5RdkMuNUAklWdS4LA5OQw7ce+KoXOpNLvaJnVkI2EgHjv/SqFxLJcPl3y2OO2P84qEk+WRuAB5IFdrfRHBbuabaidnmu6yzNgAyDcy47+lWNN1Z0uo/PKADdxtwAT1rFUDA6/UdcfSnbVYMU+XHYnH4UgPSNJ14ZeS0bDxKoKyEDcpOTlu547+wqX7e+oXtqRKxt4gxWMtwMc5PHAJ4x27155bEQfNIEYqwIU8kn/ACKfJqFwzZX5VGdoHHbknFZOjG91ua/WJ2s+h6ImoXH2sr5zC2iO+WZ3+UtjcFHBBPTP+RSW2uSRs8NnfqN8plLSIev1JyTk8DjrziuPTWpIrMW0aMsjdCQMKPYdjnPPvUcNwQWuPNzOxLDd7jnPrz/WhUE9GW8TJPRnRtrLwpLJPMhcHdI0SBTJnPAz07Dr/SseTV5JYjGGKM7DeVOB9MDr3/PvWHcLIzHz5QqnIJ+h9B3zRZ+WN21woAzufsc4wK0jCK2OeVSUt2dB9onuJmjgG64ZtzSNzsx/Eo+mSTjPFe8fDDQZooJwWKQEL5ZYdATksc/xHr+NeL6FZxzhy3ltaW3zbfuq5PBGR/Fznrjj3r6h8M2YWASXG4NgssYJ9etcGMlqoo78JH3XJnTWsSoiAZOB16VcjbIbGevJ71WRCUBZuD0FSqNm0bsA1hF6FtXHuewOcmvOf2g2z8HPE4/2Lf8A9Koa9Ek46c15t+0Af+LQeJhjrHbnP/b1DWlN3miJr3GfFlFFFeqeaFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABX6J9+TX52V+iSneOcD6152P8As/P9Dtwf2vkV7gkKQpPtg1g6ykmzcFw3UN2/Gt+f5Q23OcdqxL8lULAEnGT6j3rzJLQ9Om7ankHjJRE0wR5SzZfC4xjHPB715ZqcshR0iDHjOHPGPcetem+PNUa9u5BIrHysoUC8tjkN/hXkviO+aKfapDblDKehXtXq4BWhdnFmD5rI56VfnkIB49sZppPIOO/TtSSSM7lpDknkmlZs9eAe3rXYcFh65CnPRh0FDDAUnOT26U2MgNnOD1B96mEZlZnBCjGW3DAoERMdxBdyc8d8gVIFYjJAbaD144H6VcTT3ktjJIyoAoxgHP8A+s9aZFZSzMQm94icZVcDP4/Tr7U7CImDbHdmDHhRzzgUxTIZhuxkHoeO3T8a6PT9Mj8iT9x5gGR879Dngj9Kxb+1lhuXWdTzny84Jx+fbFMLPdlZzvfcFwMBtqjpwOpq9aRGaVFWL5cZwBuHP4VQiUPwCACepPAHvW9ptpFLPE1u5DbQCXRisfp6+hpdAsdv4Zt7aR1ggRZG2tho1Hmhj7/dGQMcYxjnrX0d4b8wWEWFwNoBcjGSOPyrwnwTZST63brbMYysZRp2UfPk9WB9SpHrx68V7tp0DrE3nNgklsIMd+n/ANavHxErz0PapR/d6m7GC23JXPfBq0D8o4/GqMGAihQFq4jbuOoApRZlJBIecDrXm/x/yPg74mz/AHLf/wBKoa9IbAOf1rzj9oA/8Wc8TcfwW3/pVDWlL416kVPgZ8VUUUV655YUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFfoeRtPJr88K/RCRSQcmvOx/2fn+h3YL7XyIZwXTk4GOorIvUPkMGBI5+bNapAICnPQ/hVC5zHH8oBPXA5BrzJI9KPY8G+IERttbcNG0ayJkyMAOOh2+1eS+IICJY3jdCgBXAPTn/DFfQHxesori2tLuSMKy5iYdtp9+vBH614Lq9sjKrCNgCcNlvutXsYKSnSPOxt1NNnPgDdzjrTskKQDgHqM9aJEwCCcY6Ajk0hXjlh7Cuk4xyEmQEkL7ntVmKVTKiuflJOdox265qocbQT6+/NWbBFaaNjk4IypbBYexpoGdNYwMHTzbl0DDOMDO0ZAIGOO35+1aqaWhiedrgeSBuUOSATjkcf5/OsfzRE8eyULhShbqcHg/5+laGlzLKZYmlAfaY0cr8hzwOnA7/SlUi7XTNaMo7NG3pMKJ56i5kSMorKqqoGTxnpxxivP/ABG7tqEy5+WPgZ6kf5/lXXWWrS2W6B1O6N9wBX7+DyCfXjNZsFpBeatJdSsFickgFSqqOi5IHX2rKClFyctjWrKM4xjHcx9O0tynnTyLGAQrApvIH0PGemPbmtTTpp5pJrWwZ0hiTAI479W9WI9PWtO/tmu0W3kncwJISP3ZBzgAt2yMYAHXAHHWtnwvpsFiirHDckhlZ5/K3biCDgcDpj19KVSsoxv1FSw7lO3Q9N8D6K0NvEJXlJTDSKSMbuMKeMjA689a9Ht/3eTkj0zxiuX0Z5WhQTu6o4BCs2WIz359a6W2UOck9vXPevDUuZuTPYlFJWNe1Y7gwOT3z0NXM85wBn0qhbDBGd2Perud3FdENDlmKxBGBXnf7QS4+DXiX/dt/wD0qhr0QjP1rzz9oIf8WZ8Tf7lv/wClUNbUvjRlUX7tnxPRRRXrnlBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV+ikynGR0r866/RhlyRmvOx6+H5/oduD6/Izpgc5UkjHX1qhO+3f8vQc5rTkAB+Uk5qheALyTzXmS7HpxZw/xAtxceH5nhjMrKpYA9ee1fN907q8m5CVVsEkcEHsK+odej/0e4XLKrrgEDIXPByPyNfMfigmJ5FwhQyEkg9O/T3/AKV6OWy0lE5MwjpGRzU+05VTlgcD3quoY4wOfanOc5JB4I7VLbODu8zH3eeOT6Yx+dei9TzdiLBYBR9MVo2ts6mMoAGxn5lzj8Ofy9q0NC0/fM1xuGyMbQ7D+LHIP4Efqa0bG0ge8meRx5EaqmSSQGfgfl/Si6W4+Vu3mZtvp7yTss7kq/I7ZY9MenTP4V2Wi6XbypDFOojTALt/FI3sPTvmuVs5yb0krlNzMvHUZ2/+y/rXeaCdqpPMCjMeTggdOB9MAVy4ucoxvE78vpwlN3Jb7w891aPPpqRpeRLuUKOZB3B7bvSsDTraQ3G26YLKfmAXqpzzx6jv6V6Npk6TM5XLZHDdqoeINBaSZrq2jA+0EecFOMOOh56g/wCetcNHGSX7uZ6GIwcbqrAoWunWUskDzyzqDxsIYF3Hbpz2z9a7LQNO8pTLHJIikDdCGB2DOMDA7AjjNZnhywUxJLcIgkyVbBJ6dgPzOe+a7Kytg8Cxl8bicrGcDFcdWq5PludMYKKujWsbVLfYEAKjkEnqe9b9tCFA3YDex61n2kJTYWAOOmO9aMJZuQuOwzVQVjlqu5cXg5FTJ0B6E1FCuAM5q0mCePpXRE5nuKBuOM5rzn9oX/kjfiX/AHbf/wBKoa9IxivOP2hf+SN+Jv8Adtv/AEqirakrTRlVfuM+JaKKK9Y8sKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACv0YOSOSD9K/Oev0XOR24rz8d9n5/od2D+18irIoDHGMYqpcbTGVPcetX5FB7VmXiDJzkAH1rzWj0I6nO69ZtPEoWUkegHT618t/EmBrXxNdxZGFY/KOBnNfWN0qyDDhipyMjtXy18ZUMPjq+UKyg4ZcnPBrpy5/vJLyM8ev3S9Thl4zkfnVqyQPKcnIUFgfXHaq23djC9RXR6HaI7QgxkiRwz/LnI7LjvnpXrx3PIevu9zoYbZYtItbS3JM8zF2AHIHViT6Dp/wDro0m0S5tbxpnKs00TnHoe/p3Fa2nqzXWoFowsnkiNAo/ifsPwx0960raxaG+u1UrIrIqoOwKKOP8APpXFOvypxR69LC+1cZ9NvzPO4Ds1CeErtaJmUgHod3aup0qbeVWVtq8KqL3HfrXPeLLT+yvEYbjZMAXZRgA57e1XtMlH2hCSe2STiuiolVp3Rx0JOjVcGen6aknkKflRR0P+FdJbQLc2skTqSpAAye/Y/hXM6TKJQgztHGO9drpSJGVL7iMAZ6Cvm22pH1MrOGhW0jTxbxtmQBi5LAc8nrXQ2CbQCCcDgdyfxqo1uBdCQ7RGeeO/19q1Y1VUAQLj2PFOK1uck3oXoM+Yc9BVvcAMcjjgelVIRltoGc9WrQjVQcnFdCOORPDjaAM1bRcYxVaFuCPyq3G2Bk/St4I5pMkY4BrzX9oXn4M+Jf8Adt//AEqhr0oDjNebftC4HwZ8TDvttv8A0qhran8a9TOp8DPiSiiivVPMCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAr9GASBnHavznr9E/m4xye4rgx28fn+h3YPaXyFcgj8KyroDueRWo45rOu1wCcAketeazvjoY11uUn5Rg+/WvmT46Lt8dynnc1vGTuOcHmvpq9AZcsBkLwRXzF8bwx8cPn/AJ90+p61rgL+2foLHfwV6nF2EHmzYbAUDt7muv0uBE8sqCG3AAcjHHUH1Brm/D4BmkySSBk+9ddZqpUrxjGO2DzXs1HaGh52GjzTuzptMjj2EtuEkk4YN3VcYBz9BnmtmwGXYLGViJbDN1LE9R+WPxrMsGKzI0mFDkcFuPlAwD6Dpmti2nP3gFy43YHG04yMA/lXhVW9T6ajFWSR598Vdpns5MMUYsWQjBGWzisPS23xpvO4gdciul+LEmLeyVDxuZivBI4HP0rifDkx5UjIU8D616+Ed6KPncb7uKk/M9e8Nzfuo/3m4r7816Dpc4MMZds8d68j8P3ISdegJ6V6Pol0ZCEA3k4614eLpuE2fRYaSqUzsrVlYqH5UjnjtWkihUGB046dKzrS3kEILqVUjvV+3YvAuTwDgmohfdmFTfQtxBz2+UdKuw4JyecVno21VySPxq8gJUHOa2RyzLkXzEFuParUZ5/nVaHAAx1qaL5pOeK2ic7Jic9+a82/aGkA+D3iSMq2WS3IOOOLqGvSXI2gd681/aEJPwd8S5/u2/8A6VQ1vS+NGVT4GfFFFFFeqeYFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABX6IFyccYr876/RAsBzkc9q8/H/Z+f6HfgvtfIMc55zVa5XB479Ksq4BAyaq3O4554xzmvPZ2rcwbrAJL4wM8Yr5j+OeB48kKEfNbRngY9a+ndRZgz7frx618z/Hj/kfAdv/AC6R9fxrTA/xreQYz+D8zjNFkC3bAccDBPWushbYNy9OR/WuM0j/AI/V54wa6u2LbVbJ9Nw9K9tq8Ty6MuWR12iziVMhQWA2++0D+VdKghVB8pxjBB6qfX+v51w+m3O3yhkuwGd3Yg9vwrpv7QEOnzSbtwVd5U5BIx0NeJXpPnsj6PD117Nvseb/ABAvWuNTeIDMcY27wu3ccDOf89qxvDcbPcOATjFVtXuHu7yV26lixP41o+EwAzs7ADt7V7EY+zjZdD5yUva1OZ9Wdr4et5HukHJCHrjGK9V8PyRW6DK/N15HSvO/D23zm2k/XNd7pZQqq5UgdMmvCx0m5n0+DglTsdZFqM1wnK4QcCtOxXMSZOQeaw43WKEOCCxXP1rb0/cbaMvjDKCcVjBtmdZJbGqkaswKA+/FXYxgjGTiqkCk4xwCOAKtJwcBvlXrWyOKRaGcYGOPQ1LHkHOcVDD156dqnUc56c1tFGLY98j3rzX9oPj4PeJAf7lv/wClUNejs2O2RXmvx/wfg94m452W/wD6VQ1rS+NepFRfu36HxbRRRXrHlBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV+hI3fx4+tfntX6HEAgHODXnY/wCz8/0O/A/a+RHuwcDp6+tQXOSNxHQZqzjJ6n2FVboHnnGBXns9BbmPd5OTjJzXzb8f4dni62crjfaJznphmr6VvAwThc/jXzv8cofM8XQqByLVMkjJB3NxW2BV6+nZmeNdqPzR5NG5SRXX7w5FdLY3oeAYYBx6noaz20suSxfnsRzVmDRmUFlcr755r3Erbnjp8z0Olsp9xCloun3vX6+1ReJNYMVgEDlmPG3OcJ6Z/Sq9ppe1f+PgqOhPv9cVftfC1tdt/pEu9if7/T8PeuWcqcZc0md8I1px5Etzz8B7mX5EBduAqj+Qrb0y1fTVR5iCH++B/B7E16RZeFrSJNkCgMRnkD8un/16oajoU9vuKxpJERjFZwxtOUrXHLL6kI8xn6LfrBLhhgHkDpXc6ZelwhjZdua8vvNLns0M0Sh7dDk88oPf1FdB4avWkuY44wrO46L/AA8dTWeKoRqR54HTgsVOnL2VRHrdnO0yLCp3MxxxXaRsQoAPAUDHeuV8JWB8uO9mHybcx7hy/v8ASulGGJK5Bz2ryoJI760lJ2RpRTYOSQqjufWtCFwccjnrWWLfzYcNll/uk1oWw8sDGMD9K1RyTSNFc7RzkVJ0HJFQxc4JxUx5xW8TnsNkzjjPNec/tAA/8Ke8S5/uW/8A6VQ16QSc8V5z+0GP+LPeJDxnZb/+lUNXS/iL1Jq/Az4qooor1zyQooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK/Q13GcA89+a/PKv0IkRSQeQccgdK87H/Z+f6HoYH7XyEVywbGQe1VZ5GAYHlgME1NL+6kG7gZxwaqSBnaRt2e4+lebJnpJdShdliCGHUY4NfPnxbeNvGT8g7IkX39f619A3PzITn6+1fPHxN+fxzqB4IxGpB9dgrry7+M/Q5sf/B+ZzcIGQAD0/WtK0hX7xHU1FbIhUA9BxwOSatxrsH3SevI57V6dWdtDlw9PS5YiRd3yqNg6qDya3tPiAjG1icdj0xWTaRgtuZOeq4rcsEwxAyueMHuf8K8mvI9ihE1bMMCc87u1bccCyjaARx2GaxrNQzZMmAvoa3IZVTDAkjGOPWuCe+h2dCrbeH42uiX+4Tkg+n0rQ8OeENM0i5uJ7QZ3uWVGUfKDyVB64p9vI5kZ5MBRyxJrWtZPMiUg4VunpTjUnqr6GNWCutNTSXDJsU5A6N0q3aKOelZ8LLgheSvvWjZxlkOAeK1hqYSdkX4woQEc59KnjQbhwMgVEgY7c4Bx0q1AvTdwxFao55MtRDIBKgVM2fTioogQMHOfap/vDt6VojEYBy38q82/aAZj8IvEw/h2W/8A6VQ16WzbQD615p+0FhPhF4jH95ID/wCTUNa0vjXqTU+CXofF1FFFeseSFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABX6FK6+WCOBnpX5610P/CbeKz/zM2uf+B8v/wAVXLiaDrWs9jpw9dUr3W59v3cgCHoMDNVVJKnBwB618Unxp4pPXxLrZ+t/L/8AFUh8Z+KD18Sa0frfS/8AxVcn9ny7nWsfHsfY18fLhlONzbc4FfN/jl/O8Zamy5/123k9MKB/SuHbxf4kf7/iHWG+t7Kf/ZqzZtRvZpWkmvLmSRzlneViWPqTmujC4V0JuTd7oxxOLVaCgl1O/s03DnBwPWrlvH82QMqO+ckV5mL+8HS7uB/20b/GnDVL8dL66H/bZv8AGuidNyJpYmMFZo9bs1keYDC468jB/Ot6xtgw+c8Hpt6/nXhC6vqQxjULwY9Jm/xqQa7q+Mf2pf4/6+H/AMa46mCnPqjsp5nCH2WfRNqixx4ABX0FacDM0gGVHGBXzKviDWVHy6vqIHtcv/jTl8R64pyus6kD7XT/AONYf2ZP+Y2/teH8rPqqJkKlDtO09cdTV+L/AFIwwJAzwK+SB4n14LtGt6pt9Ptcn+NOXxV4hAAGvasAOMC8k/xo/s2XdGbzSL6M+wrRQkYbqxGORWzCSI9qjdjoB3r4nHi/xKowPEOsADsL2X/4qnL4z8UKfl8Sa0Ppfy//ABVaLL5LqZSzCL6H3NHGS+WAwABVtSM5A+uTXwh/wm/iv/oZ9c/8GEv/AMVS/wDCceLO3ijXf/BhL/8AFVf1KXcyeNi+h96xjn/ZNTIFPOSCa+Bf+E68Wj/made/8GE3/wAVS/8ACd+Lv+hq17/wYzf/ABVNYOXcn61Hsfe8xKkGvLP2iLoJ8Ldag4zKkOOfS4iNfLZ8eeLz18Va+f8AuIzf/FVS1LxLruqQGHU9a1O8hIwY7i7kkUjIPRie4B/AVpDCuMk2yZ4lSi1YyKKKK7DjCiiigAooooAKKKKACiiigAooooA//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Stages of pubic hair development in boys. Stage 1: Prepubertal, with no pubic hair. Stage 2: Sparse, straight pubic hair along the base of the penis. Stage 3: Hair is darker, coarser, and curlier, extending over the mid-pubis. Stage 4: Hair is adult-like in appearance, but does not extend to thighs. Stage 5: Hair is adult in appearance, extending from thigh to thigh.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Figure from: Roede MJ, van Wieringen JC. Growth diagrams 1980: Netherlands third nation-wide survey. Tijdschr Soc Gezondheids 1985; 63:1. Reproduced with permission from the author.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sexual maturity rating (Tanner staging) of pubic hair development in girls",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 379px; height: 564px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Stages of development in pubic hair in girls.",
"    <br>",
"     Stage 1: Prepubertal with no pubic hair.",
"     <br>",
"      Stage 2: Sparse, straight hair along the lateral vulva.",
"      <br>",
"       Stage 3: Hair is darker, coarser, and curlier, extending over the mid-pubis.",
"       <br>",
"        Stage 4: Hair is adult-like in appearance, but does not extend to the thighs.",
"        <br>",
"         Stage 5: Hair is adult in appearance, extending from thigh to thigh.",
"         <div class=\"footnotes\">",
"         </div>",
"         <div class=\"reference\">",
"          Figure from: Roede MJ, van Wieringen JC. Growth diagrams 1980: Netherlands third nation-wide survey. Tijdschr Soc Gezondheids 1985; 63:1. Reproduced with permission from the author.",
"         </div>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32152=[""].join("\n");
var outline_f31_25_32152=null;
var title_f31_25_32153="Hyperimmunoglobulin E syndrome";
var content_f31_25_32153=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hyperimmunoglobulin E syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/25/32153/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/25/32153/contributors\">",
"     Timothy R LaPine, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/25/32153/contributors\">",
"     Harry R Hill, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/25/32153/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/25/32153/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/25/32153/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/25/32153/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/25/32153/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A syndrome of recurrent staphylococcal abscesses, sinopulmonary infections, and severe eczema was described in 1966 in two red-haired girls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/1\">",
"     1",
"    </a>",
"    ]. The condition was initially called \"Job syndrome,\" based upon a description of the biblical character Job: \"so went Satan forth from the presence of the Lord and smote Job with sore boils from the sole of his foot unto his crown\" (Job, II, 7). The cutaneous abscesses in patients with this disorder appeared \"cold\" (ie, lacking the typical signs of inflammation). It was speculated that the immune defect in Job syndrome lay in an abnormality in nonspecific mechanisms of local bacterial resistance and perhaps in abnormalities of mediators of the acute inflammatory response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This disorder was termed hyperimmunoglobulin E syndrome (HIES) when an associated increase in serum levels of immunoglobulin (Ig) E was described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Subsequent work revealed a broader array of clinical features and defined some of the functional defects in immune regulation. Patients with this syndrome may be male or female, have characteristic facial features and skeletal findings, and suffer recurrent infections (principally bacterial) and dermatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In addition to elevated levels of serum IgE, there are intermittent defects in polymorphonuclear leukocyte chemotaxis and associated immune regulatory defects.",
"   </p>",
"   <p>",
"    Dominant-negative mutations in the DNA-binding domain of signal transducer and activator of transcription 3 (STAT3) cause the autosomal dominant form of hyperimmunoglobulin IgE syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. A homozygous null mutation in tyrosine kinase 2 (TYK2) has been identified in two patients with autosomal recessive HIES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/8\">",
"     8",
"    </a>",
"    ]. Autosomal recessive mutations in the dedicator of cytokinesis 8 (DOCK8) gene encoding a protein implicated in the regulation of the actin cytoskeleton were identified in patients who had a syndrome similar to hyper IgE (recurrent viral and bacterial infections, extreme hypereosinophilia without dental, facial, or skeletal abnormalities). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/58/40873?source=see_link&amp;anchor=H31#H31\">",
"     \"Combined immunodeficiencies\", section on 'Dedicator of cytokinesis 8 (DOCK8) deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The epidemiology, clinical and laboratory features, pathogenesis, diagnosis, and management of HIES will be discussed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIES is rare; the precise incidence is not known. It is found equally among males and females, and is observed in members of succeeding generations. It has been reported in Caucasians as well as in individuals of Asian and African origin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIES is characterized by dermatitis, recurrent infections (principally bacterial), and elevated serum IgE, although there is significant variation in the constellation of symptoms and signs among individual patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/9\">",
"     9",
"    </a>",
"    ]. Classification of HIES into two subtypes has been proposed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/10\">",
"     10",
"    </a>",
"    ]. Patients with the autosomal dominant type 1 HIES have abnormalities in multiple systems, including immune, skeletal, and dental (MIM 147060), whereas patients with the autosomal recessive type 2 HIES have abnormalities limited to the immune system (MIM 243700 and 611521).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Skin manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin manifestations are the most obvious clinical finding in HIES. These begin within the first few weeks of life, with a papulopustular, often crusted, rash that begins on the face and scalp and spreads to the upper",
"    <span class=\"nowrap\">",
"     trunk/shoulders",
"    </span>",
"    and buttocks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/11\">",
"     11",
"    </a>",
"    ]. This rash progresses to an eczematous, impetiginized, severely pruritic rash that is similar to atopic dermatitis (",
"    <a class=\"graphic graphic_picture graphicRef61049 \" href=\"mobipreview.htm?38/24/39302\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/3,12,13\">",
"     3,12,13",
"    </a>",
"    ]. The rash is diffusely distributed and may be lichenified. Patients usually lack other common atopic symptoms, such as wheezing, allergic features, or a family history of atopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The intense pruritus of the dermatitis is attributed to the release of histamine from cutaneous mast cells in response to the presence of candida and staphylococci in the skin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/3\">",
"     3",
"    </a>",
"    ]. This theory is supported by high serum concentrations of IgE specific for these two main microbial pathogens. Skin biopsy often shows a predominance of eosinophilic infiltrates.",
"   </p>",
"   <p>",
"    Skin infections frequently begin in early infancy, including abscesses, furuncles, and cellulitis, frequently leading to lymphadenitis. Staphylococcal abscesses often develop on and around the face, neck, and scalp (",
"    <a class=\"graphic graphic_picture graphicRef75307 \" href=\"mobipreview.htm?21/24/21888\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/14\">",
"     14",
"    </a>",
"    ]. These abscesses may appear \"cold\" or lacking the classical signs and symptoms of inflammation, or alternately, they may be erythematous, warm, and tender. As mentioned previously, the most common microorganisms infecting the skin in patients with HIES are Staphylococcus aureus and Candida albicans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/1-4,15,16\">",
"     1-4,15,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Sinopulmonary and other infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients often have chronic upper airway infections with persistent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    recurrent episodes of sinusitis, suppurative otitis media, and mastoiditis, which may require surgical intervention. In addition to Staphylococcus and Candida, Haemophilus influenzae, groups A and B streptococci, gram negative pathogens including pseudomonas, and fungi have been implicated in these infections.",
"   </p>",
"   <p>",
"    Patients with HIES may have significant pulmonary infections, yet remain afebrile and report feeling well [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/17\">",
"     17",
"    </a>",
"    ]. This is probably due to impairment of inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonary infections, which are most commonly due to Staphylococcus aureus, are recurrent and may be life-threatening. Pneumonias are frequently complicated by bronchiectasis, bronchopleural fistulae, and pneumatoceles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/14,18\">",
"     14,18",
"    </a>",
"    ]. Pneumatoceles can then become superinfected with Aspergillus or Pseudomonas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/19\">",
"     19",
"    </a>",
"    ]. Nontuberculous mycobacterial infections are also common in STAT3 deficient patients with HIES who have developed structural airway disease, such as bronchiectasis, nodules, and cavities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H33\">",
"     'Prognosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Opportunistic infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opportunistic infections may be seen in patients with sufficient immune impairment.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mucocutaneous candidiasis affects the oral or vaginal mucosa. The nails often become dystrophic due to chronic infection with Candida albicans (",
"      <a class=\"graphic graphic_picture graphicRef53677 \" href=\"mobipreview.htm?41/25/42385\">",
"       picture 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pulmonary infections with Pneumocystis jirovecii (formerly Pneumocystis carinii), Aspergillus, and Nocardia have been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/16,19,21\">",
"       16,19,21",
"      </a>",
"      ]. Patients with autosomal dominant HIES are at risk of late-onset invasive pulmonary fungal disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Systemic infection following Bacille-Calmette-Guerin (BCG) immunization is a rare complication in HIES patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Facial features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Affected patients resemble each other more than they resemble members of their own family [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/16,23\">",
"     16,23",
"    </a>",
"    ]. The most characteristic feature is an increased alar width (broad nasal base) and broad nasal bridge (",
"    <a class=\"graphic graphic_picture graphicRef63040 \" href=\"mobipreview.htm?16/6/16494\">",
"     picture 4",
"    </a>",
"    ). Other features include protrusion of the forehead (\"frontal bossing\"), wide outer canthal distances, and deep set eyes.",
"   </p>",
"   <p>",
"    There is notable thickening of the soft tissues of the face, ears, and nose that give the skin an appearance of doughy consistency that is often described as \"coarse facies\" (",
"    <a class=\"graphic graphic_picture graphicRef53778 \" href=\"mobipreview.htm?18/49/19221\">",
"     picture 5",
"    </a>",
"    ). These features are apparent in 80 to 100 percent of autosomal dominant HIES patients and become more pronounced with age, particularly post-puberty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/16,23\">",
"     16,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Skeletal abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skeletal and dental abnormalities, as well as growth retardation, have been associated with HIES:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is common for patients to retain the primary teeth, leading to two rows of teeth [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/24\">",
"       24",
"      </a>",
"      ]. The primary teeth may require extraction. Abnormalities of the hard palate and dorsal tongue are also seen [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A high incidence of scoliosis and hyperextensible joints has been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/14,16\">",
"       14,16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bone fractures are associated with minor trauma and can be recurrent. The long bones are most frequently affected. Osteopenia and decreased bone mineralization are noted in many patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/26\">",
"       26",
"      </a>",
"      ], possibly due to cytokine-mediated bone resorption. It has been suggested that the cytokine profile of HIES patients is similar to that of postmenopausal women [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Increased risk of lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of non-Hodgkin's lymphoma is increased in patients with HIES, although the degree of increased risk is not precisely known [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/28\">",
"     28",
"    </a>",
"    ]. A review of the literature described 13 patients with HIE syndrome and lymphoma, of whom at least 5 died directly from this complication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H33\">",
"     'Prognosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Neurologic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;One series described focal T2 hyperintensities visible on magnetic resonance imaging of the brain in 35 of 50 patients with HIES, which ranged in number from 2 to greater than 50 per patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/29\">",
"     29",
"    </a>",
"    ]. The etiology of these lesions is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Vascular abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The exact prevalence of vascular abnormalities in HIES is unknown, but a systemic review suggests these structural anomalies are a major clinical feature of HIES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/30\">",
"     30",
"    </a>",
"    ]. Vascular abnormalities can be venous or arterial, congenital or acquired, and they can cause significant morbidity and mortality. They include aneurysms, pseudoaneurysms, and vasculitides. Abnormalities of the coronary arteries in patients with HIES include tortuosity, ectatic dilation, and focal aneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     LABORATORY FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An elevated serum immunoglobulin E (IgE) level and peripheral eosinophilia are the most common laboratory findings in patients with HIES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/2,3,14,18,32,33\">",
"     2,3,14,18,32,33",
"    </a>",
"    ]. However, these findings are associated with many other clinical conditions (",
"    <a class=\"graphic graphic_table graphicRef76434 \" href=\"mobipreview.htm?26/0/26636\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef56468 \" href=\"mobipreview.htm?15/45/16091\">",
"     table 2",
"    </a>",
"    ) and are not diagnostic of HIES in the absence of typical clinical features. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Clinical features'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24745?source=see_link\">",
"     \"Approach to the patient with eosinophilia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Elevated serum IgE levels",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients almost always have elevated serum levels of IgE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/2,3,16,33\">",
"     2,3,16,33",
"    </a>",
"    ]. Serum IgE levels generally range from 2000 to greater than 50,000",
"    <span class=\"nowrap\">",
"     IU/mL.",
"    </span>",
"    A lower limit of 2000",
"    <span class=\"nowrap\">",
"     IU/mL",
"    </span>",
"    is often used as an arbitrary cutoff for this syndrome; however, we have seen patients with IgE levels as low as 400",
"    <span class=\"nowrap\">",
"     IU/mL.",
"    </span>",
"   </p>",
"   <p>",
"    The",
"    serum IgE level is not related to the severity of disease. During infancy, patients may have extremely elevated IgE levels. These may remain stable or decline over time. In some adults with HIES, serum IgE levels slowly decline to near the normal range. The anti-Staphylococcus and anti-Candida IgE titers usually remain elevated, however, and measurement of these may be useful in diagnosis, when available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role that immediate IgE-mediated hypersensitivity to Candida and S. aureus plays in HIES patients remains to be determined. There is no evidence that the IgE in serum has a direct suppressive effect on neutrophils or lymphocytes, or on their function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Elevated eosinophil counts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophil counts frequently rise just prior to acute infection. Eosinophilia has been reported in some patients, which may represent 40 to 50 percent of the total white blood cell count. This level of eosinophilia usually exceeds that noted in atopic patients. Eosinophils have also been found in the sputum of patients with HIE during acute pneumonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Other findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory evaluations used as screening tests for immunodeficiency disorders may reveal the following findings in patients with HIES:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Elevations in total serum IgG, IgM, and IgA levels.",
"     </li>",
"     <li>",
"      IgD levels have been reported to be elevated in some patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/34\">",
"       34",
"      </a>",
"      ], although we have not observed this abnormality in our patients.",
"     </li>",
"     <li>",
"      Decreased IgG subclass concentrations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/35\">",
"       35",
"      </a>",
"      ], although we have not observed this in our patients.",
"     </li>",
"     <li>",
"      Normal levels of total hemolytic complement, C3, and C4 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Total white cell counts are normal in the absence of acute inflammation. Similarly, neutropenia or lymphopenia have not been reported in the absence of infection.",
"     </li>",
"     <li>",
"      HIES patients may respond poorly to both protein and polysaccharide immunizations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/35,36\">",
"       35,36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIES is due to defects in Janus activated",
"    <span class=\"nowrap\">",
"     kinase/signal",
"    </span>",
"    transducer and activator of transcription (JAK-STAT)-mediated cytokine signals, including interleukin (IL)-6 and IL-23 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/10,37,38\">",
"     10,37,38",
"    </a>",
"    ]. Specific mutations in the DNA-binding domain of STAT3 are described in both the sporadic form of HIES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/5,6\">",
"     5,6",
"    </a>",
"    ] as well as in the familial form (MIM 147060) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/6\">",
"     6",
"    </a>",
"    ]. A null mutation in tyrosine kinase 2 (TYK2) was identified in a patient with type 2 autosomal recessive HIES (MIM 611521) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/8\">",
"     8",
"    </a>",
"    ]. Both STAT3 and TYK2 defects lead to impaired Th17 function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/10\">",
"     10",
"    </a>",
"    ]. Patients without detectable STAT3 mutations also have defective Th17 differentiation and function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/39\">",
"     39",
"    </a>",
"    ]. Patients with a milder phenotype in one family were found to have a less severe defect in C. albicans and S. aureus-induced IL-17 production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/40\">",
"     40",
"    </a>",
"    ]. The precise mechanisms that unify the infectious, dermatologic, skeletal, and immunologic aspects of this disorder remain uncharacterized.",
"   </p>",
"   <p>",
"    Susceptibility to infection is postulated to be due to the defect in Th17 function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/41\">",
"     41",
"    </a>",
"    ]. Staphylococcal infections are restricted to the skin and respiratory tract, although the defect in Th17 function is systemic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/42\">",
"     42",
"    </a>",
"    ]. Keratinocytes and bronchial epithelial cells require stimulation with both Th17 and classic proinflammatory cytokines to produce antistaphylococcal factors, whereas other cell types only require Th17 cytokines. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'T cell defects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inheritance usually follows an autosomal dominant inheritance pattern with incomplete penetrance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/15,16,43\">",
"     15,16,43",
"    </a>",
"    ]. Many sporadic cases have also been reported. An autosomal recessive pattern of inheritance is rarer and may represent a distinct entity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/8,44\">",
"     8,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    STAT3 is a cytoplasmic protein and a component of the Janus activated",
"    <span class=\"nowrap\">",
"     kinase/signal",
"    </span>",
"    transducer and activator of transcription (JAK-STAT) pathway of signal transduction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/45\">",
"     45",
"    </a>",
"    ]. The binding of various cytokines to their receptors on the cell surface results in activation of JAK proteins, which in turn phosphorylate STAT proteins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. The STATs then form dimers, translocate to the nucleus, bind to specific sites on the DNA, and activate target genes. This mechanism of signal transduction is critical to the normal functioning of a wide array of cell types.",
"   </p>",
"   <p>",
"    In patients with HIES, the most common mutations reported are missense mutations in the portions of STAT3 that bind to Src homology 2 (SH2) and DNA-binding domain (DBD) regions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/5,6,48\">",
"     5,6,48",
"    </a>",
"    ]. Larger in-frame amino acid deletions resulting in a truncated protein and mutations outside the DBD and SH2 domains have also been demonstrated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/48\">",
"     48",
"    </a>",
"    ]. However, some patients do not have STAT3 mutations. The defects in these patients are most likely further down the Th17 differentiation pathway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    STAT3 is important in the signaling induced by multiple families of cytokines, hormones, and growth factors, which is consistent with the multisystem defects seen in patients with HIES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/5,6,9\">",
"     5,6,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tyk2 is part of the Jak family of kinases that are constitutively associated with cytokine receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/8,10\">",
"     8,10",
"    </a>",
"    ]. A four nucleotide deletion in TYK2 resulting in a truncated protein that is not expressed was identified in a patient with HIES. This defect was associated with abnormal signaling for type I interferon, IL-6, -10, -12, and -23. T cell differentiation was skewed to a Th2 phenotype. Similar to the STAT3 mutations, this mutation of TYK2 was associated with defective Th17 differentiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Neutrophil chemotactic defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial clinical observation that patients with HIES are prone to the formation of cold abscesses suggested a possible defect in the inflammatory response. Patients with HIE are not neutropenic and their neutrophils engulf and kill bacteria normally. However, neutrophils demonstrate intermittent chemotactic defects in approximately 80 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/4,15,43,49,50\">",
"     4,15,43,49,50",
"    </a>",
"    ]. In addition, in vitro and in vivo inflammatory cytokine production is impaired and inflammation is minimal, leading to the characteristic cold (non-inflamed) appearance of abscesses in these patients.",
"   </p>",
"   <p>",
"    The following mechanisms have been proposed to account for these fluctuating neutrophil chemotactic defects:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One proposed theory is that invading pathogens stimulate IgE-mediated activation of mast cells, which release histamine. Histamine, in turn, may impair neutrophil migration. Elevated levels of histamine are reported in the serum, urine, and sputum of some patients with HIE syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/3,4,50,51\">",
"       3,4,50,51",
"      </a>",
"      ]. Interaction of IgE on mast cells or basophils with antigen or naturally occurring IgG anti-IgE may also result in the release of factors that down-regulate neutrophil movement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/51,52\">",
"       51,52",
"      </a>",
"      ]. Mononuclear cells from patients with HIES have been reported to produce a 61,000 Dalton factor that inhibits neutrophil and monocyte chemotaxis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/49\">",
"       49",
"      </a>",
"      ]. The production of this chemotactic inhibitory factor appears variable over time and may have a role in the neutrophil chemotactic defect.",
"     </li>",
"     <li>",
"      The role of interferon (IFN)-gamma and the pathways leading to IFN-gamma production have also been explored in patients with HIES. IFN-gamma production by mononuclear cells of affected patients may be deficient or absent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/53,54\">",
"       53,54",
"      </a>",
"      ]. IFN-gamma enhances neutrophil responses in patients with chronic granulomatous disease. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/38/43620?source=see_link\">",
"       \"Primary disorders of phagocytic function: An overview\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Incubation of neutrophils from HIES patients (in vitro) with IFN-gamma significantly enhances their chemotactic response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/55\">",
"     55",
"    </a>",
"    ]. A preliminary short-term clinical trial using IFN-gamma in four patients indicated a decrease in pulmonary symptomatology and improvement in eczema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cytokines interleukin (IL)-18 and IL-12 are capable of inducing IFN-gamma production. IL-18 was originally described as IFN-gamma inducing factor. These two interleukins are currently the focus of our research in HIES patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/57\">",
"     57",
"    </a>",
"    ]. We have shown that IL-18 is able to correct defective neonatal neutrophil chemotaxis and respiratory burst activity due to a deficiency in IFN-gamma in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. We speculate that IL-18 may also be deficient in the HIES and may function to correct both the decreased IFN-gamma production and depressed neutrophil chemotaxis. An increase in IFN-gamma production would also decrease the production of IgE.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     T cell defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;STAT3 plays a crucial role in the differentiation of naive T cells into IL-17 producing CD4+ T cells (Th17 cells) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/59\">",
"     59",
"    </a>",
"    ]. Th17 cells are involved in the response to fungal and extracellular bacterial infections. These cells are significantly reduced or absent in patients with HIES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/48,59\">",
"     48,59",
"    </a>",
"    ]. T cells stimulated with staphylococcal enterotoxin B, Candida albicans, or streptokinase failed to produce IL-17 in patients with HIES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41897?source=see_link\">",
"     \"T helper subsets: Differentiation and role in disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other T cell defects have been reported, including deficient production of IFN-gamma and TNF-alpha [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/53,54\">",
"     53,54",
"    </a>",
"    ], decreased numbers of memory T cells, and diminished delayed-type hypersensitivity and lymphoproliferative responses to antigenic stimulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Abnormal IgE regulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is probable that the elevated levels of serum immunoglobulin E (IgE) in patients with HIES is an associated abnormality, rather than central to the pathogenesis of the disorder. Immunoglobulin E synthesis is a complex process and a defect in the regulation of its production could express itself anywhere along its pathway to synthesis. IgE regulation involves T cell stimulation, appropriate cytokine production, and the ability of B cells to class switch toward the production of IgE. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/6/31848?source=see_link\">",
"     \"The biology of IgE\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Th2 cytokines, such as IL-4, and IL-13, enhance IgE production, while the Th1 cytokines, including IFN-gamma, IL-12, and IL-18, normally suppress it. Thus, defects in IFN-gamma production or regulation could contribute to the elevated levels of IgE observed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of HIES is based upon clinical and laboratory findings. A scoring system devised by the US National Institutes of Health is available (",
"    <a class=\"external\" href=\"file://www.niaid.nih.gov/LabsAndResources/labs/aboutlabs/lcid/stat3base/Documents/scoringsystem.pdf\">",
"     file://www.niaid.nih.gov/LabsAndResources/labs/aboutlabs/lcid/stat3base/Documents/scoringsystem.pdf",
"    </a>",
"    ). The diagnosis is most commonly made in older children or adults with staphylococcal pneumonias or recurrent abscesses and chronic eczema. However, it can be made in infancy due to the presence of the distinct eczematous rash in a child with family members who are known to be affected (",
"    <a class=\"graphic graphic_picture graphicRef61049 \" href=\"mobipreview.htm?38/24/39302\">",
"     picture 1",
"    </a>",
"    ). Molecular tests for mutations in the STAT3 gene are available in research laboratories [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical features include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Skin manifestations, including eczema, beginning in the newborn period",
"     </li>",
"     <li>",
"      Recurrent skin abscesses and pneumonia",
"     </li>",
"     <li>",
"      Characteristic facial features (",
"      <a class=\"graphic graphic_picture graphicRef63040 \" href=\"mobipreview.htm?16/6/16494\">",
"       picture 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef53778 \" href=\"mobipreview.htm?18/49/19221\">",
"       picture 5",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Skeletal abnormalities and fractures with minor trauma",
"     </li>",
"     <li>",
"      Vaulted or cathedral palate (a high, narrow, arched palate)",
"     </li>",
"     <li>",
"      Prolonged retention of primary teeth",
"     </li>",
"     <li>",
"      Broad nose and nasal bridge in autosomal dominant disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Laboratory features include elevated serum level of IgE in nearly all cases, although it may not exceed 1000 IU in some patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/2,3,16\">",
"     2,3,16",
"    </a>",
"    ]. Specific IgE to Staphylococcal aureus and Candida albicans, as well as to other bacterial and fungal antigens may be markedly elevated. Eosinophilia may be prominent at the outset of infections.",
"   </p>",
"   <p>",
"    Another set of diagnostic guidelines for STAT3-deficient HIES has been proposed that takes into account the total IgE level, Th17 cell count, cardinal clinical features (recurrent pneumonia, newborn rash, pathologic bone fractures, characteristic facies, and high palate), and family history [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/61\">",
"     61",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Possible &mdash; IgE &gt;1000",
"      <span class=\"nowrap\">",
"       IU/mL",
"      </span>",
"      plus a weighted score &gt;30 of the five cardinal clinical features",
"     </li>",
"     <li>",
"      Probable &mdash; The \"possible\" criteria are met plus Th17 cells are low to absent or there is a family history of confirmed HIES",
"     </li>",
"     <li>",
"      Definitive &mdash; The \"possible\" criteria are met plus a dominant-negative heterozygous STAT3 mutation is identified",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following also strongly suggest the diagnosis of STAT3-deficient HIES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/62\">",
"     62",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abscesses of internal organs",
"     </li>",
"     <li>",
"      Severe infections",
"     </li>",
"     <li>",
"      Pneumatoceles",
"     </li>",
"     <li>",
"      Nail and mucocutaneous candidiasis",
"     </li>",
"     <li>",
"      Scoliosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Suspected cases should be referred to a research center to have mutational analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of HIES includes atopic dermatitis, Wiskott-Aldrich syndrome, severe combined immunodeficiency, and DOCK8 deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. The differential diagnoses of elevated levels of IgE or eosinophil counts were reviewed previously. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Laboratory findings'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Atopic dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A few patients with atopic dermatitis may also have extremely high IgE levels and recurrent superficial S. aureus skin infections, and must therefore be distinguished from patients with HIES. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/40/42631?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The range of serum IgE levels found in all patients with the syndrome of HIES does not significantly differ from that found in patients with severe atopic dermatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/14\">",
"     14",
"    </a>",
"    ]. The two disorders can usually be distinguished based upon the other infections and clinical features that are associated with HIES. Specifically, patients with severe atopic dermatitis may have superficial skin infections, however, they do not develop deep seated abscesses or pneumonias, nor do they have bone fractures or abnormal facies.",
"   </p>",
"   <p>",
"    An important difference between patients with atopic dermatitis and those with HIE syndrome is the antibody reactivity of the IgE:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The IgE in patients with atopic dermatitis has reactivity to a broad range of food and inhalant allergens.",
"     </li>",
"     <li>",
"      By comparison, although patients with HIES may also have immediate skin reactions to a number of inhalant and food allergens, they often demonstrate specific IgE and immediate skin test reactions to Staphylococcal aureus (although this can also be seen in patients with atopic dermatitis) and Candida albicans, as well as to other bacterial and fungal antigens [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/14,65\">",
"       14,65",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Wiskott-Aldrich syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with Wiskott-Aldrich syndrome also may have eczema and elevated levels of total IgE. However, Wiskott-Aldrich patients have thrombocytopenia, small platelets, and may exhibit bruising. In addition, abscesses are not common in patients with Wiskott-Aldrich. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=see_link\">",
"     \"Wiskott-Aldrich syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Severe combined immunodeficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe combined immunodeficiency (SCID) may present with desquamative skin rash, although this is usually distinguishable from the eczema of the hyper IgE syndrome. Some patients may also have elevated levels of IgE. Flow cytometry would indicate significantly reduced T cell numbers in SCID. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Dedicator of cytokinesis 8 (DOCK8) deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients with DOCK8 deficiency, a combined immunodeficiency, were previously thought to have autosomal recessive hyperimmunoglobulin E syndrome (HIES) due to similarities in presentation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/58/40873?source=see_link\">",
"     \"Combined immunodeficiencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of the patient with HIES is difficult, principally because the pathophysiology of the immunodeficiency leading to infection has not been completely elucidated. At present, the general management goals are the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Control the pruritus and eczematoid dermatitis",
"     </li>",
"     <li>",
"      Prevent the occurrence of severe systemic infection with early diagnosis and thorough treatment",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Skin care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of the eczematoid dermatitis consists of skin hydration and the use of emollient creams. Frequent baths with time to soak and hydrate followed by application of Eucerin is very useful. The judicious use of glucocorticoids on inflamed but uninfected areas may also be helpful. Antihistamines can be useful in controlling the associated pruritus. Cutaneous lesions should also be examined closely for evidence of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/18,66,67\">",
"     18,66,67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Prophylactic antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prophylactic administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    is useful in the prevention of cutaneous staphylococcal infections. We utilize this in most patients with severe infections and with a high incidence of infections. We have found the administration of the drug in a single daily dose to be very useful in preventing bacterial infections, including abscesses, sinusitis, otitis media, and probably even pneumonia, in patients with the hyper IgE syndrome, just like in patients with chronic granulomatous disease. This agent is useful even in the presence of methicillin resistant staphylococcal infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/53/8026?source=see_link\">",
"     \"Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/21/30042?source=see_link&amp;anchor=H8#H8\">",
"     \"Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children\", section on 'Microbiologic characteristics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Treatment of infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep-seated bacterial infections should be aggressively managed using systemic antibiotics. Surgical drainage may be necessary and the clinician should be vigilant for the development of osteomyelitis. Every effort should be made to isolate the infecting organism and determine its sensitivity. Methicillin-resistant staphylococci (MRSA) have become problematic in these patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/6/29802?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children\", section on 'Treatment approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For chronic mucocutaneous Candida infections, oral and topical antifungal agents are beneficial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/18,66,67\">",
"     18,66,67",
"    </a>",
"    ]. Prophylactic regimens similar to those used in patients with HIV infection are employed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33450?source=see_link\">",
"     \"Primary prevention of opportunistic infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Control of pulmonary complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary complications include pulmonary insufficiency and pneumatoceles.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary insufficiency from repeated bacterial pneumonias is common.",
"     </li>",
"     <li>",
"      We follow patients with persistent pneumatoceles using yearly pulmonary function studies and x-rays and try various modes of pulmonary therapy.",
"     </li>",
"     <li>",
"      As mentioned previously, the only agent we employ for bacterial prophylaxis is",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Large, persistent pneumatoceles may require removal of segments of the lung or even lobectomy. This may then be followed by involvement of other lobes, which can lead to pulmonary compromise.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Immunomodulating agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recombinant human IFN-gamma has been administered to patients with HIES [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/68\">",
"     68",
"    </a>",
"    ], based upon the observations that IFN-gamma inhibits murine IL-4-induced IgE synthesis and improves the chemotaxis of human neutrophils in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. This therapy may result in slightly lower IgE levels and decreased respiratory secretions and symptomatology, although a randomized controlled trial has yet to be conducted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/55,56,68\">",
"     55,56,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At present, we administer recombinant human IFN-gamma therapy only to patients with very serious infections, such as pulmonary aspergillus.",
"   </p>",
"   <p>",
"    Other immunomodulators, such as levamisole, ascorbic acid,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/54/2921?source=see_link\">",
"     cimetidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    , and transfer factor, have been used to treat HIES patients with limited and variable success [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/71\">",
"     71",
"    </a>",
"    ]. Similarly, the use of high dose IVIG has not consistently been shown to provide benefit to HIES patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. We do not suggest the administration of these agents.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/46/38629?source=see_link\">",
"     Omalizumab",
"    </a>",
"    , or anti-IgE, is a monoclonal antibody developed for patients with severe allergic asthma, which blocks IgE-mediated histamine release from mast cells. The use of omalizumab in HIE patients should be approached with caution because of the extreme elevation of IgE in these patients. Omalizumab was used successfully in one patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/72\">",
"     72",
"    </a>",
"    ]. Further study is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14550623\">",
"    <span class=\"h2\">",
"     Transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early attempts of hematopoietic cell transplantation (HCT) for HIES did not demonstrate long-term benefits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. Subsequently, two patients with HIES with severe recurrent pulmonary infections and non-Hodgkin lymphoma who underwent HCT with HLA-identical sibling donors have shown sustained benefit over 10 and 14 years of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/75\">",
"     75",
"    </a>",
"    ]. No significant infections were reported after the immediate posttransplantation period. In addition, nonimmunologic manifestations of HIES resolved or did not develop.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infectious pulmonary complications appear to be the leading cause of death in patients with HIE syndrome, followed by lymphoma.",
"   </p>",
"   <p>",
"    Pneumatoceles can become colonized with fungi and gram negative bacteria, including Aspergillus fumigatus and Pseudomonas aeruginosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/19\">",
"     19",
"    </a>",
"    ]. Infected pneumatoceles can cause subsequent pneumonia, systemic infection, or sudden pulmonary hemorrhage. Vascular invasion by fungi may give rise to mycotic aneurysms with subsequent hemorrhagic complications in the lungs and other organs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lymphoma in these patients has a relatively poor prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/28\">",
"     28",
"    </a>",
"    ]. One of our patients with a history of HIE syndrome underwent a peripheral stem cell transplant for a B-cell lymphoma. This patient remained HIE symptom free post transplantation; however, he later died of pulmonary interstitial fibrosis related to the transplant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32153/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyper-IgE syndrome (HIES) is characterized by recurrent skin and pulmonary infections (principally bacterial), eczematous dermatitis (",
"    <a class=\"graphic graphic_picture graphicRef61049 \" href=\"mobipreview.htm?38/24/39302\">",
"     picture 1",
"    </a>",
"    ), and elevated serum IgE levels. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HIES is a rare disorder found in both males and females and in populations around the world. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Associated abnormalities in some patients include coarse facial features (",
"      <a class=\"graphic graphic_picture graphicRef63040 \" href=\"mobipreview.htm?16/6/16494\">",
"       picture 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef53778 \" href=\"mobipreview.htm?18/49/19221\">",
"       picture 5",
"      </a>",
"      ), failure or delay of shedding of primary teeth, recurrent fractures, hyperextensible joints, and scoliosis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory abnormalities include elevated total serum IgE levels, typically ranging from 1000 to greater than 50,000",
"      <span class=\"nowrap\">",
"       IU/mL,",
"      </span>",
"      and variable eosinophilia. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Laboratory findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mutations in the signaling protein STAT3 have been identified in multiple patients with HIES and are believed to be responsible for the syndrome. STAT3 is important in the signaling induced by multiple families of cytokines, hormones, and growth factors, although the precise mechanisms that unify the infectious, dermatologic, skeletal, and immunologic features of this disorder are not yet known. DOCK8 mutations have been identified in the majority of patients who were previously diagnosed with autosomal recessive hyper IgE syndrome. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/58/40873?source=see_link&amp;anchor=H31#H31\">",
"       \"Combined immunodeficiencies\", section on 'Dedicator of cytokinesis 8 (DOCK8) deficiency'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Diagnosis and management",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of HIES is based upon the presence of suggestive clinical and laboratory findings. A definitive laboratory test is not commercially available at present. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management of patients with HIES is focused on skin care, prevention of infection, prompt and complete treatment of infections that do develop, and control of pulmonary complications. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prophylactic administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      is useful in the prevention of cutaneous staphylococcal infections. We utilize this in most patients with a high incidence of infections",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      severe infections. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Prophylactic antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Significant bacterial infections and pneumonias should be aggressively managed with systemic antibiotics, guided by culture and sensitivity data on the infecting organism. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Treatment of infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We administer IFN-gamma therapy to HIES patients only in the setting of potentially life-threatening infections, such as pulmonary aspergillus. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Immunomodulating agents'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/1\">",
"      Davis SD, Schaller J, Wedgwood RJ. Job's Syndrome. Recurrent, \"cold\", staphylococcal abscesses. Lancet 1966; 1:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/2\">",
"      Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 1972; 49:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/3\">",
"      Hill HR, Quie PG. Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1974; 1:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/4\">",
"      Hill HR, Ochs HD, Quie PG, et al. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent \"cold\" staphylococcal abscesses. Lancet 1974; 2:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/5\">",
"      Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007; 448:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/6\">",
"      Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007; 357:1608.",
"     </a>",
"    </li>",
"    <li>",
"     Gene Reviews. file://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=higes (Accessed on June 02, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/8\">",
"      Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006; 25:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/9\">",
"      Paulson ML, Freeman AF, Holland SM. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Curr Opin Allergy Clin Immunol 2008; 8:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/10\">",
"      Minegishi Y, Karasuyama H. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int Immunol 2009; 21:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/11\">",
"      Olaiwan A, Chandesris MO, Fraitag S, et al. Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis. J Am Acad Dermatol 2011; 65:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/12\">",
"      Eberting CL, Davis J, Puck JM, et al. Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol 2004; 140:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/13\">",
"      Cho C, Ferdman RM, Church JA, Ong PY. Skin-deep clues to a complex disease. Ann Allergy Asthma Immunol 2010; 104:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/14\">",
"      Shyur SD, Hill HR. Immunodeficiency in the 1990s. Pediatr Infect Dis J 1991; 10:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/15\">",
"      Van Scoy RE, Hill HR, Ritts RE, Quie PG. Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E. Ann Intern Med 1975; 82:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/16\">",
"      Grimbacher B, Holland SM, Gallin JI, et al. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med 1999; 340:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/17\">",
"      Grimbacher B, Holland SM, Puck JM. Hyper-IgE syndromes. Immunol Rev 2005; 203:244.",
"     </a>",
"    </li>",
"    <li>",
"     Shyur SD, Hill HR. Job's syndrome of hyperimmunoglobulin E and recurrent infections. In: Current therapy in allergy, immunology, and rheumatology, Lichtenstein LM, Fauci AS (Eds), Mosby-Year Book, Inc, Saint Louis, MO 1992. p.322.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/19\">",
"      Freeman AF, Kleiner DE, Nadiminti H, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol 2007; 119:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/20\">",
"      Melia E, Freeman AF, Shea YR, et al. Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol 2009; 124:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/21\">",
"      Freeman AF, Davis J, Anderson VL, et al. Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome. Pediatrics 2006; 118:e1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/22\">",
"      Vinh DC, Sugui JA, Hsu AP, et al. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol 2010; 125:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/23\">",
"      Borges WG, Hensley T, Carey JC, et al. The face of Job. J Pediatr 1998; 133:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/24\">",
"      O'Connell AC, Puck JM, Grimbacher B, et al. Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/25\">",
"      Domingo DL, Freeman AF, Davis J, et al. Novel intraoral phenotypes in hyperimmunoglobulin-E syndrome. Oral Dis 2008; 14:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/26\">",
"      Kirchner SG, Sivit CJ, Wright PF. Hyperimmunoglobulinemia E syndrome: association with osteoporosis and recurrent fractures. Radiology 1985; 156:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/27\">",
"      Cohen-Solal M, Prieur AM, Prin L, et al. Cytokine-mediated bone resorption in patients with the hyperimmunoglobulin E syndrome. Clin Immunol Immunopathol 1995; 76:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/28\">",
"      Leonard GD, Posadas E, Herrmann PC, et al. Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma 2004; 45:2521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/29\">",
"      Freeman AF, Collura-Burke CJ, Patronas NJ, et al. Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics 2007; 119:e1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/30\">",
"      Yavuz H, Chee R. A review on the vascular features of the hyperimmunoglobulin E syndrome. Clin Exp Immunol 2010; 159:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/31\">",
"      Gharib AM, Pettigrew RI, Elagha A, et al. Coronary abnormalities in hyper-IgE recurrent infection syndrome: depiction at coronary MDCT angiography. AJR Am J Roentgenol 2009; 193:W478.",
"     </a>",
"    </li>",
"    <li>",
"     de Saint-Basile G. Other well-defined immunodeficiency syndromes (The Hyper-IgE Syndrome). In: Immunologic disorders in infants and children, 5th, Stiehm ER, Ochs HD, Winkelstein JA (Eds), Elsevier Saunders, Philadelphia 2004. p.544.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/33\">",
"      Joshi AY, Iyer VN, Boyce TG, et al. Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience. Allergy Asthma Proc 2009; 30:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/34\">",
"      Buckley RH. The hyper-IgE syndrome. Clin Rev Allergy Immunol 2001; 20:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/35\">",
"      Sheerin KA, Buckley RH. Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. J Allergy Clin Immunol 1991; 87:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/36\">",
"      Leung DY, Ambrosino DM, Arbeit RD, et al. Impaired antibody responses in the hyperimmunoglobulin E syndrome. J Allergy Clin Immunol 1988; 81:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/37\">",
"      Heimall J, Freeman A, Holland SM. Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol 2010; 38:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/38\">",
"      Mar&oacute;di L, Cypowyj S, T&oacute;th B, et al. Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species. J Allergy Clin Immunol 2012; 130:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/39\">",
"      Al Khatib S, Keles S, Garcia-Lloret M, et al. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol 2009; 124:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/40\">",
"      van de Veerdonk FL, Marijnissen RJ, Marijnissen R, et al. Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency. Clin Exp Immunol 2010; 159:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/41\">",
"      Ochs HD, Oukka M, Torgerson TR. TH17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol 2009; 123:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/42\">",
"      Minegishi Y, Saito M, Nagasawa M, et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 2009; 206:1291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/43\">",
"      Hill DJ, Thompson PJ, Stewart GA, et al. The Melbourne house dust mite study: eliminating house dust mites in the domestic environment. J Allergy Clin Immunol 1997; 99:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/44\">",
"      Renner ED, Puck JM, Holland SM, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 2004; 144:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/45\">",
"      Darnell JE Jr. STATs and gene regulation. Science 1997; 277:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/46\">",
"      Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002; 285:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/47\">",
"      Levy DE, Lee CK. What does Stat3 do? J Clin Invest 2002; 109:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/48\">",
"      Renner ED, Rylaarsdam S, Anover-Sombke S, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol 2008; 122:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/49\">",
"      Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature. Medicine (Baltimore) 1983; 62:195.",
"     </a>",
"    </li>",
"    <li>",
"     Hill HR, Quie PG. Defective neutrophil chemotaxis associated with hyperimmunoglobulinemia E. In: The Phagocytic cell in host resistance, Bellanti JA, Dayton DA (Eds), Raven Press, New York 1975. p.249.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/51\">",
"      Hill HR. The syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Dis Child 1982; 136:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/52\">",
"      Leung DY, Geha RS. Clinical and immunologic aspects of the hyperimmunoglobulin E syndrome. Hematol Oncol Clin North Am 1988; 2:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/53\">",
"      Borges WG, Augustine NH, Hill HR. Defective interleukin-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome. J Pediatr 2000; 136:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/54\">",
"      Del Prete G, Tiri A, Maggi E, et al. Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome. J Clin Invest 1989; 84:1830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/55\">",
"      Jeppson JD, Jaffe HS, Hill HR. Use of recombinant human interferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia E and recurrent infections. J Pediatr 1991; 118:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/56\">",
"      Petrak BA, Augustine NH, Hill HR. Recombinant human interferon gamma treatment of patients with Job's syndrome of hyperimmunoglobulin E and recurrent infections. Clin Res 1994; 42:1A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/57\">",
"      La Pine TR, Joyner JL, Augustine NH, et al. Defective production of IL-18 and IL-12 by cord blood mononuclear cells influences the T helper-1 interferon gamma response to group B Streptococci. Pediatr Res 2003; 54:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/58\">",
"      LaPine TR, Augustine NH, Hill HR. The Th-1 cytokine, IL-18, stimulates the movement of neonatal neutrophils. Pediatr Res 2004; 55:390A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/59\">",
"      Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/60\">",
"      Kum&aacute;novics A, Wittwer CT, Pryor RJ, et al. Rapid molecular analysis of the STAT3 gene in Job syndrome of hyper-IgE and recurrent infectious diseases. J Mol Diagn 2010; 12:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/61\">",
"      Woellner C, Gertz EM, Sch&auml;ffer AA, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol 2010; 125:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/62\">",
"      Schimke LF, Sawalle-Belohradsky J, Roesler J, et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol 2010; 126:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/63\">",
"      Pien GC, Orange JS. Evaluation and clinical interpretation of hypergammaglobulinemia E: differentiating atopy from immunodeficiency. Ann Allergy Asthma Immunol 2008; 100:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/64\">",
"      Ozcan E, Notarangelo LD, Geha RS. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol 2008; 122:1054.",
"     </a>",
"    </li>",
"    <li>",
"     Buckley RH. Other well-defined immunodeficiency syndromes (The Hyper-IgE Syndrome). In: Immunologic disorders in infants and children, 5th ed, Stiehm ER, Ochs HD, Winkelstein JA (Eds), Elsevier Saunders, Philadelphia 2004. p.550.",
"    </li>",
"    <li>",
"     Quie PG, Belani KR. Hyperimmunoglobulin E syndrome. In: Current therapy in allergy, immunology, and rheumatology, Lichtenstein LM, Fauci AS (Eds), Mosby-Year Book, Inc, Saint Louis, MO 1988. p.313.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/67\">",
"      Erlewyn-Lajeunesse MD. Hyperimmunoglobulin-E syndrome with recurrent infection: a review of current opinion and treatment. Pediatr Allergy Immunol 2000; 11:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/68\">",
"      King CL, Gallin JI, Malech HL, et al. Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc Natl Acad Sci U S A 1989; 86:10085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/69\">",
"      Coffman RL, Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J Immunol 1986; 136:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/70\">",
"      P&egrave;ne J, Rousset F, Bri&egrave;re F, et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci U S A 1988; 85:6880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/71\">",
"      Trendelenburg M, Schifferli JA. Rituximab in a patient with Hyper-IgE syndrome. Arch Dermatol 2007; 143:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/72\">",
"      Chularojanamontri L, Wimoolchart S, Tuchinda P, et al. Role of omalizumab in a patient with hyper-IgE syndrome and review dermatologic manifestations. Asian Pac J Allergy Immunol 2009; 27:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/73\">",
"      Nester TA, Wagnon AH, Reilly WF, et al. Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Med 1998; 105:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/74\">",
"      Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant 2000; 25:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32153/abstract/75\">",
"      Goussetis E, Peristeri I, Kitra V, et al. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol 2010; 126:392.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3960 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-2522EA1FE6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32153=[""].join("\n");
var outline_f31_25_32153=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H34\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Skin manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Sinopulmonary and other infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Opportunistic infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Facial features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Skeletal abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Increased risk of lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Neurologic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Vascular abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      LABORATORY FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Elevated serum IgE levels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Elevated eosinophil counts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Other findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Neutrophil chemotactic defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      T cell defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Abnormal IgE regulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Atopic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Wiskott-Aldrich syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Severe combined immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Dedicator of cytokinesis 8 (DOCK8) deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Skin care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Prophylactic antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Treatment of infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Control of pulmonary complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Immunomodulating agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14550623\">",
"      Transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Diagnosis and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3960\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3960|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/24/39302\" title=\"picture 1\">",
"      Severe eczema hyper IgE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/24/21888\" title=\"picture 2\">",
"      Staphylococcal abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/25/42385\" title=\"picture 3\">",
"      Fungal nail infections Hyper-IgE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?16/6/16494\" title=\"picture 4\">",
"      Facial features hyper IgE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/49/19221\" title=\"picture 5\">",
"      Typical facial features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3960|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/0/26636\" title=\"table 1\">",
"      Eosinophil associated diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/45/16091\" title=\"table 2\">",
"      Causes elevated IgE",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24745?source=related_link\">",
"      Approach to the patient with eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/58/40873?source=related_link\">",
"      Combined immunodeficiencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/21/30042?source=related_link\">",
"      Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/53/8026?source=related_link\">",
"      Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/38/43620?source=related_link\">",
"      Primary disorders of phagocytic function: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33450?source=related_link\">",
"      Primary prevention of opportunistic infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/30/42471?source=related_link\">",
"      Severe combined immunodeficiency (SCID): An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41897?source=related_link\">",
"      T helper subsets: Differentiation and role in disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/6/31848?source=related_link\">",
"      The biology of IgE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/6/29802?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/29/36313?source=related_link\">",
"      Wiskott-Aldrich syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_25_32154="Transabdominal ultrasonography of the small and large intestine";
var content_f31_25_32154=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Transabdominal ultrasonography of the small and large intestine",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/25/32154/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/25/32154/contributors\">",
"     Christoph F Dietrich, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/25/32154/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/25/32154/contributors\">",
"     John R Saltzman, MD, FACP, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/25/32154/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/25/32154/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/25/32154/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transabdominal ultrasonography is most commonly used to obtain images of hepatobiliary, urogenital, and pelvic structures. Its utility for imaging the alimentary gastrointestinal tract is less well established, principally because of technical difficulties in obtaining quality images of these regions. However, improvements in ultrasound technology and increasing familiarity with ultrasonographic findings in a variety of gastrointestinal disorders are broadening its applications.",
"   </p>",
"   <p>",
"    An advantage of ultrasound imaging compared with endoscopy and contrast radiography is that it permits evaluation of the transmural aspects of inflammatory or neoplastic pathology within its surrounding structures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/1\">",
"     1",
"    </a>",
"    ]. This can provide an important contribution for diagnosis and monitoring of disease activity. Other advantages are that it is widely available, noninvasive, and can be performed without preparation.",
"   </p>",
"   <p>",
"    On the other hand, important limitations of ultrasonography are that the alimentary tract cannot be visualized over its entire length, many of the findings are nonspecific, and obtaining and interpreting the images is highly operator dependent. Furthermore, ultrasound is far less useful in obese patients in whom high frequency scanning may not be possible.",
"   </p>",
"   <p>",
"    This topic review will provide an overview of transabdominal ultrasonography of the small and large bowel, while summarizing its use in a variety of gastrointestinal disorders. Ultrasonography for the evaluation of the hepatobiliary tract is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/30/21992?source=see_link\">",
"     \"Ultrasonography of the hepatobiliary tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TECHNICAL CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging of the alimentary tract requires high frequency (5 to 17 MHz), high resolution linear or convex array transducers, a great deal of scanning experience, and patience. The standardized evaluation should optimally take place preprandially, since images from filled intestines can be difficult to interpret, particularly when motility is being evaluated. On the other hand, under emergency conditions, such as ileus (eg, due to obstruction, an incarcerated hernia, or intussusception), appendicitis, or diverticulitis, the exam may be performed postprandially.",
"   </p>",
"   <p>",
"    The ileocecal region and the sigmoid colon can be identified by ultrasound imaging in most patients. Landmarks in the ileocecal region are the right iliac artery and vein, while landmarks in the sigmoid region are the left iliac artery and vein. The remaining colonic segments can also be evaluated adequately by continuous scanning in many patients. The rectum and distal parts of the colon cannot always be displayed satisfactorily.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Intestinal wall thickness and sonomorphology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A central element of alimentary tract imaging is the correct estimation of intestinal wall thickness. A number of different reference values for defining normal have been proposed (ranging from 1 to 5 mm). In our experience, the normal intestinal tract thickness in the terminal ileum, cecum, and right and left colon is &lt;2 mm when examined with graded compression. It is important to appreciate that a contracted intestinal segment can be misinterpreted as a thickened wall. In addition to the wall thickness, its overall echo texture and appearance within surrounding structures should be considered when interpreting the results.",
"   </p>",
"   <p>",
"    High resolution transducers usually permit visualization of the five layers of the colonic and stomach walls (",
"    <a class=\"graphic graphic_table graphicRef74168 \" href=\"mobipreview.htm?3/60/4043\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Imaging of the walls of the small intestine usually requires it to be filled with liquid. The small and large intestines can be distinguished by scanning the haustra of the colon and the circular folds of Kerckring in the small intestine. In unclear cases, scanning of the intestines during various filling stages can be helpful. The specific appearance of these features can also help to establish a diagnosis. As an example, widening of the spaces between the Kerckring folds can be seen in patients with villous atrophy (such as celiac disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Color Doppler imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of authors have described the utility of color Doppler imaging during standard ultrasound examination in a variety of gastrointestinal disorders, particularly in patients with Crohn's disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/4-11\">",
"     4-11",
"    </a>",
"    ], celiac disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/12-17\">",
"     12-17",
"    </a>",
"    ], and mesenteric artery stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/18-22\">",
"     18-22",
"    </a>",
"    ]. However, experience with these imaging modalities is limited, and their accuracy has not been well defined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. As a result, their role in diagnosis of or in monitoring disease activity remains unclear. A promising approach is combining mesenteric inflow by Duplex scanning (systolic and diastolic velocities, resistance index) with visualization of the end-organ vascularity by color Doppler imaging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute inflammation of the intestinal wall (such as in patients with Crohn's disease, celiac disease or food allergies) is accompanied by increased perfusion of the mesentery, which can be displayed non-quantitatively with color duplex, with or without the administration of echo-enhancing agents (eg, SonoVue&reg;). In patients with Crohn's disease, the perfusion pattern may facilitate differentiation of inflammatory from cicatricial-fibroid stenosis with high sensitivity and specificity and a strong correlation with the CDAI [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/26\">",
"       26",
"      </a>",
"      ]. However, technical factors (eg, depth of penetration, pressure and equipment used) may influence the ability to make this distinction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/27,28\">",
"       27,28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mesenteric Doppler ultrasonography has been advocated as a reasonably accurate screening modality for the detection of high-grade superior mesenteric artery stenoses. Sensitivity exceeding 90 percent and a negative predictive value of close to 99 percent have been reported in patients with more than a 50 percent stenosis of the superior mesenteric or celiac arteries. As a result, it is reasonable to pursue other etiologies of abdominal pain after a negative study. A positive study should be followed by angiography, which can further establish the feasibility of revascularization. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33206?source=see_link\">",
"       \"Chronic mesenteric ischemia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ADDITIONAL SONOGRAPHIC EXAMINATION TECHNIQUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of modifications of standard ultrasound techniques continue to be developed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One of these, hydrocolonic ultrasonography, involves the retrograde instillation of water into the colon, which helps to provide excellent images of the colonic wall morphology [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/29-31\">",
"       29-31",
"      </a>",
"      ]. However, its clinical utility is unclear.",
"     </li>",
"     <li>",
"      In a pilot study, the diagnostic accuracies of ultrasound, color Doppler ultrasound (CD-US), and contrast-enhanced ultrasound (CE-US) using sulfur hexafluoride-filled microbubbles for detecting inflammation were evaluated in 47 patients with Crohn's disease (CD) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/26\">",
"       26",
"      </a>",
"      ]. Sensitivity and specificity of CE-US were 94 and 94 percent, respectively, compared with endoscopic and histologic findings as the reference standards. CE-US revealed three bowel wall perfusion patterns in patients with inflammation: submucosal enhancement and inward and outward transparietal enhancement. More studies are needed to clarify the clinical value of this approach.",
"     </li>",
"     <li>",
"      Transrectal, transvaginal, and other perineal ultrasound techniques can provide detailed information about perineal structures. We have found these approaches to be particularly helpful in the initial evaluation of patients with perineal fistulas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/32\">",
"       32",
"      </a>",
"      ]. However, they are of limited value in patients with deep or complex fistulas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/33,34\">",
"       33,34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     APPENDICITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography has been used successfully in diagnosing acute appendicitis primarily in children, but also in adults (",
"    <a class=\"graphic graphic_table graphicRef59522 \" href=\"mobipreview.htm?19/48/20239\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/40/31370?source=see_link\">",
"     \"Acute appendicitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/61/19416?source=see_link\">",
"     \"Acute appendicitis in children: Diagnostic imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The normal outer appendiceal diameter (with and without) compression was measured in 205 consecutive children without clinical signs of appendicitis, [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/35\">",
"     35",
"    </a>",
"    ]. The mean age of the children included in the study was nine years. The appendix was visualized in 142 of 205 children (69 percent). The mean appendiceal diameter without and with compression was 4.2",
"    <span class=\"nowrap\">",
"     +/-",
"    </span>",
"    0.9 mm and 3.5",
"    <span class=\"nowrap\">",
"     +/-",
"    </span>",
"    0.8 mm, respectively, with 54 percent of the appendices appearing in the mid-pelvic location. Age, weight, and height all affected the visualization rate of the normal appendix.",
"   </p>",
"   <p>",
"    Sonographic signs of appendicitis include (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70354 \" href=\"mobipreview.htm?22/11/22705\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56139 \" href=\"mobipreview.htm?43/43/44735\">",
"     image 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A noncompressible tubular structure with a diameter of &gt;6 mm at the base of the cecum at the confluence of the three taenia coli, with or without luminal distension",
"     </li>",
"     <li>",
"      Concentric thickening of the inflamed appendiceal wall (&gt;1 to 2 mm) with corresponding pain on compression",
"     </li>",
"     <li>",
"      Free fluid",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a retrospective review of 304 consecutive patients, the highest sensitivity (99 percent) and specificity (95 percent) for making a diagnosis of appendicitis were a mean outer diameter of &ge;7 mm or wall thickness &gt;1.7 mm, resulting in one (0.5 percent) false-negative and six (3 percent) false-positive studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some patients, the whole length of the appendix (up to 10 cm or more) can be visualized, especially if localized retrocecally. Obstruction of the appendix (eg, by an appendicolith, neoplasia or, in endemic areas, parasites) can be identified in some patients.",
"   </p>",
"   <p>",
"    Inflammation of the appendiceal wall may be followed by localized ischemia (which may be visualized by color Doppler imaging) and necrosis. Complications of acute appendicitis (perforation and abscess formation with or without generalized peritonitis and pylephlebitis) can also be detected during ultrasonography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     EPIPLOIC APPENDAGITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epiploic appendagitis (also known as appendicitis epiploica) is a rarely recognized disease of the colonic epiploicae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/37-46\">",
"     37-46",
"    </a>",
"    ]. Its main clinical feature is acute abdominal pain that is often mistaken for appendicitis or diverticulitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/16/35076?source=see_link\">",
"     \"Epiploic appendagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The disorder can be recognized ultrasonographically by the presence of small hyperechoic (surrounding infiltrated fat) and hypoechoic (inflamed tissue) structures next to the colon wall, in addition to slightly enlarged mesenteric lymph nodes. There may also be an absence of vascularity on color Doppler ultrasonography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/47\">",
"     47",
"    </a>",
"    ]. The transverse colon is rarely involved. Ultrasonography can establish the diagnosis, although computed tomography is more commonly used. Contrast enhanced ultrasound has also proven to be helpful in the diagnosis of epiploic appendagitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIVERTICULITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of diverticulitis is usually established based upon the history, physical examination, and the results of imaging tests, most commonly CT scanning. However, high-resolution, graded, compression ultrasonography continues to be widely used in many centers to evaluate patients with suspected diverticulitis. It can also be used to assess the resolution of the disease. Reported sensitivities range from 84 to 98 percent and specificities from 80 to 99 percent (",
"    <a class=\"graphic graphic_table graphicRef68658 \" href=\"mobipreview.htm?7/33/7710\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/49-57\">",
"     49-57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/6/34919?source=see_link\">",
"     \"Clinical manifestations and diagnosis of colonic diverticular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Typical ultrasonographic features seen in patients with acute diverticulitis include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A hypoechoic peridiverticular inflammatory reaction",
"     </li>",
"     <li>",
"      Mural and peridiverticular abscess formation with or without gas bubbles",
"     </li>",
"     <li>",
"      Bowel wall thickening (segmental mural thickening greater than 3 to 4 mm) at the point of maximal tenderness",
"     </li>",
"     <li>",
"      Normal appearing diverticula in the surrounding segments",
"     </li>",
"     <li>",
"      A prominent muscularis layer (a general feature of diverticulosis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ultrasonography can also identify the major complications of diverticulitis, including obstruction, peritonitis (with ascites and sometimes diffuse peritoneal thickening and scattered loculated fluid collections), and fistula and abscess formation (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56822 \" href=\"mobipreview.htm?17/56/18312\">",
"     image 3",
"    </a>",
"    ). Fistulas appear as hypoechoic areas next to inflamed diverticula with extraluminal air bubbles extending in the bladder, vagina, or abdominal wall.",
"   </p>",
"   <p>",
"    Once the diagnosis has been established, ultrasonography can be used to facilitate percutaneous drainage of localized abscesses, thereby downstaging complicated diverticulitis, avoiding emergency surgery, and permitting single stage elective surgical resection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13450?source=see_link\">",
"     \"Treatment of acute diverticulitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CROHN'S DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transabdominal ultrasonography is useful for the detection of bowel wall thickening and for determining the extent of involved segments in active Crohn's disease (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65648 \" href=\"mobipreview.htm?22/3/22579\">",
"     image 4",
"    </a>",
"    ). Several studies comparing the value of ultrasonography with endoscopic and radiologic results in Crohn's disease have found a sensitivity between 73 and 96 percent and a specificity between 90 and 100 percent (",
"    <a class=\"graphic graphic_table graphicRef80268 \" href=\"mobipreview.htm?27/35/28208\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73338 \" href=\"mobipreview.htm?12/58/13227\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/31,58-79\">",
"     31,58-79",
"    </a>",
"    ]. Sonographic features of the colon include (asymmetric) segmental bowel wall thickening corresponding to endoscopic signs of focal ulcerations, and polypoid mucosal changes with pathologically thickened skip areas adjacent to areas of normal appearing mucosa (cobblestone appearance). This pattern is different from the continuous involvement observed in ulcerative colitis, which can also be identified by ultrasonography (",
"    <a class=\"graphic graphic_table graphicRef79536 \" href=\"mobipreview.htm?18/27/18875\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/31,66-68,80\">",
"     31,66-68,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lymph node enlargement is a common ultrasonographic finding in patients with Crohn's disease (25 percent of 240 patients in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/81\">",
"     81",
"    </a>",
"    ]). In one report, lymph node enlargement was more frequent in young patients and in the presence of septic complications such as fistulas and abscesses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/81\">",
"     81",
"    </a>",
"    ]. The finding of lymph node enlargement was of limited valued in assessing disease activity.",
"   </p>",
"   <p>",
"    Ultrasonography can also detect complications such as fistulas (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68922 \" href=\"mobipreview.htm?20/41/21139\">",
"     image 5",
"    </a>",
"    ), abscesses, carcinoma, and ileus. As discussed above, the addition of color Doppler imaging can help to distinguish active disease from a post-inflammatory stricture. Estimates of the sensitivity and specificity of ultrasonography for detecting fistulas have ranged between 50 to 89 and 90 to 95 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/82\">",
"     82",
"    </a>",
"    ]. Estimates of the sensitivity and specificity for detecting abscesses have ranged between 71 to 100 and 77 to 94 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/69,80,83-85\">",
"     69,80,83-85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A prospective study suggested that routine ultrasonography in patients with Crohn's disease can reveal unexpected pathologic findings that have therapeutic implications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/86\">",
"     86",
"    </a>",
"    ]. The study included 255 patients with CD who underwent regular ultrasonography irrespective of symptoms and disease activity. Patients with abnormal findings underwent further evaluation with additional radiologic and endoscopic imaging and treatment as needed.",
"   </p>",
"   <p>",
"    Of 17 patients with inactive disease, ultrasonography revealed four with an enteroenteric fistula, seven with a mesenteric or perirectal fistula, and six with transmural mesenteric inflammation without a fistula. Ultrasonography of the remaining abdominal organs revealed pathological findings with further diagnostic implications in 25 of 255 (10 percent) patients and with therapeutic implications in 9 of 255 (4 percent). Ultrasound might be helpful in monitoring the effects of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ULCERATIVE COLITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of ulcerative colitis is usually established by the patient's history and typical endoscopic appearance of the mucosa and histology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11386?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment is based in part upon the extent of disease. Thus, it is useful at the initial presentation to document the extent of inflammation, which can be accomplished by combining flexible sigmoidoscopy and ultrasonography. Early sonographic signs of active ulcerative colitis include a thickened hypoechoic mucosa layer, corresponding to the endoscopic findings of engorgement of the erythematous mucosa with petechiae, exudates, and friability. More severe cases may be associated with transmural bowel wall thickening corresponding to the endoscopic findings of exudates and ulcerations (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59627 \" href=\"mobipreview.htm?11/0/11269\">",
"     image 6",
"    </a>",
"    ). Patients with fulminant disease may have sonographically transmural inflammation, an appearance similar to Crohn's disease.",
"   </p>",
"   <p>",
"    However, the clinical and sonographic findings at initial presentation and during exacerbations are not specific to ulcerative colitis, and may be seen in a number of other disorders, including colitis due to drugs (such as NSAIDs, retinoic acid, gold, and possibly oral contraceptives), infectious colitis (due to Clostridium difficile, Salmonella, Shigella, Campylobacter, Aeromonas, and Escherichia coli 0157:H7), and other chronic inflammatory bowel diseases (such as Crohn's disease and ischemic colitis). The differential diagnosis is broader in patients who are immunocompromised. Thus, sonographic findings should be used to complement other clinical and laboratory features of the presentation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     INFECTIOUS ENTEROCOLITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various bacteria are associated with acute infectious enterocolitis. The most frequently encountered agents include Salmonella, Campylobacter, and Yersinia species, and enteropathogenic and enterohemorrhagic E. coli. Shigellosis is uncommon in Europe and the United States. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/17/32025?source=see_link\">",
"     \"Approach to the adult with acute diarrhea in developed countries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The sonographic differentiation of individual bacterial infections is not possible, although the images obtained may point toward the final diagnosis. All forms of secretory small bowel derived diarrhea can initially present with a fluid filled small bowel [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/88\">",
"     88",
"    </a>",
"    ]. Most of these infections are associated with intestinal wall thickening, with preservation of the wall layers (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71974 \" href=\"mobipreview.htm?7/4/7235\">",
"     image 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/1,88-92\">",
"     1,88-92",
"    </a>",
"    ]. Prominent mesenteric lymph nodes are frequently seen (",
"    <a class=\"graphic graphic_table graphicRef69867 \" href=\"mobipreview.htm?12/57/13213\">",
"     table 7",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Salmonella enteritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of diarrhea in Salmonella gastroenteritis results from complex interactions between bacterial products and host cells. Salmonellae selectively attach to specialized epithelial cells overlying Peyer's patches in the colon known as M cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/93\">",
"     93",
"    </a>",
"    ]. These cells are an important portal of entry of Salmonellae and other pathogens into the submucosal lymphoid system. Involvement of the submucosal lymphoid system explains the occasional disparity between the sonographic findings of a thickened bowel but with endoscopically normal appearing mucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/91,94-99\">",
"     91,94-99",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/8/26761?source=see_link\">",
"     \"Approach to the patient with nontyphoidal Salmonella in a stool culture\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Campylobacter enteritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of Campylobacter enteritis (either as a small bowel or large bowel pathogen) cannot be made on clinical and sonographic grounds alone. However, the presence of severe abdominal pain with diarrhea and sonographic findings of ileocecitis may suggest the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/91,97,98,100\">",
"     91,97,98,100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Yersiniosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are no distinct clinical, radiologic, or hematologic findings that are pathognomonic for Yersiniosis, sonographic findings of ileocecitis may be suggestive, especially in patients with mesenteric lymphadenopathy. However, lymph nodes are almost always enlarged with other bacterial infections as well. Another suggestive finding is thickening of the distal ileum, which corresponds to the presence of the dense inflammatory infiltrate, which is typical of Yersiniosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/88-91,97,98,101,102\">",
"     88-91,97,98,101,102",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Enterohemorrhagic Escherichia coli",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enterohemorrhagic E. coli, most notably E. coli 0157:H7, is relatively common but probably an under-recognized cause of infectious colitis. Sonographic signs include thickening of the bowel wall, especially the right colon. The sonographic diagnosis of colitis without identifiable infectious agents should raise suspicion for the infection, whose confirmation requires specialized cultures that may not be performed as part of routine stool cultures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/19/18745?source=see_link\">",
"     \"Microbiology, pathogenesis, epidemiology, and prevention of enterohemorrhagic Escherichia coli (EHEC)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Shigella",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shigella is the classic cause of colonic or dysenteric diarrhea, mostly documented as a food borne disease. As few as 10 organisms can initiate disease, and person-to-person spread is feasible. Ultrasonography may show signs similar to ulcerative colitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/26/39334?source=see_link\">",
"     \"Treatment and prevention of Shigella infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Vibrio cholera",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vibrio cholera infection is uncommon in Europe and the United States. This organism is associated with small bowel diarrheal illnesses. Sonographically detectable bowel wall thickening is rarely recognized, but may be prominent in patients with severe disease with edema of the bowel wall. Fluid filled small bowel due to secretory mechanisms induced by the toxin may be the only sonographically detectable sign.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Intestinal tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of intestinal tuberculosis increased with the AIDS pandemic. As with Crohn's disease, all regions of the intestine may be involved, although the ileocecal region is affected in up to 90 percent of patients. Both sides of the ileocecal valve are typically inflamed, preventing it from closing satisfactorily [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ultrasound image displays a hyperechoic (sometimes asymmetrically thickened) mucosa with loss of folds and unclear demarcation from (sometimes asymmetrically) thickened submucosa, so that a pseudo-polypoid image prevails. Short stenoses, mesenteric hyperechoic inflammatory signs, fistulas, and abscesses can be seen on the ultrasound image. Other characteristic signs include severe mesenteric lymphadenopathy (sometimes more than 10 hyperechoic round to oval-shaped lymph nodes are detected) and a distended ileocecal valve, with asymmetric (sometimes tumorous) thickening, especially affecting the medial cecal wall. Patients with peritoneal tuberculosis may also have ascites and thickening of the peritoneum.",
"   </p>",
"   <p>",
"    The differential diagnosis includes Crohn's disease, lymphoma, carcinoma of the cecum, and amebiasis. Less common diseases such as syphilitic gummas of the cecum, actinomycosis, or other opportunistic infections (eg, cytomegalovirus infection, or atypical mycobacterial infection) can also produce similar sonographic findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Whipple's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whipple's disease is characterized by accumulation of macrophages in the lamina propria with intensely PAS positive intracellular material. The etiologic agent was identified in 1992 as Tropheryma whipplei, which is closely related to many other soil-borne Actinomycetes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/35/11833?source=see_link\">",
"     \"Whipple's disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ultrasonography may reveal duodenal and small bowel wall thickening due to edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/104\">",
"     104",
"    </a>",
"    ], ascites, and mesenteric lymphadenopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/105-111\">",
"     105-111",
"    </a>",
"    ]. Whipple's disease appears sonographically similar to intestinal Mycobacterium avium complex (MAC) infection in patients with AIDS presenting the so-called \"white bowel\" caused by intestinal lymphedema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/112\">",
"     112",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Virus related enteritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rotaviruses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/113,114\">",
"     113,114",
"    </a>",
"    ], Norovirus (Norwalk agent), enteric adenoviruses, astroviruses, and coronaviruses are among the leading causes of diarrhea in children but are of less importance in adults. Fluid filled small bowel due to secretory mechanisms may be the only sonographically detectable sign.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Cytomegalovirus colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typical sonographic features of cytomegalovirus virus (CMV) infection include hypoechoic transmural thickening (similar to Crohn's disease) accompanied by an echo rich mesenteric inflammatory reaction. Although the entire intestine may be affected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/115\">",
"     115",
"    </a>",
"    ], special attention should be given to the ileocecal region, the ascending colon, and the duodenum in immunocompromised patients.",
"   </p>",
"   <p>",
"    The exact cause of the above sonographic features is unclear. One possibility is that the changes are the result of occlusive vasculitis, which could explain similarities with Crohn's disease. CMV lesions of the intestinal wall are often found in conjunction with mucosal Kaposi's sarcoma in patients with AIDS. By ultrasound image, Kaposi's sarcoma is often detected as a hypoechoic outlined enlargement of the mucosa with a distinct delimitation from the submucosa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Giardia lamblia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sonographic changes in the development of Giardia lamblia infection are nonspecific. Thickening of the intestinal wall does not occur. Patients who have developed significant malabsorption may have a liquid-filled",
"    <span class=\"nowrap\">",
"     jejunum/ileum",
"    </span>",
"    with hypermotility. Sonographic detection of nonenlarged mesenteric lymph nodes (&lt;17 mm) with normal echogenicity may occasionally be seen. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/28/33224?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of giardiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Amebiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amebic colitis, with its various signs and extraintestinal manifestations, cannot be distinguished sonographically from other inflammatory diseases of the colon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/116,117\">",
"     116,117",
"    </a>",
"    ]. Nevertheless, suggestive sonographic findings (eg, an ameboma or a liver abscess) should be sought.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Cyclospora",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cyclospora cayetanensis is another cause of infectious diarrhea that has been identified in both sporadic cases and in outbreak settings. Sonographic signs are nonspecific, with fluid filled small bowel in the absence of bowel wall thickening. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/48/31493?source=see_link\">",
"     \"Cyclospora infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     ANTIBIOTIC ASSOCIATED COLITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with antibiotic-related diarrhea do not have colitis, and thus have no detectable sonographic abnormalities. On the other hand, patients who develop pseudomembranous colitis, or much less commonly, penicillin-induced colitis, may have sonographic abnormalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Pseudomembranous colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common finding in patients with pseudomembranous colitis caused by Clostridium difficile is symmetric mucosal wall thickening, which is often most prominent in the left colon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/118-127\">",
"     118-127",
"    </a>",
"    ]. However, sonographic findings are insufficiently specific to distinguish pseudomembranous colitis from other bacterial causes of colitis (",
"    <a class=\"graphic graphic_table graphicRef77028 \" href=\"mobipreview.htm?3/27/3517\">",
"     table 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/119,128,129\">",
"     119,128,129",
"    </a>",
"    ]. In severe cases, the colonic wall thickening is asymmetric and may resemble an intestinal lymphoma (",
"    <a class=\"graphic graphic_picture graphicRef51120 \" href=\"mobipreview.htm?27/15/27890\">",
"     picture 1",
"    </a>",
"    ). Other sonographic features of severe infection include transmural inflammatory reactions, free pericolic fluid, and intramural gas echoes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Penicillin-induced segmental hemorrhagic colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A characteristic sonographic feature of penicillin-induced segmental hemorrhagic colitis is the appearance of partially asymmetric wall thickening of the colon (typically in the right colon) with loss of intestinal wall layers due to edema and bleeding (",
"    <a class=\"graphic graphic_table graphicRef77028 \" href=\"mobipreview.htm?3/27/3517\">",
"     table 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/119,128-130\">",
"     119,128-130",
"    </a>",
"    ]. Relative hypovascularization can be detected with color Doppler ultrasound examination. The surrounding colon may appear normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     NEUTROPENIC ENTEROCOLITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutropenic enterocolitis (typhlitis) is a potentially fatal complication of severe neutropenia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/131-133\">",
"     131-133",
"    </a>",
"    ]. It typically affects the ileocecal region, which on ultrasound may reveal a distinct hyperechoic edematous hemorrhagic thickening of the intestinal wall. The presence of intramural gas and pericolic free fluid should raise concerns about imminent perforation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27125?source=see_link\">",
"     \"Typhlitis (neutropenic enterocolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     ACUTE GRAFT VERSUS HOST DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute graft versus host disease (aGvHD) of the gastrointestinal tract is one of the major complications of allogeneic hematopoietic cell transplantation. Conventional B-mode ultrasonography (US) and color Doppler imaging (CDI) were used in combination to assess the extent, severity, course and prognosis of aGvHD of the gastrointestinal tract in 12 patients with suspected intestinal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    severe cutaneous aGvHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/25,134\">",
"     25,134",
"    </a>",
"    ]. The structure and thickness of the bowel wall and blood flow pattern in the superior mesenteric artery and bowel wall were useful for detection of aGvHD even before symptoms developed. All patients had thickened bowel wall segments, particularly in the ileocecal region. Four patients had ischemic bowel wall lesions as evidenced by a high resistance flow pattern in the SMA; these patients did not respond to immunosuppressive therapy and ultimately died. These sonographic features can also be helpful for distinguishing aGvHD from other causes of bowel disturbance that occur in the transplant setting, such as pseudomembranous or CMV colitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/135,136\">",
"     135,136",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/22/25960?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     CYSTIC FIBROSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stenosing fibrosis of the colon in association with cystic fibrosis was first described in 1994 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/137\">",
"     137",
"    </a>",
"    ]. Its pathogenesis is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/137-144\">",
"     137-144",
"    </a>",
"    ]. One hypothesis is that the fibrosis is due to use of high doses of pancreatic enzymes. However, similar intestinal wall changes have also been observed in patients who were not taking pancreatic enzymes. Furthermore, stenosing fibrosis has not been described in patients taking high doses of pancreatic enzymes for other disorders (such as alcoholic pancreatitis).",
"   </p>",
"   <p>",
"    The characteristic ultrasound image shows the accentuation and thickening of the submucosa, which appears echogenic. Intestinal wall thickening is mainly found in the cecum and, slightly less pronounced, in the ascending colon, hepatic flexure, and the terminal ileum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/145\">",
"     145",
"    </a>",
"    ]. These changes are seldom detected in the sigmoid or distal colon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     INTUSSUSCEPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic ultrasound image of intussusception is a \"bull's eye lesion\", representing layers of the intestine within the intestine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/96,144-148\">",
"     96,144-148",
"    </a>",
"    ]. In addition, a lack of perfusion in the intussusceptum detected with color duplex imaging may indicate the development of ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/149-152\">",
"     149-152",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     CELIAC DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main feature on ultrasound suggesting celiac disease is widening of the spaces between the Kerckring's folds (",
"    <a class=\"graphic graphic_table graphicRef58070 \" href=\"mobipreview.htm?35/6/35947\">",
"     table 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef65260 \" href=\"mobipreview.htm?21/38/22123\">",
"     table 10",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/153-155\">",
"     153-155",
"    </a>",
"    ]. Other suggestive features include slight dilatation of the affected jejunal loops with irregular, \"looser-appearing\" Kerckring's folds, a distinct increase in fluid content vivid peristalsis, and mesenteric lymphadenopathy. In addition, gas and chyme within the intestinal lumen may produce coarse hyperechoic images, like laundry in the drum of a washing machine (hence the term \"laundry phenomenon\"). As a result, it can be extremely difficult to obtain sharp pictures of the enteral content [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/153\">",
"     153",
"    </a>",
"    ]. The laundry phenomenon is a typical finding in disorders associated with villous atrophy.",
"   </p>",
"   <p>",
"    Wall thickening of the intestinal wall is usually not observed. Exceptions are patients with hypoalbuminemia, who may have edematous wall thickening similar to that seen in patients with vasculitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mesenteric lymph nodes are usually less than 17 mm and have an echo pattern similar to that of the liver [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/128\">",
"     128",
"    </a>",
"    ]. An increased size of the lymph nodes, irregular echogenicity, or a cluster-like distribution pattern may indicate the development of an intestinal lymphoma. Much less frequently, ultrasonography may reveal the development of carcinoma of the small intestine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     BENIGN AND MALIGNANT TUMORS OF THE SMALL AND LARGE INTESTINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;B-cell lymphoma, metastases (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77150 \" href=\"mobipreview.htm?8/29/8659\">",
"     image 8",
"    </a>",
"    ), and benign tumors of the small intestine are infrequent. Their sonographic appearance is usually that of a hypoechoic masses emanating from the intestinal wall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/156-160\">",
"     156-160",
"    </a>",
"    ]. The sonographic diagnosis of gastrointestinal stromal tumors has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/161\">",
"     161",
"    </a>",
"    ]. Hematomas of the intestinal wall cannot be reliably differentiated from tumors.",
"   </p>",
"   <p>",
"    Polyps, colon cancers, and carcinoid tumors appear on ultrasonography as hypoechoic masses. However, their identification can be difficult. Although mesenteric lymph nodes may be seen, the sensitivity and specificity of transabdominal ultrasonography is insufficient to be used for staging.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     ISCHEMIC COLITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography, including color duplex imaging, can facilitate the identification of ischemic-hemorrhagic and secondary inflammatory or necrotic thickenings of the intestinal wall in patients with ischemic colitis, and may also help predict patients at risk for complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/18,19,22,162-172\">",
"     18,19,22,162-172",
"    </a>",
"    ]. A slightly symmetrical hypoechoic wall thickening is often an indication of the non-obstructive form of ischemic colitis with chronic compensated changes. In contrast, asymmetric wall thickening with an ileus may be seen in patients with acute mesenteric ischemia.",
"   </p>",
"   <p>",
"    Duplex imaging reliably evaluates the velocity profile in the celiac trunk and the superior and inferior mesenteric arteries. Color duplex and, in some cases, additional echo enhancing agents may be helpful in the evaluation of intestinal wall perfusion and in the identification of the mesenteric vessels. Systolic velocities of &gt;250 to 300",
"    <span class=\"nowrap\">",
"     cm/s",
"    </span>",
"    are sensitive indicators of severe mesenteric arterial stenosis. However, the clinical significance of these findings is not always clear since ultrasonography does not permit the evaluation of the compensatory collateral circulation (which often requires angiography).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     AMYLOIDOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound features in patients with amyloidosis of the small intestine include asymmetric circular bowel wall thickening with distinct deposits (submucosal masses) with diminished peristalsis and dilatation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/1,173-176\">",
"     1,173-176",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/63/12280?source=see_link\">",
"     \"Gastrointestinal amyloidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     VASCULITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with gastrointestinal manifestations of a systemic vasculitis have other symptoms suggesting the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/23/37241?source=see_link\">",
"     \"Classification of and approach to the vasculitides in adults\"",
"    </a>",
"    .) Imaging studies, such as ultrasonography, CT scanning, or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    studies, are frequently normal. When they are abnormal, they usually have nonspecific findings such as a thickened, edematous bowel wall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/104\">",
"     104",
"    </a>",
"    ] unless mesenteric infarction has occurred.",
"   </p>",
"   <p>",
"    The sequelae of systemic vasculitis involving the gastrointestinal tract are usually due to inflammation and mesenteric ischemia, which may be identified by color Doppler ultrasonography. The onset of clinical manifestations may be acute and severe (eg, mesenteric infarction) or chronic. Chronic mesenteric ischemia may be associated with a variety of sonographic findings including bowel wall thickening and small bowel obstruction secondary to strictures, resembling Crohn's disease or intussusception. Ultrasonography can also detect perforation with ascites and free (peritoneal) air.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     RADIATION ENTERITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sonographic changes of radiation enteritis are usually characterized by a slight symmetrical thickening of the intestinal wall. Stenotic intestinal segments may be suggested by hypertrophy of the muscular layer. Bowel wall thickening may be seen in those with radiation colitis, although the finding is nonspecific [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/177-181\">",
"     177-181",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h1\">",
"     SARCOIDOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sarcoidosis of the small bowel, appendix, and the colon is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/155,182-186\">",
"     155,182-186",
"    </a>",
"    ]. The most common symptoms are nonbloody diarrhea and abdominal pain. Sonographic signs are nonspecific, showing thickened bowel wall of the small",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    large intestine. Ultrasonography may be helpful for monitoring the therapeutic response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     BOWEL WALL THICKENING DUE TO HEMATOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A bowel wall hematoma typically occurs in patients who are coagulopathic. On ultrasonography, the hematoma may be recognized as echo poor circumscribed bowel wall thickening. A similar picture may be seen in Schonlein Henoch Purpura involving the gastrointestinal tract and with small or large bowel tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h1\">",
"     FUNCTIONAL DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound provides a useful tool for visualization of motion sequences since it is a real-time imaging methodology in contrast to other imaging methods. However, its role in this setting has not yet been well defined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/187\">",
"     187",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     RECTAL AND PERINEAL DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perineal ultrasound (PNUS) is an effective, inexpensive, easily available, but still rarely applied diagnostic tool. In addition to demonstration of anatomy, PNUS can be helpful for detecting a variety of pathological conditions of the rectum and perineum, such as transmural inflammation, fistulas, and abscesses in patients with inflammatory bowel disease. PNUS is more flexible than endorectal ultrasound (ERUS), particularly when oblique processes of transsphincteric fistulae are to be examined. For staging of perirectal tumors, PNUS can be used as a complement to conventional ERUS. A valuable extension of the diagnostic application of PNUS is its supportive role during invasive interventions, such as drainage of fluids or targeted puncture of tissue lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h1\">",
"     OTHER USES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positioning of enteral feeding tubes using bedside sonograms may be an alternative to radiologic placement, especially in patients without extensive abdominal surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/188\">",
"     188",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transabdominal ultrasound, in addition to established endoscopic ultrasound, may help in identifying and characterizing submucosal lesions of the upper and lower gastrointestinal tract, but experience is limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/189\">",
"     189",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3359654\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transabdominal ultrasonography is most commonly used to obtain images of hepatobiliary, urogenital, and pelvic structures. Its utility for imaging the alimentary gastrointestinal tract is less well established, principally because of technical difficulties in obtaining quality images of these regions. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An advantage of ultrasound imaging compared with endoscopy and contrast radiography is that it permits evaluation of the transmural aspects of inflammatory or neoplastic pathology within its surrounding structures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/25/32154/abstract/1\">",
"       1",
"      </a>",
"      ]. This can provide an important contribution for diagnosis and monitoring of disease activity. Other advantages are that it is widely available, noninvasive, and can be performed without preparation. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Important limitations of ultrasonography are that the alimentary tract cannot be visualized over its entire length, many of the findings are nonspecific, and obtaining and interpreting the images is highly operator dependent. Furthermore, ultrasound is far less useful in obese patients in whom high frequency scanning may not be possible. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transabdominal ultrasound can be used to evaluate a large number of conditions including:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Appendicitis (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Appendicitis'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Epiploic appendagitis (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Epiploic appendagitis'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Diverticulitis (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Diverticulitis'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Inflammatory bowel disease (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Crohn's disease'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Ulcerative colitis'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Infectious enterocolitis (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Infectious enterocolitis'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Intussusception (see",
"      <a class=\"local\" href=\"#H31\">",
"       'Intussusception'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Tumors (see",
"      <a class=\"local\" href=\"#H33\">",
"       'Benign and malignant tumors of the small and large intestine'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Celiac disease (see",
"      <a class=\"local\" href=\"#H32\">",
"       'Celiac disease'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/1\">",
"      Dietrich CF, Brunner V, Lembcke B. [Intestinal ultrasound in rare small and large intestinal diseases]. Z Gastroenterol 1998; 36:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/2\">",
"      Meckler U, Caspary WF, Clement T, et al. [Sonography in Crohn disease--the conclusions of an experts' group]. Z Gastroenterol 1991; 29:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/3\">",
"      Meckler U, Herzog P. [Sonographic structure of the intestinal wall--significance for the diagnosis of inflammatory intestinal diseases]. Ultraschall Med 1989; 10:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/4\">",
"      Angerson WJ, Allison MC, Baxter JN, Russell RI. Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease. Gut 1993; 34:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/5\">",
"      Britton I, Maguire C, Adams C, et al. Assessment of the role and reliability of sonographic post-prandial flow response in grading Crohn's disease activity. Clin Radiol 1998; 53:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/6\">",
"      Ludwig D, Wiener S, Br&uuml;ning A, et al. Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: a prospective follow-up study. Am J Gastroenterol 1999; 94:2942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/7\">",
"      Silv&aacute;n Delgado M, Juanco Pedregal C, Parra Blanco JA, Barreda Gonz&aacute;lez M. Usefulness of Doppler ultrasound in the evaluation of patients with active Crohn's disease. Rev Esp Enferm Dig 1997; 89:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/8\">",
"      van Oostayen JA, Wasser MN, Griffioen G, et al. Activity of Crohn's disease assessed by measurement of superior mesenteric artery flow with Doppler ultrasound. Neth J Med 1998; 53:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/9\">",
"      van Oostayen JA, Wasser MN, van Hogezand RA, et al. Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: correlation with clinical evaluation, Crohn's disease activity index, and alpha 1-antitrypsin clearance in feces. AJR Am J Roentgenol 1997; 168:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/10\">",
"      van Oostayen JA, Wasser MN, van Hogezand RA, et al. Activity of Crohn disease assessed by measurement of superior mesenteric artery flow with Doppler US. Radiology 1994; 193:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/11\">",
"      Spalinger J, Patriquin H, Miron MC, et al. Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 2000; 217:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/12\">",
"      Aliotta A, Pompili M, Rapaccini GL, et al. Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion. J Ultrasound Med 1997; 16:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/13\">",
"      Alvarez D, Vazquez H, Bai JC, et al. Superior mesenteric artery blood flow in celiac disease. Dig Dis Sci 1993; 38:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/14\">",
"      Arienti V, Califano C, Brusco G, et al. Doppler ultrasonographic evaluation of splanchnic blood flow in coeliac disease. Gut 1996; 39:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/15\">",
"      Bolondi L, Li Bassi S, Gaiani S, et al. Changes in mesenteric venous flow due to celiac sprue. Dig Dis Sci 1992; 37:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/16\">",
"      Ertem D, T&uuml;ney D, Baloglu H, Pehlivanoglu E. Superior mesenteric artery blood flow in children with celiac disease. J Pediatr Gastroenterol Nutr 1998; 26:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/17\">",
"      Giovagnorio F, Picarelli A, Di Giovambattista F, Mastracchio A. Evaluation with Doppler sonography of mesenteric blood flow in celiac disease. AJR Am J Roentgenol 1998; 171:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/18\">",
"      Danse EM, Laterre PF, Van Beers BE, et al. Early diagnosis of acute intestinal ischaemia: contribution of colour Doppler sonography. Acta Chir Belg 1997; 97:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/19\">",
"      Danse EM, Van Beers BE, Goffette P, et al. Diagnosis of acute intestinal ischemia by color Doppler sonography. Color Doppler sonography and acute intestinal ischemia. Acta Gastroenterol Belg 1996; 59:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/20\">",
"      Patriquin HB, Garcier JM, Lafortune M, et al. Appendicitis in children and young adults: Doppler sonographic-pathologic correlation. AJR Am J Roentgenol 1996; 166:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/21\">",
"      Siegel MJ, Friedland JA, Hildebolt CF. Bowel wall thickening in children: differentiation with US. Radiology 1997; 203:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/22\">",
"      Teefey SA, Roarke MC, Brink JA, et al. Bowel wall thickening: differentiation of inflammation from ischemia with color Doppler and duplex US. Radiology 1996; 198:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/23\">",
"      Clautice-Engle T, Jeffrey RB Jr, Li KC, Barth RA. Power Doppler imaging of focal lesions of the gastrointestinal tract: comparison with conventional color Doppler imaging. J Ultrasound Med 1996; 15:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/24\">",
"      Ruess L, Blask AR, Bulas DI, et al. Inflammatory bowel disease in children and young adults: correlation of sonographic and clinical parameters during treatment. AJR Am J Roentgenol 2000; 175:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/25\">",
"      Klein SA, Martin H, Schreiber-Dietrich D, et al. A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imaging. Br J Haematol 2001; 115:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/26\">",
"      Migaleddu V, Scanu AM, Quaia E, et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease. Gastroenterology 2009; 137:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/27\">",
"      Dietrich CF, Jedrzejczyk M, Ignee A. Sonographic assessment of splanchnic arteries and the bowel wall. Eur J Radiol 2007; 64:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/28\">",
"      Braden B, Ignee A, Hocke M, et al. Diagnostic value and clinical utility of contrast enhanced ultrasound in intestinal diseases. Dig Liver Dis 2010; 42:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/29\">",
"      Dixit R, Chowdhury V, Kumar N. Hydrocolonic sonography in the evaluation of colonic lesions. Abdom Imaging 1999; 24:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/30\">",
"      Elewaut AE, Afschrift M. Hydrocolonic sonography: a novel screening method for the detection of colon disease? Bildgebung 1995; 62:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/31\">",
"      Limberg B, Osswald B. Diagnosis and differential diagnosis of ulcerative colitis and Crohn's disease by hydrocolonic sonography. Am J Gastroenterol 1994; 89:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/32\">",
"      Nuernberg D, Ignee A, Dietrich CF. [Current status of ultrasound in gastroenterology--bowel and upper gastrointestinal tract--part 1]. Z Gastroenterol 2007; 45:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/33\">",
"      Maconi G, Ardizzone S, Greco S, et al. Transperineal ultrasound in the detection of perianal and rectovaginal fistulae in Crohn's disease. Am J Gastroenterol 2007; 102:2214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/34\">",
"      Dietrich CF, Barreiros AP, Nuernberg D, et al. [Perianal ultrasound]. Z Gastroenterol 2008; 46:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/35\">",
"      Ozel A, Orhan UP, Akdana B, et al. Sonographic appearance of the normal appendix in children. J Clin Ultrasound 2011; 39:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/36\">",
"      Goldin AB, Khanna P, Thapa M, et al. Revised ultrasound criteria for appendicitis in children improve diagnostic accuracy. Pediatr Radiol 2011; 41:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/37\">",
"      Daar AS. Acute primary epiploic appendagitis. Br J Clin Pract 1981; 35:333, 335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/38\">",
"      Lee MP. Small bowel obstruction due to epiploic appendagitis. Am J Gastroenterol 1990; 85:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/39\">",
"      Legome EL, Sims C, Rao PM. Epiploic appendagitis: adding to the differential of acute abdominal pain. J Emerg Med 1999; 17:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/40\">",
"      Moll&agrave; E, Ripoll&eacute;s T, Mart&iacute;nez MJ, et al. Primary epiploic appendagitis: US and CT findings. Eur Radiol 1998; 8:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/41\">",
"      Rao PM, Novelline RA. Case 6: primary epiploic appendagitis. Radiology 1999; 210:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/42\">",
"      Rao PM, Rhea JT, Wittenberg J, Warshaw AL. Misdiagnosis of primary epiploic appendagitis. Am J Surg 1998; 176:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/43\">",
"      Rao PM, Wittenberg J, Lawrason JN. Primary epiploic appendagitis: evolutionary changes in CT appearance. Radiology 1997; 204:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/44\">",
"      Rioux M, Langis P. Primary epiploic appendagitis: clinical, US, and CT findings in 14 cases. Radiology 1994; 191:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/45\">",
"      Rosen P, Berlin RD, Poore GP. Appendagitis masquerading as appendicitis. J Emerg Med 1999; 17:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/46\">",
"      Vinson DR. Epiploic appendagitis: a new diagnosis for the emergency physician. Two case reports and a review. J Emerg Med 1999; 17:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/47\">",
"      Danse EM, Van Beers BE, Baudrez V, et al. Epiploic appendagitis: color Doppler sonographic findings. Eur Radiol 2001; 11:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/48\">",
"      G&ouml;rg C, Egbring J, Bert T. Contrast-enhanced ultrasound of epiploic appendagitis. Ultraschall Med 2009; 30:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/49\">",
"      Federmann G. [Sonography in the diagnosis of acute colonic diverticulitis]. Chirurg 1989; 60:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/50\">",
"      Pradel JA, Adell JF, Taourel P, et al. Acute colonic diverticulitis: prospective comparative evaluation with US and CT. Radiology 1997; 205:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/51\">",
"      Schwerk WB, Schwarz S, Rothmund M. Sonography in acute colonic diverticulitis. A prospective study. Dis Colon Rectum 1992; 35:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/52\">",
"      Schwerk WB, Schwarz S, Rothmund M, Arnold R. [Colon diverticulitis: imaging diagnosis with ultrasound--a prospective study]. Z Gastroenterol 1993; 31:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/53\">",
"      Verbanck J, Lambrecht S, Rutgeerts L, et al. Can sonography diagnose acute colonic diverticulitis in patients with acute intestinal inflammation? A prospective study. J Clin Ultrasound 1989; 17:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/54\">",
"      Zielke A, Hasse C, Nies C, et al. Prospective evaluation of ultrasonography in acute colonic diverticulitis. Br J Surg 1997; 84:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/55\">",
"      Chou YH, Chiou HJ, Tiu CM, et al. Sonography of acute right side colonic diverticulitis. Am J Surg 2001; 181:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/56\">",
"      Hollerweger A, Macheiner P, Rettenbacher T, et al. Colonic diverticulitis: diagnostic value and appearance of inflamed diverticula-sonographic evaluation. Eur Radiol 2001; 11:1956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/57\">",
"      Moll R, Mittelk&ouml;tter U, Reith HB, et al. [Which imaging in case of sigmoid diverticulitis? The value of ultrasound (Conventional B-mode in combination with hydrocolonsonography and colour flow Doppler) in comparison to the well-established modalities like contrast enema and helical computertomography]. Zentralbl Chir 2002; 127:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/58\">",
"      Bozkurt T, Richter F, Lux G. Ultrasonography as a primary diagnostic tool in patients with inflammatory disease and tumors of the small intestine and large bowel. J Clin Ultrasound 1994; 22:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/59\">",
"      Faure C, Belarbi N, Mougenot JF, et al. Ultrasonographic assessment of inflammatory bowel disease in children: comparison with ileocolonoscopy. J Pediatr 1997; 130:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/60\">",
"      Khaw KT, Saverymuttu SH, Joseph AE. Correlation of 111indium WBC scintigraphy with ultrasound in the detection and assessment of inflammatory bowel disease. Clin Radiol 1990; 42:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/61\">",
"      Pradel JA, David XR, Taourel P, et al. Sonographic assessment of the normal and abnormal bowel wall in nondiverticular ileitis and colitis. Abdom Imaging 1997; 22:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/62\">",
"      Reimund JM, Jung-Chaigneau E, Chamouard P, et al. [Diagnostic value of high resolution sonography in Crohn's disease and ulcerative colitis]. Gastroenterol Clin Biol 1999; 23:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/63\">",
"      Andreoli A, Cerro P, Falasco G, et al. Role of ultrasonography in the diagnosis of postsurgical recurrence of Crohn's disease. Am J Gastroenterol 1998; 93:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/64\">",
"      Brignola C, Belloli C, Iannone P, et al. Comparison of scintigraphy with indium-111 leukocyte scan and ultrasonography in assessment of X-ray-demonstrated lesions of Crohn's disease. Dig Dis Sci 1993; 38:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/65\">",
"      DiCandio G, Mosca F, Campatelli A, et al. Sonographic detection of postsurgical recurrence of Crohn disease. AJR Am J Roentgenol 1986; 146:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/66\">",
"      Hata J, Haruma K, Suenaga K, et al. Ultrasonographic assessment of inflammatory bowel disease. Am J Gastroenterol 1992; 87:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/67\">",
"      Hollerbach S, Geissler A, Schiegl H, et al. The accuracy of abdominal ultrasound in the assessment of bowel disorders. Scand J Gastroenterol 1998; 33:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/68\">",
"      Limberg B. Diagnosis of acute ulcerative colitis and colonic Crohn's disease by colonic sonography. J Clin Ultrasound 1989; 17:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/69\">",
"      Maconi G, Bollani S, Bianchi Porro G. Ultrasonographic detection of intestinal complications in Crohn's disease. Dig Dis Sci 1996; 41:1643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/70\">",
"      Pedersen BH, Gr&oslash;nvall S, Dorph S, et al. The value of dynamic ultrasound scanning in Crohn's disease. Scand J Gastroenterol 1986; 21:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/71\">",
"      Sheridan MB, Nicholson DA, Martin DF. Transabdominal ultrasonography as the primary investigation in patients with suspected Crohn's disease or recurrence: a prospective study. Clin Radiol 1993; 48:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/72\">",
"      Solvig J, Ekberg O, Lindgren S, et al. Ultrasound examination of the small bowel: comparison with enteroclysis in patients with Crohn disease. Abdom Imaging 1995; 20:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/73\">",
"      Sonnenberg A, Erckenbrecht J, Peter P, Niederau C. Detection of Crohn's disease by ultrasound. Gastroenterology 1982; 83:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/74\">",
"      Stiatti A, Martinuzzi A, Bartolini M, et al. [Ultrasonography in the diagnosis of chronic inflammatory intestinal disease]. Radiol Med 1990; 80:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/75\">",
"      Parente F, Maconi G, Bollani S, et al. Bowel ultrasound in assessment of Crohn's disease and detection of related small bowel strictures: a prospective comparative study versus x ray and intraoperative findings. Gut 2002; 50:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/76\">",
"      Miao YM, Koh DM, Amin Z, et al. Ultrasound and magnetic resonance imaging assessmentof active bowel segments in Crohn's disease. Clin Radiol 2002; 57:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/77\">",
"      Potthast S, Rieber A, Von Tirpitz C, et al. Ultrasound and magnetic resonance imaging in Crohn's disease: a comparison. Eur Radiol 2002; 12:1416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/78\">",
"      Schmidt T, Reinshagen M, Brambs HJ, et al. [Comparison of conventional enteroclysis, intestinal ultrasound and MRI-enteroclysis for determining changes in the small intestine and complications in patients with Crohn's disease]. Z Gastroenterol 2003; 41:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/79\">",
"      Parente F, Greco S, Molteni M, et al. Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn's disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy. Gut 2004; 53:1652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/80\">",
"      Pera A, Cammarota T, Comino E, et al. Ultrasonography in the detection of Crohn's disease and in the differential diagnosis of inflammatory bowel disease. Digestion 1988; 41:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/81\">",
"      Maconi G, Di Sabatino A, Ardizzone S, et al. Prevalence and clinical significance of sonographic detection of enlarged regional lymph nodes in Crohn's disease. Scand J Gastroenterol 2005; 40:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/82\">",
"      Maconi G, Sampietro GM, Russo A, et al. The vascularity of internal fistulae in Crohn's disease: an in vivo power Doppler ultrasonography assessment. Gut 2002; 50:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/83\">",
"      Gasche C, Moser G, Turetschek K, et al. Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut 1999; 44:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/84\">",
"      Orsoni P, Barthet M, Portier F, et al. Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease. Br J Surg 1999; 86:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/85\">",
"      Seitz K, Reuss J. [Sonographic detection of fistulas in Crohn disease]. Ultraschall Med 1986; 7:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/86\">",
"      Hirche TO, Russler J, Schr&ouml;der O, et al. The value of routinely performed ultrasonography in patients with Crohn disease. Scand J Gastroenterol 2002; 37:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/87\">",
"      Guidi L, De Franco A, De Vitis I, et al. Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease. Eur Rev Med Pharmacol Sci 2006; 10:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/88\">",
"      Petit P, Vidal V, Chaumoitre K, et al. [Atypical sonographic findings of bacterial colitis]. J Radiol 2000; 81:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/89\">",
"      Matsumoto T, Iida M, Sakai T, et al. Yersinia terminal ileitis: sonographic findings in eight patients. AJR Am J Roentgenol 1991; 156:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/90\">",
"      Puylaert JB. Mesenteric adenitis and acute terminal ileitis: US evaluation using graded compression. Radiology 1986; 161:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/91\">",
"      Puylaert JB, Bodewes HW, Vermeijden RJ, et al. [Bacterial ileocecitis, a \"new\" disease]. Ned Tijdschr Geneeskd 1991; 135:2176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/92\">",
"      Quillin SP, Siegel MJ. Gastrointestinal inflammation in children: color Doppler ultrasonography. J Ultrasound Med 1994; 13:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/93\">",
"      Gebert A, G&ouml;ke M, Rothk&ouml;tter HJ, Dietrich CF. [The mechanisms of antigen uptake in the small and large intestines: the roll of the M cells for the initiation of immune responses]. Z Gastroenterol 2000; 38:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/94\">",
"      Khaw KT, Yeoman LJ, Saverymuttu SH, et al. Ultrasonic patterns in inflammatory bowel disease. Clin Radiol 1991; 43:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/95\">",
"      Mathis G, Metzler J. [Sonography in salmonella enterocolitis]. Ultraschall Med 1992; 13:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/96\">",
"      Matsushita M, Suzaki T, Hajiro K. Intussusception associated with Salmonella typhimurium enterocolitis. Am J Gastroenterol 1994; 89:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/97\">",
"      Puylaert JB, Vermeijden RJ, van der Werf SD, et al. Incidence and sonographic diagnosis of bacterial ileocaecitis masquerading as appendicitis. Lancet 1989; 2:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/98\">",
"      Seelen JL, Puylaert JB. [Bacterial ileocecitis: a \"new\" disease]. Ultraschall Med 1991; 12:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/99\">",
"      Ueda D, Sato T, Yoshida M. Ultrasonographic assessment of Salmonella enterocolitis in children. Pediatr Radiol 1999; 29:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/100\">",
"      Puylaert JB, Lalisang RI, van der Werf SD, Doornbos L. Campylobacter ileocolitis mimicking acute appendicitis: differentiation with graded-compression US. Radiology 1988; 166:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/101\">",
"      Coussi A, Athanassiou M, Tsantali C, et al. Yersinia enterocolitica mesenteric adenitis suspected by ultrasound examination. Eur J Pediatr 1994; 153:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/102\">",
"      Janowitz P, Wechsler JG, Malfertheiner P, et al. [Yersinia enterocolitica infection with extraintestinal manifestations: case report and overview]. Z Gastroenterol 1994; 32:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/103\">",
"      Barreiros AP, Braden B, Schieferstein-Knauer C, et al. Characteristics of intestinal tuberculosis in ultrasonographic techniques. Scand J Gastroenterol 2008; 43:1224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/104\">",
"      Hollerweger A, Macheiner P, Dirks K, Dietrich CF. [Differential diagnosis of severe hypoechoic oedema of the small bowel]. Ultraschall Med 2006; 27:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/105\">",
"      Br&uuml;ggemann A, Burchardt H, Lepsien G. Sonographical findings in Whipple's disease. A case report with regard to the literature. Surg Endosc 1992; 6:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/106\">",
"      Carroccio A, Soresi M, Montalto G, et al. Whipple's disease: a non-invasive approach for suspected diagnosis. Case report. Ital J Gastroenterol 1996; 28:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/107\">",
"      Castagnone D, Mandelli C, Rivolta R, et al. [Echography and computerized tomography of the abdomen in Whipple's disease]. Radiol Med 1991; 82:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/108\">",
"      Davis SJ, Patel A. Distinctive echogenic lymphadenopathy in Whipples disease. Clin Radiol 1990; 42:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/109\">",
"      de Wazi&egrave;res B, Fest T, Litzler JF, et al. [Mesenteric lymph node cavitations in Whipple's disease. Apropos of a case]. J Radiol 1993; 74:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/110\">",
"      Hollerbach S, Holstege A, Muscholl M, et al. [Masked course of Whipple disease with uveitis, infection, endocardial involvement and abdominal lymphomas--case report and review of the literature]. Z Gastroenterol 1995; 33:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/111\">",
"      Janisch HD, von Kleist D, Pfretzschner C, et al. [Mesenteric lipodystrophy: differential diagnosis of a benign abdominal tumor]. Wien Med Wochenschr 1984; 134:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/112\">",
"      Hollerweger A, Dietrich CF. [\"White bowel\". A sonographic sign of intestinal lymph edema?]. Ultraschall Med 2005; 26:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/113\">",
"      Bass D, Cordoba E, Dekker C, et al. Intestinal imaging of children with acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 2004; 39:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/114\">",
"      Robinson CG, Hernanz-Schulman M, Zhu Y, et al. Evaluation of anatomic changes in young children with natural rotavirus infection: is intussusception biologically plausible? J Infect Dis 2004; 189:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/115\">",
"      Gorschl&uuml;ter M, Marklein G, H&ouml;fling K, et al. Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology. Br J Haematol 2002; 117:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/116\">",
"      Tsujimoto T, Kuriyama S, Yoshiji H, et al. Ultrasonographic findings of amebic colitis. J Gastroenterol 2003; 38:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/117\">",
"      Hussain S, Dinshaw H. Ultrasonography in amebic colitis. J Ultrasound Med 1990; 9:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/118\">",
"      Bolondi L, Ferrentino M, Trevisani F, et al. Sonographic appearance of pseudomembranous colitis. J Ultrasound Med 1985; 4:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/119\">",
"      Dietrich CF, Lembcke B, Seifert H, et al. [Ultrasound diagnosis of penicillin-induced segmental hemorrhagic colitis]. Dtsch Med Wochenschr 2000; 125:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/120\">",
"      Gebel M. [Ultrasound of the gastrointestinal tract: good educational background is required]. Dtsch Med Wochenschr 2000; 125:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/121\">",
"      Ludolph T, Schmidt-Wilcke HA. [Ultrasound diagnosis of pseudomembranous colitis]. Dtsch Med Wochenschr 2000; 125:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/122\">",
"      Oei TK, van Engelshoven JM. Pseudomembranous colitis: an ultrasound diagnosis. Eur J Radiol 1992; 15:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/123\">",
"      Pieri L, Mazzeo S, Caramella D, et al. [Imaging diagnosis in pseudomembranous colitis]. Radiol Med 1994; 87:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/124\">",
"      Ros PR, Buetow PC, Pantograg-Brown L, et al. Pseudomembranous colitis. Radiology 1996; 198:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/125\">",
"      Thomas SM, Howlett DC, Hearn FJ. Ultrasound appearance of pseudomembranous colitis. Australas Radiol 1996; 40:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/126\">",
"      Truong M, Atri M, Bret PM, et al. Sonographic appearance of benign and malignant conditions of the colon. AJR Am J Roentgenol 1998; 170:1451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/127\">",
"      Zamora S, Coppes MJ, Scott RB, Mueller DL. Clostridium difficile, pseudomembranous enterocolitis: striking CT and sonographic features in a pediatric patient. Eur J Radiol 1996; 23:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/128\">",
"      Dietrich CF, Zeuzem S, Caspary WF, Wehrmann T. [Ultrasound lymph node imaging in the abdomen and retroperitoneum of healthy probands]. Ultraschall Med 1998; 19:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/129\">",
"      Downey DB, Wilson SR. Pseudomembranous colitis: sonographic features. Radiology 1991; 180:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/130\">",
"      Matsumoto T, Iida M, Matsui T, et al. Ultrasonic and CT findings in penicillin-induced nonpseudomembranous colitis. Gastrointest Radiol 1990; 15:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/131\">",
"      Alexander JE, Williamson SL, Seibert JJ, et al. The ultrasonographic diagnosis of typhlitis (neutropenic colitis). Pediatr Radiol 1988; 18:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/132\">",
"      Glass-Royal MC, Choyke PL, Gootenberg JE, Grant EG. Sonography in the diagnosis of neutropenic colitis. J Ultrasound Med 1987; 6:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/133\">",
"      Gootenberg JE, Abbondanzo SL. Rapid diagnosis of neutropenic enterocolitis (typhlitis) by ultrasonography. Am J Pediatr Hematol Oncol 1987; 9:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/134\">",
"      Klein SA, Hermann S, Dietrich JW, et al. Transplantation-related toxicity and acute intestinal graft-versus-host disease after conditioning regimens intensified with Rhenium 188-labeled anti-CD66 monoclonal antibodies. Blood 2002; 99:2270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/135\">",
"      Benya EC, Sivit CJ, Quinones RR. Abdominal complications after bone marrow transplantation in children: sonographic and CT findings. AJR Am J Roentgenol 1993; 161:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/136\">",
"      Haber HP, Schlegel PG, Dette S, et al. Intestinal acute graft-versus-host disease: findings on sonography. AJR Am J Roentgenol 2000; 174:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/137\">",
"      Mac Sweeney EJ, Oades PJ, Buchdahl R, et al. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet 1995; 345:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/138\">",
"      Antonelli M, Matrunola M, Tontini A, Diamanti S. Colonic changes in cystic fibrosis: clinical-ultrasonographic features and their value for treatment. Ital J Gastroenterol Hepatol 1998; 30:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/139\">",
"      Connett GJ, Lucas JS, Atchley JT, et al. Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis. Eur J Gastroenterol Hepatol 1999; 11:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/140\">",
"      Haber HP, Benda N, Fitzke G, et al. Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls. Gut 1997; 40:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/141\">",
"      Hahn H, von Kalle T, Pfadler E, et al. [Ultrasound appendix imaging in mucoviscidosis patients]. Rofo 1999; 170:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/142\">",
"      Pohl M, Krackhardt B, Posselt HG, Lembcke B. Ultrasound studies of the intestinal wall in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1997; 25:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/143\">",
"      Ramsden WH, Moya EF, Littlewood JM. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis. Arch Dis Child 1998; 79:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/144\">",
"      Wilschanski M, Fisher D, Hadas-Halperin I, et al. Findings on routine abdominal ultrasonography in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 1999; 28:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/145\">",
"      Bargon J, Stein J, Dietrich CF, et al. [Gastrointestinal complications of adult patients with cystic fibrosis]. Z Gastroenterol 1999; 37:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/146\">",
"      Quillin SP, Siegel MJ. Color Doppler US of children with acute lower abdominal pain. Radiographics 1993; 13:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/147\">",
"      Sianesi M, Rossi A, Miselli A, Farinon AM. Ultrasonic detection of colonic carcinoma in emergency. Dis Colon Rectum 1984; 27:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/148\">",
"      Vignault F, Filiatrault D, Brandt ML, et al. Acute appendicitis in children: evaluation with US. Radiology 1990; 176:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/149\">",
"      Lagalla R, Caruso G, Novara V, et al. Color Doppler ultrasonography in pediatric intussusception. J Ultrasound Med 1994; 13:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/150\">",
"      Lam AH, Firman K. Value of sonography including color Doppler in the diagnosis and management of long standing intussusception. Pediatr Radiol 1992; 22:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/151\">",
"      Lim HK, Bae SH, Lee KH, et al. Assessment of reducibility of ileocolic intussusception in children: usefulness of color Doppler sonography. Radiology 1994; 191:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/152\">",
"      Patsikas MN, Papazoglou LG, Jakovljevic S, Dessiris AK. Color Doppler ultrasonography in prediction of the reducibility of intussuscepted bowel in 15 young dogs. Vet Radiol Ultrasound 2005; 46:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/153\">",
"      Dietrich CF, Brunner V, Seifert H, et al. [Intestinal B-mode sonography in patients with endemic sprue. Intestinal sonography in endemic sprue]. Ultraschall Med 1999; 20:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/154\">",
"      Rettenbacher T, Hollerweger A, Macheiner P, et al. Adult celiac disease: US signs. Radiology 1999; 211:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/155\">",
"      Riccabona M, Rossipal E. Sonographic findings in celiac disease. J Pediatr Gastroenterol Nutr 1993; 17:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/156\">",
"      Bozkurt T, Lux G. [Transabdominal ultrasonography in inflammatory and tumorous intestinal diseases]. Dtsch Med Wochenschr 1998; 123:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/157\">",
"      Limberg B. Diagnosis and staging of colonic tumors by conventional abdominal sonography as compared with hydrocolonic sonography. N Engl J Med 1992; 327:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/158\">",
"      Schwerk WB, Braun B. [The use of ultrasound in the diagnosis of gastrointestinal tumors (author's transl)]. Z Gastroenterol 1978; 16:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/159\">",
"      Wood WJ, Archer R, Schaefer JW, et al. Coexistence of regional enteritis and carcinoid tumor. Gastroenterology 1970; 59:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/160\">",
"      Goerg C, Schwerk WB, Goerg K. Gastrointestinal lymphoma: sonographic findings in 54 patients. AJR Am J Roentgenol 1990; 155:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/161\">",
"      Catalano O, De Lutio di Castelguidone E, Nunziata A, et al. Gastrointestinal stromal tumours: Pictorial review. Radiol Med 2005; 110:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/162\">",
"      Danse EM, Van Beers BE, Goffette P, et al. Acute intestinal ischemia due to occlusion of the superior mesenteric artery: detection with Doppler sonography. J Ultrasound Med 1996; 15:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/163\">",
"      Erden A, Yurdakul M, Cumhur T. Marked increase in flow velocities during deep expiration: A duplex Doppler sign of celiac artery compression syndrome. Cardiovasc Intervent Radiol 1999; 22:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/164\">",
"      Geelkerken RH, van Bockel JH. Duplex ultrasound examination of splanchnic vessels in the assessment of splanchnic ischaemic symptoms. Eur J Vasc Endovasc Surg 1999; 18:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/165\">",
"      Koslin DB, Mulligan SA, Berland LL. Duplex assessment of the splanchnic vasculature. Semin Ultrasound CT MR 1992; 13:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/166\">",
"      Mirk P, Cotroneo AR, Palazzoni G, Bock E. [Doppler ultrasonography assessment of the inferior mesenteric artery. Feasibility study and definition of morphologic and flowmetric characteristics]. Radiol Med 1994; 87:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/167\">",
"      Nicoloff AD, Williamson WK, Moneta GL, et al. Duplex ultrasonography in evaluation of splanchnic artery stenosis. Surg Clin North Am 1997; 77:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/168\">",
"      Perko MJ, Just S, Schroeder TV. Importance of diastolic velocities in the detection of celiac and mesenteric artery disease by duplex ultrasound. J Vasc Surg 1997; 26:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/169\">",
"      Zwolak RM, Fillinger MF, Walsh DB, et al. Mesenteric and celiac duplex scanning: a validation study. J Vasc Surg 1998; 27:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/170\">",
"      Danse EM, Van Beers BE, Jamart J, et al. Prognosis of ischemic colitis: comparison of color doppler sonography with early clinical and laboratory findings. AJR Am J Roentgenol 2000; 175:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/171\">",
"      Gandhi SK, Hanson MM, Vernava AM, et al. Ischemic colitis. Dis Colon Rectum 1996; 39:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/172\">",
"      Ripoll&eacute;s T, Sim&oacute; L, Mart&iacute;nez-P&eacute;rez MJ, et al. Sonographic findings in ischemic colitis in 58 patients. AJR Am J Roentgenol 2005; 184:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/173\">",
"      Beyer D, Krug B, Stelzner M. [Gastrointestinal amyloidosis as a differential diagnostic problem]. Rofo 1986; 145:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/174\">",
"      Watanabe T, Kato K, Sugitani M, et al. A case of solitary amyloidosis localized within the transverse colon presenting as a submucosal tumor. Gastrointest Endosc 1999; 49:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/175\">",
"      Whitby EH, Peck RJ. Case report: ultrasound of primary generalised AL amyloid of the small bowel. Clin Radiol 1996; 51:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/176\">",
"      Barreiros AP, Otto G, Ignee A, et al. Sonographic signs of amyloidosis. Z Gastroenterol 2009; 47:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/177\">",
"      Creteur V, De Poerck AF, De Raedemaeker K, et al. [diagnostic ultrasonography of air in the portal venous system: apropos of a case of colonic radionecrosis and literature review]. J Belge Radiol 1994; 77:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/178\">",
"      Nguyen BD, Hamper UM. Pelvic silicone prosthesis for prevention of radiation enteritis: US and CT features. Abdom Imaging 1997; 22:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/179\">",
"      Puylaert JB, Hoekstra F, de Vries BC, et al. Radiation appendicitis: demonstration with graded compression US. Radiology 1987; 164:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/180\">",
"      Shimizu S, Tada M, Kawai K. Endoscopic ultrasonography in inflammatory bowel diseases. Gastrointest Endosc Clin N Am 1995; 5:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/181\">",
"      Solomon MJ, McLeod RS, Cohen EK, Cohen Z. Anal wall thickness under normal and inflammatory conditions of the anorectum as determined by endoluminal ultrasonography. Am J Gastroenterol 1995; 90:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/182\">",
"      Bulger K, O'Riordan M, Purdy S, et al. Gastrointestinal sarcoidosis resembling Crohn's disease. Am J Gastroenterol 1988; 83:1415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/183\">",
"      Clague RB. Sarcoidosis or Crohn's disease? Br Med J 1972; 3:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/184\">",
"      Dumot JA, Adal K, Petras RE, Lashner BA. Sarcoidosis presenting as granulomatous colitis. Am J Gastroenterol 1998; 93:1949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/185\">",
"      Ell SR, Frank PH. Spectrum of lymphoid hyperplasia: colonic manifestations of sarcoidosis, infectious mononucleosis, and Crohn's disease. Gastrointest Radiol 1981; 6:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/186\">",
"      MacRury SM, McQuaker G, Morton R, Hume R. Sarcoidosis: association with small bowel disease and folate deficiency. J Clin Pathol 1992; 45:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/187\">",
"      Dietrich CF, Braden B. Sonographic assessments of gastrointestinal and biliary functions. Best Pract Res Clin Gastroenterol 2009; 23:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/188\">",
"      Gubler C, Bauerfeind P, Vavricka SR, et al. Bedside sonographic control for positioning enteral feeding tubes: a controlled study in intensive care unit patients. Endoscopy 2006; 38:1256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/25/32154/abstract/189\">",
"      Jenssen C, Dietrich CF. Endoscopic ultrasound of gastrointestinal subepithelial lesions. Ultraschall Med 2008; 29:236.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2565 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-200.215.4.194-8300F9CC1D-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32154=[""].join("\n");
var outline_f31_25_32154=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3359654\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TECHNICAL CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Intestinal wall thickness and sonomorphology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Color Doppler imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ADDITIONAL SONOGRAPHIC EXAMINATION TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      APPENDICITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      EPIPLOIC APPENDAGITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIVERTICULITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CROHN'S DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ULCERATIVE COLITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      INFECTIOUS ENTEROCOLITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Salmonella enteritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Campylobacter enteritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Yersiniosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Enterohemorrhagic Escherichia coli",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Shigella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Vibrio cholera",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Intestinal tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Whipple's disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Virus related enteritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Cytomegalovirus colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Giardia lamblia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Amebiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Cyclospora",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      ANTIBIOTIC ASSOCIATED COLITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Pseudomembranous colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Penicillin-induced segmental hemorrhagic colitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      NEUTROPENIC ENTEROCOLITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      ACUTE GRAFT VERSUS HOST DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      CYSTIC FIBROSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      INTUSSUSCEPTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      CELIAC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      BENIGN AND MALIGNANT TUMORS OF THE SMALL AND LARGE INTESTINE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      ISCHEMIC COLITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      AMYLOIDOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      VASCULITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      RADIATION ENTERITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      SARCOIDOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      BOWEL WALL THICKENING DUE TO HEMATOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      FUNCTIONAL DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      RECTAL AND PERINEAL DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      OTHER USES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3359654\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2565\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2565|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?22/11/22705\" title=\"diagnostic image 1\">",
"      Normal appendix US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?43/43/44735\" title=\"diagnostic image 2\">",
"      Appendicitis ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?17/56/18312\" title=\"diagnostic image 3\">",
"      Diverticulitis US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?22/3/22579\" title=\"diagnostic image 4\">",
"      Crohns B mode US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?20/41/21139\" title=\"diagnostic image 5\">",
"      Crohns disease fistula US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?11/0/11269\" title=\"diagnostic image 6\">",
"      Ulcerative colitis US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?7/4/7235\" title=\"diagnostic image 7\">",
"      Infectious colitis Doppler US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?8/29/8659\" title=\"diagnostic image 8\">",
"      Metastasis small intestine US",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2565|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/15/27890\" title=\"picture 1\">",
"      Pseudomembranous colitis US",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2565|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/60/4043\" title=\"table 1\">",
"      Bowel wall layers on ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/48/20239\" title=\"table 2\">",
"      Accuracy US acute appendicitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/33/7710\" title=\"table 3\">",
"      Accuracy of US diverticulitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/35/28208\" title=\"table 4\">",
"      Accuracy of US in Crohns disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/58/13227\" title=\"table 5\">",
"      Accuracy US in Dx IBD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/27/18875\" title=\"table 6\">",
"      Accuracy US ulcerative colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/57/13213\" title=\"table 7\">",
"      US patterns infectious diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/27/3517\" title=\"table 8\">",
"      US findings antibiotic colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/6/35947\" title=\"table 9\">",
"      US findings celiac disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/38/22123\" title=\"table 10\">",
"      US findings active celiac disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/40/31370?source=related_link\">",
"      Acute appendicitis in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/61/19416?source=related_link\">",
"      Acute appendicitis in children: Diagnostic imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/17/32025?source=related_link\">",
"      Approach to the adult with acute diarrhea in developed countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/8/26761?source=related_link\">",
"      Approach to the patient with nontyphoidal Salmonella in a stool culture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33206?source=related_link\">",
"      Chronic mesenteric ischemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/23/37241?source=related_link\">",
"      Classification of and approach to the vasculitides in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/6/34919?source=related_link\">",
"      Clinical manifestations and diagnosis of colonic diverticular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/22/25960?source=related_link\">",
"      Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11386?source=related_link\">",
"      Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/48/31493?source=related_link\">",
"      Cyclospora infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/28/33224?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of giardiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/16/35076?source=related_link\">",
"      Epiploic appendagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/63/12280?source=related_link\">",
"      Gastrointestinal amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/19/18745?source=related_link\">",
"      Microbiology, pathogenesis, epidemiology, and prevention of enterohemorrhagic Escherichia coli (EHEC)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/26/39334?source=related_link\">",
"      Treatment and prevention of Shigella infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13450?source=related_link\">",
"      Treatment of acute diverticulitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27125?source=related_link\">",
"      Typhlitis (neutropenic enterocolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/30/21992?source=related_link\">",
"      Ultrasonography of the hepatobiliary tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/35/11833?source=related_link\">",
"      Whipple's disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_25_32155="Heart rate maximum reserve";
var content_f31_25_32155=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F50179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F50179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Calculation of target heart rate maximum reserve",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Lower Limit (60% capacity)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Upper Limit (80% capacity)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximal heart rate",
"       </td>",
"       <td>",
"        180",
"       </td>",
"       <td>",
"        180",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Resting heart rate",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heart rate reserve",
"       </td>",
"       <td>",
"        120",
"       </td>",
"       <td>",
"        120",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exercise intensity",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        72",
"       </td>",
"       <td>",
"        96",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Add resting heart rate",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Target",
"heart rate",
"        </strong>",
"       </td>",
"       <td>",
"        132",
"       </td>",
"       <td>",
"        156",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     The resting heart rate is subtracted from the maxima; heart rate to calculate the heart rate reserve. The heart rate reserve is multiplied by the desired exercise intensity (0.6 or 0.8 in this example) and the resting heart rate is added to the value obtained to estimate the target heart rate during exercise. All heart rates are in beats per minute.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32155=[""].join("\n");
var outline_f31_25_32155=null;
var title_f31_25_32156="Stool culture isolates";
var content_f31_25_32156=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F82535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F82535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Isolates recovered from stool cultures performed in the United States, 1980-1997",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Reference,",
"study",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Number",
"of cultures performed",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"        Isolates",
"recovered, percent of cultures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Total",
"       </td>",
"       <td class=\"subtitle2\">",
"        Salmonella; Shigella; Campylobacter",
"jejuni",
"       </td>",
"       <td class=\"subtitle2\">",
"        STEC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Koplan, JP, et al. Lancet 1980; 2:413",
"       </td>",
"       <td>",
"        2468",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"       <td>",
"        2.4*",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Guerrant, RL, et al. Bull NY Acad Med",
"1987; 63:484",
"       </td>",
"       <td>",
"        2020",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        1.5*",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Siegel, DL, et al. JAMA 1990; 263:979",
"       </td>",
"       <td>",
"        1964",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        0.6; .2; 1.2",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ova and parasites",
"       </td>",
"       <td>",
"        1423",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clostridium",
"difficile",
"       </td>",
"       <td>",
"        2668",
"       </td>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Choi, SW, et al. J Clin Microbiol 1996;",
"34:928",
"       </td>",
"       <td>",
"        1800",
"       </td>",
"       <td>",
"        2.9",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Slutsker, L, et al. Ann Intern Med 1997;",
"126:505",
"       </td>",
"       <td>",
"        30,463",
"       </td>",
"       <td>",
"        5.6",
"       </td>",
"       <td>",
"        1.8; 1.1; 2.3",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Voetsch, AC, et al. Clin Infect Dis",
"2004; 38:S190",
"       </td>",
"       <td>",
"        339,000",
"       </td>",
"       <td>",
"        2.9",
"       </td>",
"       <td>",
"        0.9; 0.4; 1.3",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ova and parasites",
"       </td>",
"       <td>",
"        217,886",
"       </td>",
"       <td>",
"        2.1&bull;",
"       </td>",
"       <td>",
"        0.9; 0.4; 1.3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     STEC: Shiga toxin producing Escherichia coli.",
"     <br>",
"      * Cumulative percentages for isolates of all 3 organisms.",
"      <br>",
"       &bull; Cryptosporidium, 1.7 percent; Cyclospora, 0.4 percent.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from Guerrant, RL, Van Gilder, T, Steiner, TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32:331.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32156=[""].join("\n");
var outline_f31_25_32156=null;
var title_f31_25_32157="Serum IgG levels less than 5 y";
var content_f31_25_32157=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F73913&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F73913&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 485px\">",
"   <div class=\"ttl\">",
"    Serum immunoglobulin G (IgG) levels in the first five years of life",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 465px; height: 281px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Placental transfer of IgG provides the neonate with a serum level that is usually slightly higher than the mother's at the time of birth. These antibodies are decreased by at least 50 percent in two to three months after birth (red line). The rate of the infant's IgG production becomes greater than the rate of loss of the mother's IgG by about four to six months of age (blue line). Serum IgG levels increase gradually in the first three years, then plateau at about 60 percent of the adult concentration, while the rate of increase becomes very slow. Normal adult levels are reached in late childhood or early adolescence.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Johansson and Berg, 1967. Reproduced with permission from: Bona, C, Bonilla, F. B Cells and Humoral Immunity. In: Textbook of Immunology, second edition, Harwood Academic Publishers 1996. Page 116, figure 5.I0. Original source: Johansson, SG, Berg, T. Immunoglobulin levels in healthy children. Acta Paediatr Scand 1967; 56:572.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32157=[""].join("\n");
var outline_f31_25_32157=null;
var title_f31_25_32158="Red blood cell EM";
var content_f31_25_32158=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F72999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F72999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal red blood cell",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 302px; height: 252px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD8AS4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5u3E4GOlAbIyeT0oJATjOfWmkYwc4zyKzIJCV6Hn6UgAGcng03ogOPfmlAwPXPrQA4YRmGCQR0pMDH15pOjDH60KNzHJwaYCqw24yc0/PJ3fhTAFAHr607LMT0xjk0AODA85PPamHke+acwJzwc03qAvIIpAOz8gwMGmtnn26mlUgDnkdqCSGJBJzQA4Agbc544oGcFcdO9KpBUY4PekAKkZwQaAAqc85ApWGCOOvTFI4Jbjoe1LsY+pJ9KAE/iHoKcoOzsc0mw7Tnge5pSdyAc5HvQA3I7HrTZM5ORx0zTwuMjncBmmlM8A896AE+9k5PSkIIYc01SQD604HnI59c96AFdAV4OQBmm54HH5U88Dbn73ambduTkECgABw/SnM27GB2poK5yV+tO5bOwHGaAGjbuIbBz60zO09DkHilyd2W7UrbCob+LNMYZycnOT1pCecL096X5flOTTCMYGelADxgrkZphYnIyBSnPUHimkg5yKAFBGDkD0poyeTnmhjgDb1puSO/HvTGSg8HbyKYp65HSmjJB9BRxgA0AKWJFNJ45FKTg+1Ix+ooAlV/l2tnBp5PO08kU3b1/U0AdcHketIkUZIOelDAqc85xxSHjjPFOGC2BQApxxjj/GkPU4PFPUdQRyaQgAk5zjtigAUAkdBS9wOMZ5pFC7yR26U4gggMOD0NIBxO4EgcD9ajH3+eB6mp2IOMnOOnFMC8DI4JoEIVAPPftSqChweaV1IIwKVAW3ZGDQA4lWxxzikZCFGDyOKCOVB6gcmpIwASRknpzQBAoI980/b0weal8r5iOBQEIVs8Y60BcjkU87eRjFRqrYznnGOlWdoHTuOPamhcHn5h0wDQFyIArkk5HegAMw9TUwQDOQcU6VP3YyMHqMdaAuU3Ta5DGnrFkHnPGaVuzHJx2p235gexOMUARyJ8ilSMDv70mCSQpwc4xUgG0NwCO4pEz2GCRQBDsPzZPToPWkUEIQOGB7VN/D0JYHvTWTjcTg5pjIhnHIJz7U5wADgUpB5CngetDgdx07+tAEe0scDtzTcFic5FTK2OQuSeopxOQGx06CgCAqcEk4z2pCCAM8inlwWG88elG5d38hQMYVI6gAe5pmPUd6fJywweaQMenf6UwDHUHPFNPJ4/Wnk5GTTMgk+lACc4OACKaRnoKdk9O1GBk4yaBkwGAP5UoOecYOMUjc8e/NB445zmkSOyB05/ChPvkgf/rpvIOc05Q27C96AJMMoycZPFNIBwp6mlHTknmnLgSYOdvtSENA25IwRSgE8gEsO1Lwp7+wp65buVPc+tADBlcjnFWFHykAce9M2c5PAzS4O4gHikA7kxlvwzQFHA68c+gp5BOMcZp6A7wMDJoERqvXHP9Keo8zgKADU0aDe57HotWEiGDt5x0GaLiuVAgRsFhzx0pFQHGWIUc4x1q6YNwO7nnJ9KcIgj7SDtz6UriuUjEzk7ceuQOlAizkdTWkwXyd0a4bn8aSOLcWfGRj070XC5Q8rZ2OB1yOtJLG0il9pA7e9aCRYQndkejCnvHiBXPBouFzHEeSB37+1NZTjd05q/wCQwDN3J6Y7UnkOgXIyh5I64ouO5TdVWM5B8zqagVD17EVflhJYt26A0wR/KOMk9qdwuUCNrqQ3XrjtSlckkHaMd6tBMnBTCg8io2Dc9uehp3Hcp+USSev40r5BKn8KsyIpAJ654NNMW4cg5A4oHcrD0x7c0j5C8H5alWIq2W+uM9KYybjxz6UDIGTC5yMnpTl4ByM05FIUkpkDnPpSZ6k5A9RTGNYnPB9/pSFuuV/GnAflS4B6HnrTERlhzxz0pAMMO/HPtT2AxxnNIV4bnDUDI2DAZBGKF6dM0HJOAenegcds0AXAMjp2701sjGcZpMnAHUUi8cnnHrSJHkZHB79KeqAfdPHekLZI4H4UDIG4DOOM0hCHghR171I8argrke1MXByMHJqU7m6jHHBoAcq/Lznn7tCISxXgUKWBQgnI9amGdxzzikK4zywG+ZTuNNCEkbQeuKmcOWV8nr1qbYeGLHOemKLhcjxwD/EOKljieQ4PAIyO1S+VtUDO5s5FWY43LrtG7jv2pXJuRLEI14wT0+lT20ZQE4UitnTNDvNS2xWdu8rE9l6/WvVfC3wrjh8u41yQNx/qU/qahzSIckjyzStBv9SjAs7OSTHHC11Vj8Ltem2tJHHCvX52r3m0traxt1itIUjjXjAFOecdzxWbkzN1DxuH4R3z4Sa7iRe4AzVp/hAy7Nl8uO/y16mZWVwc8dOKBcbsHnHpRdk+0Z5LL8Ip9pP2yNmHQY61lat8M9VtYC0Ma3GOyV7kZQQRkCnLLnIDYxxRdh7Rny/qHh3UbMkXFpMgA4ytZItZFyGbC9CD1r6ylSGddsqo2ezDNc9qngfRtSD/AOjiJ2/ij4p8zKVXufNBg25RemflzVfy23HIHHQCvYNf+F93aRM2nSLcoOdhGDivPtQ0e6sJPLuYpIGGdwZcVamaKaZy8iAsWVT71Bs3F2z+HetmS3U5C898+tUJomG0rjePm471aZaZn7MEBuCO1K/GAeR2xU0kZbLSfeJzxVd1YoCM8nNMpELHLEHJHpTTuwQnSpVG5uMAd81HIpA49e1MojHIb0PYU05HbpTmBHpnFMIweRTGJ95sDgULkZHP4U3J3elPUBcZ9M8UwGEkDk8etO42kbufalIPI6qaaWzgADmgBj44A701hwAelObr6EUh6Bic0DLKrz0+lCqM5yOvegkDJbg56UpAbG0c+lSSH3cgdf5UJnBGeKXn/wCvSxr8uCCMd6AHAA9yPeneYypsJz3zShSASenekDZzx070CJYSeO/rTsjzD156UDBBX24p0eCozyRxSJJIQAcnIPYetWY0PmDJxz1pqLvQFAxxW74Z8PX+u3iW9lE0hbrxwvvUt2JbKlhY3N/OkNvE8jscKEGTXsXgn4ZLFGl34gPznpAOMfWuy8E+CrHwzbLIUE19j5pSOn0rorghwQeM96ycrmE530RHptnaafEEtLeKED+6KknmyV6nJqEuIzgnPFRSS7h06VNjO495JB0bIzyDSFl289KgMgGe4FQefuzvH4UCLTtg5zhaZvLfc6Cqf2huVHWnF8ISX/KgC5vBAweaQvhwQxBqgkihSd2fTmnGc7RtwTQBo+cpwd3TtU0c/GP5VlrJkliD+Xep4pMfePApgaiuG4z1qlqmkWOrRbL63SRccEjmhZhkZxz0NTrJhiM/SmB434z+GVzab7nRg00GSSgPzL/jXmGo2TWspinUq49eOa+ulfcMCuF8f+BrbWbOW6tEC6ggJGOj/WmpWNYVOjPmtoj97nbUUgVVG7kEdB2NbGoW0tpcyW08bpJHwQ3GKy2XIPI44rRM6Eyk4CsCAfQ5FMZt6jAwKnlwzZb069KrhSBzjr69aotEedqHjpUUjgMpHPsKsbVGSevcetQsm5iygYHamUhob58j7p7Uoyqhj9CKCpYgN9BSKODjrnrTAQZAOOc96aeFzn5gfSnN6K3FN6KRnp60wGuSSO4o4IALYxS5yeMcUpUAZDDNAyYnKkA9DT1YHHGGFNICtyfypwwdwPA7GpIBTwOMiptwJ2k8VAVIQbuAadjH1xQBLgGTJIGKCvOfX0FNVcHnk96VRgEsfqvpQIkUfvOPTB9qnUlN+0Bjj8ai4HCfianjBeYFc8cD3pCNfw3pd1quqW9paJvmkYAD0+tfUfg7w9beGdIW3iCm4IzJKByT6Vy3wg8GR6JpMeq3aZv7hcjP8C1308g5J44rCTuzmqTvohJJt44PPrVVjtJy1RGbAK9garS3BIIHrUmZaeQFgcgVWklIHPQmoDMpJIBzg1FJIRGR0xz9aBEkkm0HGf8AGqstyVwOwHWqdxd4fHAJ71VuL1VfYH5647UAaUl0jITuw2OlU5LwKuQ2cjv0rEur4Fj5bAOBnGetUnvw8QZR970PenYdjpGv0TaDnfjNTR3isRtJzXBXF+xkZgWKqPvdMVNZakZ4VZpRuUgdadg5T0SC+XB3Dn1qYXWWzwVPGK4+1vd0mVkDK3atSC6Uk5IHsaVhWOjjuAz4Tt29atxT569utc/b3WTuY4xV+KRnAbBz0zQBtwyAEADjrVtGDDmse2lydufmFX4Jh5m39aaA82+MfhI3sI1ayjy8YxMFHJHY14O8OCR3NfZMqxvC4kAaNgQw9RXzd8S/Df8AYOss0CMtrcnfGx9PSqi7aG1KfQ88nHG0cDvmqvA4OAelX7hMs2CpJ5qo42g7lOSOM1qjpREw2DnOPembcMCx6jPFSScHDEmoXz74PFMpDXI/i7mkAGSAcjrihyBxTRjPBxx+dMYjZGfakGD14FSYIUfr6imkjZzzg+lADXAXGO4zQDzjOOKRjubp+Ip6Ljp0pgWCvzccijKjsOO1NUnAzwaeuATwDipJBTheQSc0pOACcD3pgzvJGST0qTBYN3I7UALjjOQOM/WlXkEsPlJ601WHHAz6U7OMq360CJVyW4B5GB712Xw20Ma74ps7ZhmJTvk57CuNhY4yBwBwK98/Z80cRWV7q8qYd8Rxkjt3qJuyM5uyPXpWWCFI4/uIMKPYVnXMu8ZB+lSXbZzhqpkkL83JrA5WQzN0AOcVWdsHcrAgcEVLM27IDdO9Vy23qOM80hEEz7RktjJ7elVZZ9r/ADAhTUl2fkbBIz0FZl78lsS0nzHqKB2IdQuFB3Rn5TxisG71TciJ9056nqafqdyBbrtA3L15/Wudub5GjbcmXVuDntVLUcUWbi9P2hychgMgjpVE6iSFZucHhV4qncXIli3FiBnGKzoT+84PyngVaRoomh9rMsr8MFGeM9aVJ87VK4weQODVCYsrk7sKOvvT1uiqsU2Y45607FWOltLxYG/dfP6nP3a3rfUTPKAwHTpjhq4K0cbyEAy3OSfzrpLCQqEdW5IAxjpUtENHbWVzIVGExg4ArctWaRgSeB2rl9MdhGoc5X17it22fyyke773NIzZsxuvmcHB9SKuQ9SR27ms2CNY+pzV5DjgHJxSJNWGTPHA9a5r4k+HB4j8OTRRqPtMQ8yJu+R2rbgJUAjJ+tX42DIAeTTGnZ3PjS4ie3leN12urFSD1qpKQT85GBziu++MOnjTfGFwqJtjl/egDvnrXAynKl9nynvWsXdHbF3VytINygg44qFmGQB0HXipU25yDj0yM1Hkc7Tz/OrLInGCCB0pAuXY9+oFOLZGWH4Uh4OTuBpjGbTzz1NGACQQeOaVc9hx3oXBJ9SOlAxgABx096dwB83egYbbnjFGFI5OR7UwJFP3c9acCTnB49qUdBlSR6elOAAXIXp1NSSNX73PHHSj+VOAL5IJyOvFK5ThcDI6mgBO+QOlKcghj6+tNBLLwM47dqTaV+vpQBah+Z1HTJHOe1fXvg6wg0zwrp0FvjaYgxb1Jr5BtkJkTawPIzmvsbRBt8Paeo5/cJj8qyqdDCt0H3TjJIPSqTvhuv3hxTrr5XyW+UdTVN5geAcsKzOYbIQ2cKcE4pSoZcEZycU2BS7ZkIx6elWVKRoBnI96QymYtr4dcqe57VS1C3BRiEBJ4OR2rp0jR06e9KbRJFIxkEUWA8l1yzYXPyIzx7eAONprldQtRHK+7H3Rxnk17Ze6SocjaBnrmvP9d0ry7lwIwjdmz1pplRkcKqZQDaMA85qjjbMcZGM4ArTuYRDIVwwZs5GOlULmPj5TtPt3rRGqIZmLAZbnr9akgIb5FGQBk9qSPGdsinnocVdhsZbgHy4wAB19KBsbZxuPm2AE54HOa6DTJHEkceeSOQO1VdO0iUtExclRwx9K6zw/4eIvRJIN8Q5AqWyG0bGkWUhQ+cAAOnHNdDFEkSoh54zk1EkJL7YuABgY7VYkATajdTUmTZKCAchhxU8LDOfWqLAnBAOc4AqaEnacn5hQI0IJcvgk+1acJ9+tYiKA3yMc1oWcjb+TQI8k/aEtAsun3YTJZSjH+VeJMBgnnA7dq+ivj9bed4UhmBwY5RXzmxKKfnJPStYbHXR1iQsCCckZ9fSo2UDJ3Dintlm3DkDqCKjc5GdtaGw0sCfrxQQMHr9KcSBz/CewpOFHy5JIzTGMfCphQDjrUaFdxyMd6kkO4jG0E9s00ghiCAKAGKp35IBBpxB3EDGB26Uq4HCnJ60jH5un59aYybOOCQfQ0deM0AZVQO3bvTsZPtUkChip9McZFB6nODnimBuSevoKTo2e5NAEm0EcgggUxWJGDjHvQ+Sdw6GmZAbBGe4xQMejEH5TX154GuxeeDdKl3EkwgE+4FfIO7PWvpX4I6h9t8BCFmBa3cpis6i0uY1lpc6u9n+chOf5VnNcNuJXkdMehp99P5e8KMAVnPPhwJDgHkY6VkcxdhZjuZjjFWYiXHzsfw5rLL4b7+M+9Sw3IVyQy4x09aAOjtXRVX5sg+9XYupIbg1zEWoqVwRx7Veg1NAwUZ56mgR0hjW4iKuAaw9Y0WOeLGAcVet9RTIVuPetBTHJ3zTA8xvfBkUzFw2B29c1lx+FDFI4cb4hxggV64bVCxIP4VVm0qN+Qefegd2eQt4VUvhUZOfrkelbNj4aQLjYVP6GvQY9GQNkjj0zV6OwhQZwOKAcmcTY6CEHKkj0xW/Z6aYlGUx6AVtgQoPlwM1HLcKq4B6UWFcz5rURJ8oCt/OqsynK5UbfWrs0277xHFZF5cswYYyAaBDnuEX+MenNQxzZkO0gH3rOf94WRSAT3zyKWOVAVDt0GM0gN6FyzjOD2zV+D5XHJyaxYTtcFK17RssufrzTA4/46zCPwNIGAJeRQK+aXdjyOBjvXvH7Q2pRpY2FiX+dmMhUenavA5GxnOSvpWkNjsor3SM55BbB/mKi3YBHIPb6U9hubILZP6Ck2gFQpBya0NgOMA9vf1poDHocCnsQBz64xSchQo7nOKYCY7sc++KTduO0dB60pBCgFs/0pY03AjIz70AMXAAJ/nRwQN2frS9VCgcDvTSM8kZHbmmBMTzggjjr60jE8gnI9qVmJIznGOKHO0YUHcRUiEGXIzwe1Kp+Vg4HsaRGOcMRS4VlYsSBnIoARiNoweCe1Nyc89aCCo5FNkOfqTx6UDHdc8CvYP2d9YSG/v8ASpGGZlEiD3HWvHC2G+YfMa1fCmryaFr9pfxsR5TjcPUd6JK6sROPNFo+ndXVxO5YjYOuemKxGmjDHccqTwavahfJfabHdwuTFOm4Y7Vxd3LIwbEpjUDuOTXPY40rnQ3lyFBkMgAUcDNVEv1eFpJAEXGFKnvXPS3irGTNli2Nob0pLm8jNssIkAdhnGOAKdgsdPHfeWsbDkZ5IParkV9GwGxwFHOT3riob+MW4XYxkHy47H3pv9qMq7SOVHFFh8p6BDqO9zsOQowTnpWxBqkkaqSw5XseK8r0/WGhIVm5zkkdxW7b6krD922V6gUWJcT0a21hWXJccdeatLqgOCCNteY/2qHlcbgmOeO9aFhqiyxna/A6E9/pSFY9Am1UBwAwJxVN9ZBZhuGK5F9SMmCcYxyaqHUAzsFYDaefTFAWOzfUSrgFsjqTVG41XKlh93PHvXLyakPMOHy5/lUM+oqIxyoJ4GTmiwWOm/tUNkq2eOAaqXF6GC7Ww2OnvXJPqObnJ2rGPlwPWrhuU8t2zu29GHWiw7GuZlLE7zuIqW3cSYYncF6VzQv90qyRD5fun2rorOVQAu4K/X2NFgeh0NrcB3jJxyMcVtWGzcXYgKoJbPaudsjuVFKgH1FYvxU8UJ4f8KSW9vIFv7weWqjqF7mhK4oq7sjyH4seIBrvi26ljZTBB+5jx6DvXESH5shst/OmtISxdic/zpVzjkDnnFdCVj0Ix5VYcpG0Hjnk59aa7biMDgU9XBkw3THFMKAlsZ54yaYwMnGGA9KU427t3I6U1hgAkcjtShwDj8jigBScMSBzjtSLnGefQUZA3AFST3poIHfj2oAXGGGSD7CmnHQHHfmgc5I6D170qLnjGCKYDiGOCvb1pxY7QDjPXNMOSxG7n2oYqGCg5460hD95P9TSSORx2bsaXOTz+FI4yQxxjGc0AKHYLhvwppBb7wHHalCgpluD2qMkHoee+aBiE8YP/wCqkY+hJHvT9u4YHHpTGBHtjvQB6h8K/EbzQvoF3Kcvzbs3OP8AZrQ1uaa2mkilJO0+leR2lxNaXUVxBIUmjYMpHY16hP4gtvFGkxS7hHqUCfvE6B/es5LW5hUp2d0UXuy7KSd3oM4Apk8yoykEs3c/0rMmmw20j5sfdFRCQKwBPzL0WiwuU2JLlB5YgdgT1B7UxHdZS0hG71NY32kvuIG3Pv0qUznILSAj0NFh8ppi6IlXzSfwq3DekZCMw/TPtWELlRkEF89KkWZkkXG3j19aLC5Tbk1BmhYHA9MdRTra/dUQJM2M9M9K59bkknJGR2p0M4TIVgAefxosHKdYupuodCwUMOcGmJqrxsMfc9R3rmFu3IZX4z1OOtMjvGYkcjBx7UrC5DpBfyecXbJQ5wM0173Lp3PIx2rBS8V2be4K9hUv2xT2+70xxRYOU13u5WlwG2+u7pVq1EjrJskIC8/WuaNwJCTk7h3q5Z3u1nb5gQh280WBxOlScGPcWHzcYPtW1YXSSyxLGNzFQeDXn0NzJJOqbCy59ea7SzuNO0nT/wC0NTbyIYxwnRpD6AUmiJRO01HWrXw9ozalftjy/lVO7n0FfOHirxBd+IdXlvbx2yzfIueEXsKueOPF134ovwz/ALu0i4hhHRR6n3rmwc4zjrWkY2OilS5NXuPBBzkZ9BTlJJHHOPyNNz2A/Kljx379cdao1HY/hI57GlOGJDULgMcA47ZofkY4wOaBCkANgDIA6GhAFB6EdOaMb+h+bHNIowpYkDHb1oAaygk47U3aCQTwR2p6cuT0wKblgd2KYDZCR0Aokc4HWlOR1OT2olJcAmgY8AISBk/WjCjB4IP6Ug2luuRSDHQ545xSEKT3P/16AcSE4yPQ04YUnGAKEclscGgBxLE528elMGN3PbrTm4GORUZBbO7qe9IB2VwTz7VEST9KmbZgKRj3pkrADCnOO9MCNgRjuaIZpIHDRMUcdxQ+ew5ppBIG7uOtAzZg1VZ9vnDbJ3IqUy7wHU9c9PSsArgZPNSW1y8Lccr/AHTSsS4djYadiuBjbnvTpJtyAHr2rNa7Er8/ID1FSF/M+VDwKLCsaEcqqp3HPpilW53NGAuT2zWYWYAjOTTo5mGB1IOc96LC5TR81WlLFfm6e1K0wDLtI456VlGb943PPSnI+0biefeiw+U1nujhssAfSq7SNHgNk55qp9oBADHJzTA5kbPX0osKxpxTqqtnhuowKGmYkAEEdTnvWas3yEAHr680+OR5CQqljnoKLBY04ZwCq4BzWvp9u11LsiX6nPSubDJbgmd9pP8ADnmm3mvTPbfZ7MeRHjDsD8z/AFpWuJxb2Owutc03w8JFh2Xt+w4xysZ9zXC6vq95q07S30rPz8q54X6CqC++TnvTsEdsmmopFxgogmOp6U/PHHSgJnG089TSnoV7+tUUKflAHRj6ULjHJ5zyaXOSMfe7UqAZO4DnikAseeSD+dS9D3K/3aiCYQZzgUu85BU9PWgQEjPX5ad8gXjIzx600lc/dxn0p6gbCWGAehpgJgEkkYGOmaa2MD260SLg5yefWmHJwe/YUAPGG7D8aik6DBNKQSOQQaRgccCgB6qofA5pVODwvzUyP7/Pbpin5bAIGCf5UgAEliMc0BdjZ2j8+tGEzjd70ANx/WgB28HjPB60w4A9x0pRG24HA5PSgYDHHUetACOQWAOQccUsi47fjS8FhnPr0pzkDG3pQIYV2nJIP9KY6nBwc4qRiCvXAHPHemlVySOfxoGhCMoN1Q7cn054qQrkZJzjtTQDtJYYx0NAxjZwT3oBOKdguM/rSnC8daYwWVkBwfwpfOOST1pAuCSe3Y0gXnPb3oEL5uD0+lKsnUM3B6mo9uSTijbgkYoAlEuCR39aGm+YkcH2qEr6UoQ4JNAWHiY84HJHNBuZV/1bbc/3eKag3Hpj0oK7c0g0E+Ykscse+aVcEdKcBk8c05EweeB3pgNICj1JpdvdTn2p2AcjsO9BXI4xk9KABQRycgdzRgc7cnB70qkkfLnIpynDEHnI5FIBu5eCvWlXkc8DuaQDCHA4oGCh+YnsaBEhyqfMNwJ4ppZlUnHXrRwCTycetRlgc4BJPqaYCsVydq09DtXDHIxTQPlByevNBOVAUcUAOztXlsgU0YIPH0x2oC+oA44pUA78E8UAIQWYcmlOGOCccUKAoGTuqNmCNkjOaYx4UE9SAe9LnHHYZpG42gdDRkjKY61Ih5ZcHdz+FGflbAz+NMUDawBJb2qReANwHt6mkA0l1VTwN1JnDHPOOOKGU7sE5NIw5JHDUwHoxBHIIpoGZD6E0oxyduB0pGPAA4BNACt/d4z6eooXAzuOAeOOtNfqMfnSZXHANACMFI65we9IDnqM0pHUfpTgp2gY5zQMjPcAdaXB79acUAIBzQgGQOtADRuxg45pDkYHepguVzjHamqAwHB470ARqRnoeeKaADwflyealVRjkY7/AFo4znoTQA3HT2oJ2j1P8qcVYqCckH1pCB7jtgUANVSHH86VlPU84pyrjceTmnMBtIANADNvzLtPBp+Mjrg9OBSbQcAHLDinsO4OcUCGqQAQQAAKVjjoykVGisXPUjuaey7SMKPrQAnOT278U3cSxz6cU8Y5GSSabgAkDOB3NACbsjJPzYp3QDIHvSAZUZyDSsPuk0DHEkr0pm3aM+vtTwd2QW4HYUnzFD320CBFUDJOFP50hyzHbjA9acwDYwODSZ4wG+X0xTAQj5MljnHFIrEk8UqDP4Un9/aeSeRQAANglefamEnJIx+NPU+WOhyR3ppDY+YZHbFAx+BxjqOeTUiZI3EYH1qMLg8HmpV+6QCKQhhX0BHpinRLgjBGR600kk9cU5ARzxluMUgCVvnJPHNJnMmBxjvT9qlcMce2KYCu3ABznrQIVVAUrxuprA9M9KVDkkYAp2BGRkd/XimA1ozt4PXpimhQQFGBj86ezZHHX2pADuOT+dAxgTB56n1oBIJz1HenYz0NCr8pGAT60ANY8kA9qE+X733qa4568HpUikKRkduaBgXweckU3HzcN2zx60rsSM4ABpVI54HIoELH94scUmFyTjn0p7Y2ggYJFMA9xkcYoAUKQPQY4FRknYR0IqTGV68VERgkde30oAdgYPPvRtHJBzTlzt3dADg0KPkb065oAYQeOo4605RzweM+tO5KkZAzRGi8+3egBFdizAdB/Khhk5H6dqlhIWTscdmpjgtIX+XJOAKAIxjZlhlumalaM7R6HsDSMqpvPXt9KRJDgDkDPJFAAcIhUEmowCcenankbcgEnNKqnO3IB96AGnCDKggkU5SME8j1oYgZyfmHHFRLgEk454xTAk6R5HfpTdhHBPPelPAAHHPT1oBAGe/pQAgOw9z9KARyeOe9CIxJ2d6AAMHg0AEgGMgjtSHcMYYgdaUscAbeOvSlLD2zQA4If4fun3pwOFIIxjv6UjDaFIJ55/SlhHmH5ietSIa8gC4A5oG47c8jPWn7QHfGeKUgbR9aAFAbBycE/rTSQB85OD09qSIks3NE56exoAd5alcgkAn86Y5CkD0pUJ3AZOMHikHPUDrTAaAQCSMjPanKMkcde1PZivygAA9qjJIkTBIzQADbgg5NCgEkY4xTk/1j/Sowx259DQMQDdgMOlPZQATn6Gmt/q+ueaenMbfTNADecDOCBzTSSTx27VI/3SaYrE4GAPpQAZ3cnP4VKq8BguQaY58uUhcU6JQUz70CY3d8v3cd8U44UscdR6VJEoIGfWmn7xBoAVBhRgjmmumM4yeM4oX5jyB+FKpLDJPPNADVQhs8Z9zTfvJyxXtnFPAzJz600ncdh+7k0DEG5ieBx696Qbm9gO1WJVVYeAAeuahT58bqBXG9jg5BH5UfdGc5DdKD+7jYr1NKAGTJ9KBgPlGW5I6Ckwd7HI57U12Kq3+cU6Lnk9RTAaCMYI5pqE7gCCMHOakH3ue5qKQYcgdjQA7JJO/gjvTVb1//AF088YIpnfpQMfnAIVsLSnBODjPamE4JXtS5+bOBQICDuAGce1JgN3Ax7U12O/b2pQccCgZ//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scanning electron microphotograph of a normal adult human red blood cell. Note the biconcave disc shape, which gives the cell more surface area than a sphere of identical volume. The normal red cell is thinnest in the center, resulting in the central pallor seen on the peripheral smear.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stanley L Schrier, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32158=[""].join("\n");
var outline_f31_25_32158=null;
var title_f31_25_32159="Hulka clip sterilization";
var content_f31_25_32159=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F63446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F63446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clip method of laparoscopic sterilization",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_25_32159=[""].join("\n");
var outline_f31_25_32159=null;
